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1 Summary 
1.1  Summary 
The C6-dicarboxylic acid adipate is one of the most important building blocks in the 
chemical industry. The chemical syntheses of adipate are connected to insanitary and 
environmentally harmful reagents and catalysts. Therefore, the establishment of a 
biotechnological process for adipate production based on renewable carbon sources is of 
substantial interest. Thus, the main objective of this work was the metabolic engineering of 
Corynebacterium glutamicum for the production of the adipate precursor 2-oxoadipate. This 
organism is an industrially established producer of amino acids, but was also shown to 
possess a high capability for the production of organic acids, such as lactate or succinate.   
Neither adipate nor 2-oxoadipate (solutions adjusted to pH 7) were metabolised by 
C. glutamicum wild type and they did not inhibit growth in glucose minimal medium in 
concentrations up to 50 mM (µ = 0.43 h-1). Addition of 150 mM or 250 mM adipate resulted 
in a 37% decreased growth rate (µ = 0.29 h-1), whereas a concentration of 500 mM adipate 
almost completely abolished growth. When adjusting the pH of the adipate solution with 
KOH to pH 7, the addition of 500 mM adipate still allowed a growth rate µ of 0.09 h-1. 
Additional supplementation of 5 mM of the compatible solute L-proline further increased the 
growth rate to 0.16 h-1. The latter result and DNA microarray experiments performed in the 
presence of 50 mM and 150 mM adipate indicated that the growth retardation might be caused 
to some extent by osmotic stress. Furthermore, the transcriptome data revealed high up-
regulation of the transcriptional regulator PcaR and its target genes pcaIJ and pcaFDO, 
belonging to the PCA (protocatechuate) branch of the β-ketoadipate pathway. Thus, adipate 
probably acts as an activator molecule of PcaR in C. glutamicum.  
The initial metabolic engineering studies focused on the introduction (plasmid-based or 
chromosomally) into C. glutamicum of the genes lys20 (Saccharomyces cerevisiae) or ttc1550 
(Thermus thermophilus) encoding homocitrate synthase (HCS) for homocitrate production 
from 2-oxoglutarate. Under standard batch cultivation conditions with 222 mM (40 g l-1) 
glucose, C. glutamicum/pEKEx2-lys20 and C. glutamicum Δgdh::Ptuf-lys20 (strain MS-1) 
excreted up to 2.6 mM (0.54 g l-1) and up to 4.1 mM (0.83 g l-1) homocitrate, respectively, 
showing that the heterologous HCS was active.  
Further studies focused on the enhancement of the titers of both products by metabolic 
engineering and by modified culture conditions. In a fed-batch cultivation with initially 
222 mM glucose and addition of 222 mM glucose and 204 mM acetate at the beginning of the 
stationary phase,  homocitrate production by strain MS-1 (C. glutamicum Δgdh::Ptuf-lys20) 
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was increased up to 27.1 mM (5.5 g l-1). Chromosomal integration of pycP458S coding for a 
pyruvate carboxylase into strain MS-1 and simultaneous deletion of pta-ackA in combination 
with an additional plasmid-based copy of lys20 resulted in the most promising homocitrate 
producer MS-3-pHCS, which accumulated up to 52.1 mM (10.6 g l-1) homocitrate in fed-
batch cultivation with glucose and acetate as an additional carbon source. This titer represents 
a yield of 0.21 mol Chomocitrate/mol Cglucose+acetate. 
2-Oxoadipate production in C. glutamicum was established by introducing (plasmid-based 
and chromosomally) a homoaconitase (HA, lys4) and a homoisocitrate dehydrogenase 
(HICDH, lys12) from S. cerevisiae. The resulting strains C. glutamicum/ pEKEx2-
lys20/pVWEx2-lys4-lys12 and C. glutamicum Δgdh::Ptuf-lys20ΔaceA::Ptuf-lys4-lys12 (strain 
MS-5) excreted 2.3 mM (0.37 g l-1) and up to 3.5 mM (0.56 g l-1) 2-oxoadipate, respectively, 
confirming the activity of the heterologous HA and HICDH. Moreover, these results showed 
that C. glutamicum has the capability to export both homocitrate and 2-oxoadipate.  
Cultivation of C. glutamicum/pEKEx2-ttc1550/pVWEx2-lys4-lys12 under nitrogen 
limitation increased 2-oxoadipate production up to 9.1 mM (1.5 g l-1). The highest 
2-oxoadipate titer of 27.1 mM (4.3 g l-1) (0.13 mol C2-oxoadipate/mol Cglucose+acetate) was produced 
by strain MS-5-pHCS, which differs from strain MS-5 by an additional plasmid-based copy of 
lys20. The results reported above demonstrate the capability of C. glutamicum for production 
of homocitrate and 2-oxoadipate and form the basis for further studies directed at conversion 
of 2-oxoadipate to adipate. 
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1.2 Zusammenfassung  
Adipat ist eine C6-Dicarbonsäure und stellt als Vorstufe für Nylon-6,6 einen der 
wichtigsten Bausteine in der chemischen Industrie dar. Bisher wird Adipat durch chemische 
Syntheseverfahren unter Verwendung von gesundheitsschädlichen und umweltbelastenden 
Reagenzien hergestellt. Daher ist die biotechnologische Produktion von Adipat, basierend auf 
erneuerbaren Kohlenstoffquellen, von großem Interesse. Vor diesem Hintergrund war das 
Hauptziel dieser Arbeit die Etablierung der Produktion der Adipatvorstufe 2-Oxoadipat 
mittels Metabolic Engineering in Corynebacterium glutamicum. Neben der industriellen 
Verwendung als Produktionsorganismus für Aminosäuren, besitzt C. glutamicum ein hohes 
Potential für die Produktion von organischen Säuren wie Lactat oder Succinat. 
Kultivierungsexperimenten ergaben, dass weder Adipat noch 2-Oxoadipat von 
C. glutamicum verstoffwechselt wird. Auf die Wachstumsrate von C. glutamicum hatte die 
Zugabe von pH-neutralisierten Adipat- (µ = 0.43 h-1) und 2-Oxoadipat-Lösungen 
(µ = 0.43 h-1) bis zu Konzentrationen von 50 mM keinen Einfluss. Die Zugabe von 150 mM 
oder 250 mM Adipat führte zu einer um 37% verminderten Wachstumsrate (µ=0.29 h-1). In 
Gegenwart von 500 mM Adipat lag hingegen eine fast vollständige Wachstumshemmung von 
C. glutamicum vor.  Eine mit KOH auf pH 7 eingestellte Adipatlösung steigerte die 
Wachstumsrate bei Zugabe von 500 mM auf µ = 0.09 h-1. Die Zugabe von 5 mM der 
osmotisch wirksamen Substanz Prolin führte zu einer Wachstumsrate von µ = 0.16 h-1. 
Diese Ergebnisse sowie DNA-Chip Experimente in Anwesenheit von 50 mM und 150 mM 
Adipat zeigten, dass die Wachstumshemmung teilweise durch osmotischen Stress bedingt sein 
kann. Des Weiteren konnte anhand der Transkriptomdaten gezeigt werden, dass als Folge der 
Adipat-Zugabe der Transkriptionsregulator pcaR als auch dessen Zielgene pcaIJ und 
pcaFDO, die im β-Ketoadipat Stoffwechselweg vorkommen, stark hoch-reguliert waren. 
Adipat fungiert in C. glutamicum somit wahrscheinlich als Aktivatormolekül des 
Transkriptionsregulators PcaR.  
Zur Etablierung der Homocitrat-Produktion ausgehend von 2-Oxoglutarat, wurden die 
Gene für die Homocitrat-Synthase (HCS) aus Saccharomyces cerevisiae (lys20) und Thermus 
thermophilus (ttc1550) in C. glutamicum (Plasmid-basiert und chromosomal) etabliert. Die 
Aktivität der heterologen HCS wurde durch die Produktion von Homocitrat in Standard-
Kultivierungsexperimenten mit 222 mM (40 g l-1) Glukose nachgewiesen. Dabei  produzierte 
der Stamm C. glutamicum/pEKEx2-lys20 bis zu 2,6 mM (0,54 g l-1) und der Stamm 
C. glutamicum Δgdh::Ptuf-lys20 (Stamm MS-1) bis zu 4,1 mM (0,83 g l-1) Homocitrat. 
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Zur Steigerung der Produkttiter wurden weitere genetische Modifikationen implementiert 
sowie die Kultivierungsbedingungen modifiziert. Die Homocitrat-Produktion mit dem Stamm 
MS-1 (C. glutamicum Δgdh::Ptuf-lys20)  konnte unter fed-batch Bedingungen mit anfänglich 
222 mM Glukose und zusätzlicher Zugabe von 222 mM Glukose und 204 mM Acetat am 
Anfang der stationären Phase auf 27,1 mM (5,5 g l-1) gesteigert werden. Die chromosomale 
Integration einer Pyruvat-Carboxylase (pycP458S), bei gleichzeitiger Deletion der pta-ackA 
Region, sowie die Expression einer weiteren Plasmid-basierten Genkopie von lys20 
(C. glutamicum MS-3-pHCS) führten unter fed-batch Bedingungen zur weiteren Erhöhung 
der Produktion auf 52,1 mM (10,6 g l-1) Homocitrat. Dies entspricht einer Ausbeute von 
0,21 mol CHomocitrat/ mol CGlukose+Acetat. 
Zur Etablierung der 2-Oxoadipat-Produktion wurden Gene, die für die Homoaconitase 
(HA) aus S. cerevisiae (lys4) und die Homoisocitrat-Dehydrogenase (HICDH) aus 
S. cerevisiae (lys12) kodieren in C. glutamicum Plasmid-basiert und chromosomal integriert, 
eingefügt. Durch die Akkumulation von bis zu 2,3 mM (0,37 g l-1) 2-Oxoadipat mit dem 
Stamm C. glutamicum/pEKEx2-lys20/pVWEx2-lys4-lys12 und von bis zu 3,5 mM (0,56 g l-1) 
mit dem Stamm  C. glutamicum Δgdh::Ptuf-lys20ΔaceA::Ptuf-lys4-lys12 (MS-5) wurde die 
Aktivität der heterolog exprimierten HA und HICDH bestätigt. Weiterhin waren diese 
Ergebnisse ein Beleg für die Fähigkeit von C. glutamicum Homocitrat und 2-Oxoadipat zu 
exportieren. 
Die Kultivierung des Stamms C. glutamicum/pEKEx2-ttc1550/pVWEx2-lys4-lys12 führte 
unter Stickstofflimitierung zur Steigerung der 2-Oxoadipat-Produktion auf 9,1 mM (1,5 g l-1). 
Mit dem aktuell besten 2-Oxoadipat-Produzenten MS-5-pHCS, welcher sich durch eine 
weitere Plasmid-basierte Genkopie von lys20 von dem Stamm C. glutamicum MS-5 
unterscheidet, wurde 27,1 mM (4,4 g l-1) 2-Oxoadipat produziert. Das entspricht einer 
Ausbeute von 0,13 mol C2-Oxoadipat/mol CGlukose+Acetat. 
Die hier präsentierten Ergebnisse zeigen somit zum einen das Potential von C. glutamicum 
zur Produktion von Homocitrat und 2-Oxoadipat und sind zum anderen die Basis für weitere 
Untersuchungen zur Umsetzung von 2-Oxoadipat zu Adipat.  
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2 Introduction 
2.1 Significance and application of adipate  
Adipate (alternative names are hexanedioic acid or 1,4-butanedicarboxylic acid) with a 
molecular mass of 146.14 g mol-1 and pKa values of 4.43 and 5.41 is the most important 
commercial aliphatic, straight-chain dicarboxylic acid. It is isolated as colourless, odourless 
crystals having an acidic taste (Musser, 2005, Davis, 1985). The GRAS (generally recognised 
as safe) compound is soluble in acetone and alcohol and slightly soluble in water (14.2 g l-1 at 
15°C) (van Kempen et al., 2001, Davis, 1985). It occurs rarely in nature and was found in 
beet red and sugar beet. The global production of adipate has been estimated to be at 
2.6 million tons/a in 2011 with 410,000 tons (16%) produced in Germany. The forecast of 
adipate production is an average growth of 4.1% annually, leading to a global production of 
3.3 million tons in 2016 (Merchant Research & Consulting Ltd., 2011). The price of adipate 
in Europe was reported to be $2,900 per ton in April 2011 and is expected to be globally at 
$3,100 per ton in 2016. The global adipate market is tightly associated with the health of the 
economy (Global Industry Analysts Inc., 2012). The price of the key material cyclohexane, 
which is coupled to the oil price, significantly impacts the adipate market (Global Industry 
Analysts Inc., 2012).  
Nearly 65% of the global adipate production is used for the manufacturing of nylon 6,6 
fibres and resins (Merchant Research & Consulting Ltd., 2011). The primary application 
process leads to nylon 6,6 by condensation of adipate and hexamethylenediamine and 
subsequent elimination of water. This important process was established in the early 1930s by 
W. H. Carothers of DuPont (Luedeke, 1977). Further application areas are the production of 
polyurethanes and polyester polyols as well as the conversion to esters for the production of 
plasticizers and lubricants (Merchant Research & Consulting Ltd., 2011, Musser, 2005). 
Adipate is also used in the food industry as ingredient (E355, E356, E357) in gelatines, jams, 
desserts and other foods that require acidulation (Merchant Research & Consulting Ltd., 
2011). Derivatives of adipate are used for target products such as fungicides, pesticides, 
pharmaceuticals and textile treatment (Merchant Research & Consulting Ltd., 2011). 
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2.2 Chemical production of petroleum-based adipate 
Most of the commercially produced adipate in the chemical industry is synthesised from 
cyclohexane through a two-step oxidation process (Fig. 1). Starting material of this route is 
benzene, which is hydrogenated to cyclohexane.  
benzene cyclohexane
OH
cyclohexanol
O
cyclohexanone
O
OH
O
HO
adipic acid
NiAl2O3,
H2, 2600-
5500 kPa +
Co,O2,
830-960 kPa
150-160°C
Cu, NH4VO3,
60% HNO3,
60-80°C
 
Fig. 1: Chemical synthesis of adipate via benzene route (Niu et al., 2002). 
 
Cyclohexane reacts in the first oxidation with oxygen in the presence of the catalysts cobalt 
or manganese at 150-160°C to produce KA oil, a mixture of cyclohexanol and 
cyclohexanone. The second oxidation step results in adipate by oxidising KA oil with nitric 
acid and air, using copper or vanadium as catalysts (Merchant Research & Consulting Ltd., 
2011, Niu et al., 2002). Two butadiene-based routes demonstrate further adipate production 
processes which are rarely used in the industry. The first route, developed by BASF in the 
early 1970s, involves the production of adipate by two carbomethoxylation steps of butadiene 
to dimethyl adipate, followed by hydrolysis to adipate (Musser, 2005). The second route was 
developed by DuPont in the mid-1980s, producing adipate by direct dihydrocarboxylation of 
butadiene (Musser, 2005). Adipate is also made by palladium halide-catalysed 
dicarbonylation of 1,4-disubstituted 2-butenes or by one-step-oxidation of cyclohexane with 
nitric acid, nitrogen dioxide or air (Musser, 2005).  
Almost all of the chemical, large scale industrial processes for adipate production are 
based on environmentally harmful reagents. Benzene, the starting material of the most 
commonly used method, is a volatile carcinogen and linked to acute myeloid leukaemia 
(Galbraith et al., 2010). During the oxidation process of KA oil to adipate, NO2, NO, N2O and 
N2 are formed (Merchant Research & Consulting Ltd., 2011). The formation of NOx 
emissions and especially the unavoidable formation of the main product nitrous oxide (1 mol 
per mol of adipate) represents a global environmental concern (Reimer et al., 1994). Nitrous 
oxide is a chemical active greenhouse gas, which leads to ozone depletion and global 
warming. Today 80% of nitrous oxide produced in adipate plants is reduced with state of the 
art techniques, for example modern catalytic decomposition of N2O and tail gas treatment to 
innocuous gases (O2 and N2) (Alini et al., 2007, van Duuren et al., 2011a, Matsuoka et al., 
2000). However, it is estimated that about 10% of N2O released per year in the atmosphere 
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originates from production of adipate (Alini et al., 2007). As an alternative “green” route Sato 
and co-workers described a direct organic-solvent and halide-free oxidation of cyclohexane to 
adipate using an aqueous 30% hydrogen peroxide solution. The efficiency of this route is 
based on many factors during the reaction steps and will only be attractive if the costs of 
hydrogen peroxide are clearly reduced (Sato et al., 1998,  Blach et al., 2010).  
 
2.3 Approaches for production of bio-based adipate 
Adipate belongs to the high-volume bulk chemicals. Substances listed as high-volume bulk 
chemicals were classified according to their potential of chemical functionality and potential 
applications i.e. based on the number of new molecules which can be produced in 
biotechnological and chemical processes (Werpy & Petersen, 2004). To date, chemical 
production of adipate is linked to the damage of the environment. Its market price is tightly 
coupled to the oil price (Merchant Research & Consulting Ltd., 2011, Niu et al., 2002). 
Therefore, the major long-term objective for the development of a sustainable industrial 
society is the shift from the dependence on petroleum to biotechnological processes based on 
renewable resources (Sauer et al., 2008). This includes the production of bulk chemicals of 
high purity in an environmentally acceptable and energy-efficient manner (Cooke, 2008). In 
the case of adipate only few microbial approaches to produce this compound or its precursors 
by fermentation processes using selected or engineered organisms have been published. 
 
2.3.1 Microbial cyclohexane oxidation to adipate 
Adipate is naturally produced by animals through a combination of β-oxidation and 
ω-oxidation (van Kempen et al., 2001, Mortensen, 1980). It has been hypothesised that it is 
important to detoxify excess fatty acids (Gregersen et al., 1983). Furthermore, adipate occurs 
naturally as an intermediate in the degradation pathways of cyclohexane, cyclohexanone and 
ε-caprolactam and is further metabolised via β-oxidation to succinyl-CoA and acetyl-CoA 
(Cheng et al., 2002, Steffensen & Alexander, 1995). Brzostowicz and co-workers used 
mRNA differential display to identify cyclohexane oxidation genes (Fig. 2, purple pathway) 
in a mixed microbial community originating from a wastewater bioreactor. The identified 
DNA fragments encode genes for cyclohexanone monooxygenase, caprolactone hydrolase, 
6-hydroxyhexanoate dehydrogenase and 6-oxohexanoic dehydrogenase, derived from the 
bacteria Arthrobacter sp., and Rhodococcus sp. (Brzostowicz et al., 2003). It was shown that 
traces of adipate could be detected in the presence of cyclohexanone in a culture of E. coli 
cells carrying cosmids encoding these genes (Brzostowicz et al., 2003). 
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2.3.2 Microbial production of the adipate precursor cis, cis-muconate 
Cis, cis-muconate is a dicarboxylic acid with conjugated double bonds, which can be 
reduced in a hydrogenation process using platinum on carbon as catalyst to form adipate (Niu 
et al., 2002, van Duuren et al., 2011b). In the past few years two different processes for the 
microbial production of cis, cis-muconate from renewable carbon sources have been 
established: (i) the degradation of benzoate and (ii) the biosynthesis based on glucose. The 
degradation of benzoate to cis, cis-muconate has been described for the bacteria Pseudomonas 
sp. B13, P. putida BM014, P. putida KT2440, Acinetobacter strain ADP1, Arthrobacter sp., 
and Spingobacterium strain GCG (Schmidt & Knackmuss, 1984, Bang & Choi, 1995, Choi et 
al., 1997, van Duuren et al., 2011b, van Duuren et al., 2012, Collier et al., 1998, Mizuno et 
al., 1988, Wu et al., 2004).  
The degradation pathway of benzoate proceeds via the ortho-cleavage pathway of catechol 
to cis, cis-muconate and further to succinyl-CoA and acetyl-CoA in the β-ketoadipate 
pathway. The benzoate pathway in P. putida (and other organisms) is encoded by the genes 
that belong to the ben, cat and pca operons (Fig. 2, green pathway) (van Duuren et al., 
2011b). Benzoate is converted by a benzoate dioxygenase (benABC) to the corresponding 
1,2-diol. The resulting 1,2-dihydroxybenzoate is dehydrogenated to catechol by a 
1,2-dihydroxybenzoate dehydrogenase (benD). The cleavage of catechol is catalysed by two 
catechol-1,2-dioxygenases, encoded on the cat operon (catA) and the ben operon (catA2), 
respectively, to form cis, cis-muconate (van Duuren et al., 2011b). The transcriptional 
regulators BenR and CatR were found to be involved in the regulation of the benzoate 
pathway in P. putida. In the presence of benzoate BenR activates transcription of the 
benABCD operon and CatR induces the transcription of the catBCA operon in response to cis, 
cis-muconate (Cowles et al., 2000, McFall et al., 1998). In the last two decades several 
attempts to increase cis, cis-muconate production were performed. A Pseudomonas sp. B13 
strain lacking the gene of muconate cycloisomerase and grown in succinate mineral medium 
reached a cis, cis-muconate titer of 7.4 g l-1 (52 mM) (Schmidt & Knackmuss, 1984). The titer 
of cis, cis-muconate could be increased to 44.1 g l-1 (310 mM) using an Arthrobacter strain 
also lacking muconate cycloisomerase activity and additionally exposed to UV irradiation 
(Mizuno et al., 1988). Recently, van Duuren and co-workers developed the strain P. putida 
KT2440-JD-1, which accumulates in a pH-controlled fed-batch process up to 18.5 g l-1 
(130 mM) cis, cis-muconate with an overall product yield close to 100% (van Duuren et al., 
2012). This strain was derived from P. putida KT2440 by random mutagenesis with 
N-methyl-N´-nitro-N-nitrosoguanidine and exposure to 3-fluorobenzoate. It was shown that 
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this strain no longer grows on benzoate as sole carbon source, but co-metabolised benzoate 
during growth on glucose. Transcriptome analysis revealed that the cat operon was no longer 
induced in the presence of benzoate due to a single point mutation in the transcriptional 
regulator gene catR. Under these conditions the genes of the ben operon were highly induced 
and the strain P. putida KT2440 JD-1 was still able to convert catechol to cis, cis-muconate. 
The conversion is based on the presence of the second catechol 1,2-dioxygenase (catA2, 
PP_3166) encoded in the ben operon, as the catA-encoded enzyme was not induced due to the 
defective CatR regulator (van Duuren et al., 2011b). 
A second approach for the synthesis of adipate from renewable carbon sources like glucose 
was reported by Draths and co-workers. An artificial pathway was established in E. coli 
converting D-glucose to cis, cis-muconate followed by hydrogenation to adipate (Fig. 2, red 
pathway) (Draths & Frost, 1994). The conversion of D-glucose to 3-dehydroshikimate is 
catalysed by enzymes naturally present in E. coli. To prevent further conversion of 
3-dehydroshikimate the strain lacks shikimate dehydrogenase. The synthesis of 
3-dehydroshikimate to cis, cis-muconate is performed by introducing three heterologous, 
plasmid-encoded enzymes in the E. coli strain: 3-dehydroshikimate dehydratase of Klebsiella 
pneumoniae (aroZ) catalyses the dehydration to protocatechuate, protocatechuate 
decarboxylase (aroY) of K. pneumoniae decarboxylates protocatechuate to catechol, which is 
then cleaved to cis, cis-muconate by catechol 1,2-dioxygenase of Acinetobacter calcoaceticus 
(catA). Batch cultivation of this E. coli strain with glucose as sole carbon source lead to the 
accumulation of about 2.4 g l-1 (17 mM) cis, cis-muconate (Draths & Frost, 1994). 
Improvement of the synthesis by integration of two additional copies of the aroZ gene in the 
parental E. coli strain leads to 36.8 g l-1 (259 mM) of cis, cis-muconate, corresponding to a 
24% (mol/mol) yield from glucose. The subsequent chemocatalytic hydrogenation of cis, cis-
muconate results in 97% conversion to adipate (Niu et al., 2002). 
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Fig. 2: Synthetic pathways for the bio-based production of adipate: The purple pathway shows 
cyclohexanone oxidation to adipate (Brzostowicz et al., 2003). Synthesis of the adipate precursor cis, cis-
muconate occurs via degradation of benzoate (green pathway, van Duuren et al., 2011b) or via an artificial 
pathway from glucose (red pathway, Niu et al., 2002). The blue pathway indicates the synthesis of the precursor 
D-glucaric acid from glucose (Moon et al., 2009). Black arrows indicate the microbial conversion of D-glucose 
to 3-dehydroshikimic acid. Continuous lines indicate enzymatic reactions, dashed lines show chemocatalytic 
reactions. The gene names of enzymes involved are shown in brackets. 
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2.3.3 Microbial production of the adipate precursor glucarate 
D-glucarate was identified as “top value-added chemical from biomass” with a high 
potential as building block for polymers (Werpy & Petersen, 2004). For the production of 
D-glucarate from glucose a synthetic pathway was established in E. coli (Fig. 2, blue 
pathway). Glucose is taken up into the cell and converted to glucose-6-phosphate via the PTS 
(phosphotransferase system). The coexpression of the gene for myo-inositol-1-phosphate 
synthase (ino1) of Saccharomyces cerevisiae and myo-inositol oxygenase (miox) of mice led 
to the formation of D-gluconate via the intermediate myo-inositol. Myo-inositol-1-phosphate 
is dephosphorylated by an endogenous phosphatase, likely SuhB of E. coli. The last step to 
D-glucarate is catalysed by an uronate dehydrogenase (udh) of Pseudomonas syringae. 
Cultivation of the E. coli strain carrying these three heterologous genes resulted in the 
accumulation of up to 1.1 g l-1 D-glucarate (Moon et al., 2009). Subsequent chemocatalytical 
conversion of D-glucarate led to adipate. It was demonstrated that the MIOX activity is the 
rate limiting step in the pathway for glucarate production from glucose. To overcome this 
limitation, polypeptide scaffolds built from protein-protein interaction domains were 
implemented to co-localise all three heterologous enzymes. This increased the MIOX activity 
resulting in an approximately 5-fold increased product titer (2.5 g l-1) of D-glucarate (Moon et 
al., 2010). 
 
2.4 A new synthetic pathway for the bio-based production of 2-oxoadipate and 
adipate 
Metabolic engineering was defined as “the improvement of cellular activities by 
manipulations of enzymatic, transport and regulatory functions of the cell with the use of 
recombinant DNA technology” (Bailey, 1991). Since the last decade, the field of synthetic 
biology which aims at the design and construction of new biological components or the 
redesign of existing biological components, became more and more prominent (Keasling, 
2008). The application of the tools of synthetic biology is a promising idea to significantly 
simplify metabolic engineering. For engineering an existing or for designing a new synthetic 
pathway there are some key points, which have to be considered: (i) The chassis (microbial 
host organism) should be genetically stable, should have the ability to grow with minimal 
requirements to the growth medium and should be able to switch on the entire biosynthetic 
pathway at the correct time point to avoid accumulation of toxic intermediates. (ii) It is 
important to coordinate the simultaneous expression of many genes carrying out multiple 
enzymatic reactions. (iii) The application of computer-aided design systems supports the 
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selection of biological components for the development of a new synthetic pathway. (iv) 
Finally, biological debugging routes help to identify and solve problems in the engineered 
pathways (Keasling, 2012).  
 
2.4.1 Production of the intermediate 2-oxoadipate from glucose 
The new synthetic bio-based pathway proposed in this work represents the conversion of 
glucose to adipate via the intermediate 2-oxoadipate, which occurs in the α-aminoadipate 
(AAA) pathway. The first three enzymatic steps of the AAA pathway convert 2-oxoglutarate 
and acetyl-CoA to 2-oxoadipate (Fig. 3). Besides the diaminopimelate pathway, which is 
found in most plants, bacteria and lower fungi, the AAA pathway is the second distinct 
pathway for the biosynthesis of L-lysine. The AAA pathway consists of eight enzymatic steps 
and was found in several yeasts and higher fungi (Vogel, 1964, Zabriskie & Jackson, 2000).  
 
 
Fig. 3: Proposed synthetic pathway for the bio-based production of 2-oxoadipate and adipate from 
glucose. Enzymes marked in blue catalyse the first three reactions of the α-aminoadipate pathway for L-lysine 
biosynthesis to form 2-oxoadipate from 2-oxoglutarate and acetyl-CoA. Dashed lines indicate the enzymatic 
reactions of glycolysis, forming pyruvate from glucose. The proposed conversion of 2-oxoadipate to 
2-hexendioate was recently reported (enzymes marked in purple, Parthasarathy et al., 2011). Genes encoding a 
2-oxoadipate reductase and an enzyme converting 2-hexendioate to adipate (green displayed enzymes) have not 
been described yet. Enzyme abbreviations: HCS = homocitrate synthase, HA = homoaconitase, HICDH = 
homoisocitrate dehydrogenase, HgdH = 2-hydroxyglutarate dehydrogenase, GctAB = glutaconate CoA-
transferase, HgdC+HgdAB = 2-hydroxyglutaryl-CoA dehydratase. 
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An AAA-like pathway is also present in the thermophilic bacteria Thermus thermophilus 
and Pyrococcus horikoshii. The synthesis of the intermediate α-aminoadipate from 
2-oxoglutarate and acetyl-CoA proceeds in the same way, but conversion of α-aminoadipate 
to L-lysine is different in the prokaryotic organisms (Kosuge & Hoshino, 1998, Nishida & 
Nishiyama, 2000). Most research for characterising the regulation and enzyme activities of 
the AAA pathway was performed using the baker’s yeast S. cerevisiae. The first three 
enzymatic steps of the AAA pathway form 2-oxoadipate, a precursor of adipate. The first 
reaction is a condensation of 2-oxoglutarate and acetyl-CoA to form homocitrate, catalysed by 
homocitrate synthase (HCS). Homocitrate synthase is the rate limiting enzyme of the AAA 
pathway due to feedback inhibition by the end product L-lysine (Feller et al., 1999, Andi et 
al., 2005). It was possible to overcome the feedback inhibition by substitutions of particular 
amino acids resulting in L-lysine-insensitive variants (Feller et al., 1999, Bulfer et al., 2010). 
The two-step conversion of homocitrate to homoisocitrate via the intermediate homoaconitate 
is catalysed by homoaconitase (HA), also known as homoaconitate hydratase. This enzyme 
belongs to the aconitase superfamily and catalyses the dehydration of homocitrate to 
homoaconitate as well as the subsequent rehydration to homoisocitrate (Xu et al., 2006). 
Homoisocitrate dehydrogenase (HICDH) catalyses the oxidative decarboxylation of 
homoisocitrate to 2-oxoadipate by a mechanism, which is proposed to be similar to that of 
isocitrate dehydrogenase (Grodsky et al., 2000). The conversion of 2-oxoglutarate to 
2-oxoadipate is also described for some archaea, including Methanocaldococcus jannaschii. 
In these strictly anaerobic methanogens the reactions are part of coenzyme B (CoB) 
biosynthesis, which is essential for methane formation. The reactions are catalysed by the 
same enzymes described for the AAA pathway, but in contrast the methanogenic pathway 
(called homocitrate pathway), recycles its products, extending 2-oxoadipate (C6) to 
2-oxopimelate (C7) and 2-oxopimelate to 2-oxosuberate (C8). In each of the elongation 
pathways (condensation of acetyl-CoA with the 2-oxoacid, rearrangement of the hydroxy 
group, oxidative decarboxylation) the reactions are catalysed by the same enzymes, including 
homocitrate synthase, homoaconitase and homoisocitrate dehydrogenase (Graham, 2011). As 
consequence of a less polar binding site, the methanogen HCS is reported to be the only 
family member catalysing acetyl addition to 2-oxoacids of varying chain length (Howell et 
al., 1998). The dicarboxylate elongation pathway provides not only precursors for CoB 
biosynthesis, but also demonstrates potential for the production of high-value polymer 
precursors (Graham, 2011).  
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2.4.2 A synthetic pathway for the conversion of 2-oxoadipate to adipate 
Up to now the challenging task to develop a synthetic pathway for the enzymatic 
conversion of 2-oxoadipate to adipate was addressed only very recently. Buckel and co-
workers demonstrated the conversion of 2-oxoadipate to 2-hexendioate, a direct precursor of 
adipate. The enzymes 2-hydroxyglutarate dehydrogenase (HgdH) and glutaconate CoA-
transferase (GctAB) from Acidaminococcus fermentans as well as 2-hydroxyglutaryl-CoA 
dehydratase (HgdC + HgdAB) from Clostridium symbiosium catalyse the conversion of 
2-oxoglutarate to glutaconate and side-activity is found for the conversion of 2-oxoadipate to 
2-hexendioate (Fig. 3) (Djurdjevic et al., 2011, Parthasarathy et al., 2011). No enzyme 
activity catalysing the reduction of 2-hexendioate to adipate is described until now. Despite 
the successful conversion of the six carbon substrates by the three enzymes, several obstacles 
have to be solved before the production pathway of adipate can work. The main problem 
seems to be the 2-hydroxyglutarate dehydrogenase, which prefers 2-oxoglutarate over 
2-oxoadipate. To solve this problem, the authors propose the construction of an enzyme, 
which does not accept 2-oxoglutarate as substrate (Parthasarathy et al., 2011). However, a few 
decades ago, it was reported that 2-oxoadipate reductase, which is involved in mammalian 
lysine and tryptophan degradation, catalyses the formation of 2-hydroxyadipate from 
2-oxoadipate (Suda et al., 1976). Originally, this enzyme was isolated from human term 
placenta and was further characterised in rat, especially from heart muscle, but the gene 
encoding this enzyme has not yet been identified (Suda et al., 1977). In addition it was 
recently reported that homoisocitrate dehydrogenase of S. cerevisiae, which naturally 
catalyses the oxidative decarboxylation of homoisocitrate to 2-oxoadipate (Fig. 3), was 
engineered to specifically catalyse the conversion of 2-oxoadipate to 2-hydroxyadipate 
(Reitman et al., 2012). This enzyme engineering approach is based on cancer-associated 
mutations of isocitrate dehydrogenase found in human brain tumor cells. By these mutations 
the active site of the isocitrate dehydrogenase were altered to gain an oxidoreductase activity 
to convert 2-oxoglutarate to 2-hydroxyglutarate. In an enzyme re-engineering approach the 
mutations of isocitrate dehydrogenase were applied to homologous residues of homoisocitrate 
dehydrogenase of S. cerevisiae. The mutated enzyme specifically catalyse the conversion of 
2-oxoadipate to 2-hydroxyadipate (Reitman et al., 2012). 
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2.5 Corynebacterium glutamicum as host for 2-oxoadipate and adipate production 
The Gram-positive, predominantly aerobic, non-pathogenic soil bacterium 
Corynebacterium glutamicum was first isolated by Kinoshita and co-workers as a result of its 
ability to excrete glutamate under biotin-limiting conditions (Kinoshita et al., 1957). This 
biotin-auxotrophic species is non-motile, non spore-forming and rod-shaped with an irregular 
morphology (Abe et al., 1967). It belongs to the class of Actinobacteria and has become a 
model organism for the order of Actinomycetes to study common features of corynebacteria 
and pathogenic mycobacteria, including the human-pathogens Corynebacterium diphtheriae 
and Mycobacterium tuberculosis. The 3.3 Mbp genome has been completely sequenced and 
revealed a high GC-content (53.8%) (Kalinowski et al., 2003, Yukawa et al., 2007). Since 
C. glutamicum is a firmly established industrial producer and since in the last decade many 
details regarding the metabolism and its regulation have been elucidated, this bacterium 
exhibits a high potential as host for the biotechnological production of various industrially 
relevant products (Eggeling & Bott, 2005). Today, it is used for the industrial production of 
amino acids, predominantly L-glutamate (2.2 mio t/a) and L-lysine (1.5 mio t/a) (Ajinomoto 
Co. Inc., 2010a, Ajinomoto Co. Inc., 2010b). Additionally, C. glutamicum has been 
engineered for the production of organic acids like pyruvate, 2-oxoglutarate or succinate 
(Wieschalka et al., 2012, Jo et al., 2012, Litsanov et al., 2012a, Litsanov et al., 2012b, 
Litsanov et al., 2013). Besides its application in biotechnological processes, extensive 
research on the regulation and especially on the regulators of the citrate cycle genes has been 
performed (Bott, 2007).  
Since 2-oxoglutarate serves as precursor for 2-oxoadipate production, regulation of the 
2-oxoglutarate dehydrogenase complex (ODHC) is of strong interest for this study. With 
respect to the regulation mechanism, it was shown, that two proteins, OdhI and PknG, are 
involved: The serine/threonine protein kinase G (PknG) was shown to phosphorylate OdhI at 
threonine residue 14, which prohibits binding of OdhI to OdhA, the E1 subunit of ODHC. 
Unphosphorylated OdhI forms a complex with OdhA and causes inhibition of the ODHC 
activity (Niebisch et al., 2006). A further study revealed that the lack of the OdhI protein 
leads to drastically diminished glutamate production, whereas a decreased ODHC activity is 
beneficial for glutamate production (Schultz et al., 2007). Besides ODHC activity and its 
regulation, the recently reported development of a strain producing increased product titers of 
2-oxoglutarate is of strong interest. For this purpose blockage of the pathways competing with 
the biosynthesis of 2-oxoglutarate resulted in elevated levels of 2-oxoglutarate (Jo et al., 
2012).   
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Based on this detailed knowledge and the proven capability to form dicarboxylic acids 
such as succinate in titers exceeding 130 g l-1, C. glutamicum was considered as a promising 
host for the development of 2-oxoadipate and adipate producer strains (Litsanov et al., 
2012b). 
 
2.6 Aim of this thesis 
The overall goal of this project is the generation of a new synthetic pathway for the bio-
based microbial production of adipate from glucose. In the study presented here, the primary 
aim was to test the potential of the model organism and biotechnologically important microbe 
Corynebacterium glutamicum to produce the adipate precursors homocitrate and 
2-oxoadipate. To this end, enzymes of the α-aminoadipate pathway should be selected, cloned 
and heterologously expressed from plasmids and chromosomally integrated. First generation 
strains should be further improved by metabolic engineering strategies improving e.g. 
precursor supply. Furthermore, growth parameters and transcriptional responses of 
C. glutamicum wild-type cells in the presence of adipate and 2-oxoadipate should be analysed 
to study the possible consumption of these compounds and their influence on global gene 
expression. 
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3 Material and methods 
3.1 Strains and plasmids 
The strains used in this study are listed in Tab. 1 and the plasmids in Tab. 2. 
Tab. 1: Strains used in this study and their relevant characteristics 
Strain Relevant characteristics  Reference 
C. glutamicum ATCC 13032 wild-type strain, biotin-auxotrophic Abe et al., 1967 
C. glutamicum ΔpknG ATCC13032 derivative with in-frame 
deletion of pknG (cg3064), encoding 
serine/threonine protein kinase G 
Niebisch et al., 2006 
C. glutamicum ΔdctA ΔdccT ATCC13032 derivative with in-frame 
deletions of dctA (cg2870) encoding  a 
Na+/H+ dicarboxylate symporter and dccT 
(cg0277) encoding another dicarboxylate 
uptake system 
Youn et al., 2009 
E. coli DH5α F- Φ80dlacΔ (lacZ)M15 Δ (lacZYA-argF) 
U169 endA1 recA1 hsdR17 (rK-, mK+) deoR 
thi-1 phoA supE44 λ- gyrA96 relA1 
Invitrogen (Germany) 
 
 
S. cerevisiae Y00000 (BY4741) MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 EUROSCARF 
(Germany) 
S. cerevisiae Δyer152c derivative of Y0000 with  
YER152c::kanMX4 
EUROSCARF 
(Germany) 
S. cerevisiae Δygl202w derivative of Y0000 with 
YGL202w::kanMX4 
EUROSCARF 
(Germany) 
C. glutamicum MS-1 ATCC13032 derivative with an in-frame 
deletion of the gdh gene (glutamate 
dehydrogenase) and chromosomal 
integration of the lys20 gene of S. cerevisiae 
encoding homocitrate synthase into the Δgdh 
locus under control of the tuf promoter  
This work 
C. glutamicum MS-1-pHCS MS-1 derivative containing pEKEx2-lys20, 
encoding homocitrate synthase (lys20) of 
S. cerevisiae under control of the tac 
promoter 
 
 
 
 
 
 
This work 
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Strain Relevant characteristics  Reference 
C. glutamicum MS-2 MS-1 derivative containing pAN6-pycP458S 
encoding a modified pyruvate carboxylase 
(pycP458S) of C. glutamicum DM1727 under 
control of the tac promoter 
This work 
C. glutamicum MS-3 MS-1 derivative with an in-frame deletion of 
pta-ackA (phosphotransacetylase, acetate 
kinase) and chromosomal integration of the 
gene pycP458S of C. glutamicum DM1727 into 
the Δpta-ackA locus under control of the tac 
promoter  
This work 
C. glutamicum MS-3-pHCS MS-3 derivative containing pEKEx2-lys20, 
encoding homocitrate synthase (lys20) of 
S. cerevisiae under control of the tac 
promoter 
This work 
C. glutamicum MS-4 C. glutamicum ΔpknG derivative with an in-
frame deletion of the gdh gene (glutamate 
dehydrogenase) and chromosomal 
integration of the lys20 gene of S. cerevisiae 
encoding homocitrate synthase into the Δgdh 
locus under control of the tuf promoter 
This work 
C. glutamicum MS-5 MS-1 derivative with an in-frame deletion of 
the aceA gene (isocitrate lyase) and 
chromosomal integration of the genes lys4 
and lys12 of S. cerevisiae encoding 
homoaconitase and homoisocitrate 
dehydrogenase into the ΔaceA locus under 
control of the tuf promoter  
This work 
C. glutamicum MS-5-pHCS MS-5 derivative containing pEKEx2-lys20, 
encoding homocitrate synthase (lys20) of 
S. cerevisiae under control of the tac 
promoter 
This work 
 
 
 
 
 
Material and methods  19 
Tab. 2: Plasmids used in this study 
Plasmid Relevant characteristics Reference 
pEKEx2 Kanr; C. glutamicum/E. coli shuttle vector 
for regulated gene expression (Ptac, lacIq, 
pBL1 oriVC. g., pUC18 oriVE. c.) 
Eikmanns et al., 1991 
pEKEx2-lys20 KanR; pEKEx2 derivative containing the 
lys20 gene encoding homocitrate synthase of 
S. cerevisiae under control of the tac 
promoter 
This work 
pEKEx2-lys20R276K KanR; pEKEx2 derivative containing the 
lys20R276K gene encoding homocitrate 
synthase of  S. cerevisiae under control of 
the tac promoter 
This work 
pEKEx2-ttc1550 KanR; pEKEx2 derivative containing the 
ttc1550 gene encoding homocitrate synthase 
of T. thermophilus under control of the tac 
promoter 
This work 
pEKEx2-nifV KanR; pEKEx2 derivative containing the 
nifV gene encoding homocitrate synthase of 
A. vinelandii under control of the tac 
promoter 
This work 
pVWEx2 TetR; C. glutamicum/E. coli shuttle vector 
for regulated gene expression; derived from 
pEKEx2  
Peters-Wendisch et al., 
2001 
pVWEx2-lys4-lys12 TetR, pVWEx2 derivative containing the 
genes lys4 encoding homoaconitase and 
lys12 encoding homoisocitrate 
dehydrogenase of S. cerevisiae under control 
of the tac promoter 
This work 
pAN6 KanR; C. glutamicum/E. coli shuttle vector 
for regulated gene expression; derivative of 
pEKEx2 (Ptac, lacIq, pBL1 oriVC.g., pUC18 
oriVE.c.); 
Frunzke et al., 2008 
pAN6-pycP458S KanR; pAN6 derivative containing the 
pycP458S gene encoding pyruvate carboxylase 
of C. glutamicum DM1727  under control of 
the tac promoter 
Litsanov et al., 2012a 
pK19mobsacB KanR.; vector for allelic exchange in 
C. glutamicum; (pK18 oriVE.c., sacB, lacZα) 
 
Schäfer et al., 1994 
20  Material and methods 
Plasmids Relevant characteristics Reference 
pK19mobsacB-Δpta-ΔackA KanR, pK19mobsacB derivative containing 
an overlap extension PCR product covering 
the flanking regions of the pta-ackA genes 
from C. glutamicum 
Litsanov et al., 2012a 
pK19mobsacB-Δpta-ΔackA::Ptuf-
pycP458S 
KanR, pK19mobsacB derivative containing a 
double overlap PCR product which carries 
the tuf promoter of C. glutamicum fused to 
the pycP458S gene encoding pyruvate 
carboxylase  of C. glutamicum DM1727 
within the flanking regions of the pta-ackA 
genes from C. glutamicum  
Litsanov et al., 2012b 
pK19mobsacB-Δgdh KanR, pK19mobsacB derivative containing 
an overlap extension product covering the 
flanking regions of the gdh gene from 
C. glutamicum  
This work 
 
pK19mobsacB-Δgdh::Ptuf-lys20 KanR, pK19mobsacB derivative containing 
the lys20 gene encoding homocitrate 
synthase of S. cerevisiae fused to the tuf 
promoter of C. glutamicum within the 
flanking region of the gdh gene of 
C. glutamicum 
This work 
pK19mobsacB-Δgdh::Ptuf- 
lys20R276K 
KanR, pK19mobsacB derivative containing 
the lys20R276K gene encoding homocitrate 
synthase of S. cerevisiae fused to the tuf 
promoter of C. glutamicum within the 
flanking region of the gdh gene of 
C. glutamicum 
This work 
pK19mobsacB-Δgdh::Pgap-lys20 KanR, pK19mobsacB derivative containing 
the lys20 gene encoding homocitrate 
synthase of S. cerevisiae fused to the gap 
promoter of C. glutamicum within the 
flanking region of the gdh gene of 
C. glutamicum 
This work 
pK19mobsacB-Δgdh::Ptac-lys20 KanR, pK19mobsacB derivative containing 
the lys20 gene encoding homocitrate 
synthase of S. cerevisiae fused to the tac 
promoter within the flanking region of the 
gdh gene of C. glutamicum 
 
 
This work 
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Plasmids Relevant characteristics Reference 
pK19mobsacB-ΔaceA KanR, pK19mobsacB derivative containing a 
crossover product covering the flanking 
regions of the aceA gene of C. glutamicum  
This work 
pK19mobsacB-ΔaceA::Ptuf-lys4-
lys12 
KanR, pK19mobsacB derivative containing 
the genes lys4 encoding homoaconitase and 
lys12 encoding homoisocitrate 
dehydrogenase of S. cerevisiae fused to the 
tuf promoter of C. glutamicum within the 
flanking region of the gdh gene of 
C. glutamicum 
This work 
 
Tab. 3: Oligonucleotides used in this study. In some cases oligonucleotides were designed to introduce sites 
for restriction endonucleases (recognition sites underlined, restriction endonucleases in parenthesis) or to 
introduce codon exchanges (printed in italics). For gene replacement the overlapping sequences are highlighted 
in bold. 
 
Name 
 
5'-3' sequence and properties Application 
  
 
ttc1550-fw 
CTAGTCGACGAAAGGAGGATATAGAT
ATGCGGGAGTGGAAGATTATTG (SalI) Amplification of the homocitrate 
synthase gene ttc1550 of 
T. thermophilus ttc1550-rv AGAGGTACCTCACGCCGTGATCCACTC
CCG (KpnI) 
nifV-fw 
CTAGGATCCGAAAGGAGGATATAGAT
ATGGCTAGCGTGATCATCGAC (BamHI) Amplification of the homocitrate 
synthase gene nifV of A. vinelandii 
nifV-rv 
CTAGGTACCTCATGCCATTCCTCCTGC
GG (KpnI) 
lys20-fw 
CTACTGCAGGAAAGGAGGATATAGAT
ATGACTGCTGCTAAACC (PstI) Amplification of the homocitrate 
synthase gene lys20 of S. cerevisiae 
lys20-rv 
AGAGGTACCTTAGGCGGATGGCTTAG 
(KpnI) 
lys4-fw 
CTAGTCGACGAAAGGAGGATATAGAT
ATGCTACGATCAACCAC (SalI) Amplification of the homoaconitase 
gene lys4 of S. cerevisiae 
lys4-rv 
ATCTATATCCTCCTTTCTAGTTATAG
TTGGGATTTGACC 
lys12-fw 
CTAGAAAGGAGGATATAGATATGTT
TAGATCTGTTGCTACT Amplification of the homoisocitrate 
dehydrogenase gene lys12 of 
S. cerevisiae lys12-rv AGATCTAGACTATAATCTCGACAAAA
CGTC (XbaI) 
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Name 
 
5'-3' sequence and properties Application 
lys20R276K-fw 
GTTGCACAAGATCAAAGACATTGAAA
ACCTGG Introduction of amino acid exchange 
R276K within the homocitrate synthase 
lys20 of S. cerevisiae lys20R276K-rv CCAGGTTTTCAATGTCTTTGATCTTGT
GCAAC 
M13-control-fw CGCCAGGGTTTTCCCAGTCAC pEKEx2-specific oligonucleotides for 
checking transformed plasmids  M13-control-rv AGCGGATAACAATTTCACACAGGA 
lys20 integration 
 
 
Δgdh-1 
CTAAAGCTTATCGGCGGAGCTTCGCA
AAT (HindIII) Amplification of overlapping fragment 
gdh-1 for in-frame deletion of the gdh 
gene (glutamate dehydrogenase) in 
C. glutamicum  Δgdh-2 
TGCGGCCGCTCACTTAAGATCCCGG
GAGCTGGCTTCAAGAAGGTAGC (NotI, 
AflII, XmaI) 
Δgdh-3 
TCCCGGGATCTTAAGTGAGCGGCCG
CATTATTATTATTAGACCTGCTCATCA
ACTGTCAT (XmaI, AflII, NotI) 
Amplification of overlapping fragment 
gdh-2 for in-frame deletion of the gdh 
(glutamate dehydrogenase) in 
C. glutamicum Δgdh-4 AGAGAATTCTCAGTCAACTGGTCTCAT
TCG (EcoRI) 
Δgdh-control-fw CAAGCTGGCGCAACTACGGT Checking of in-frame deletion of the 
gdh gene and chromosomal integration 
of lys20-variants Δgdh-control-rv TAGCGCCTATAAAAGTCGTAC   
Ptuf-fw 
CTAGCGGCCGCCCACAGGGTAGCTGG
TAGT (NotI) 
Amplification of the tuf promoter 
fragment of C. glutamicum for 
chromosomal integration into the Δgdh 
locus Ptuf-rv 
CTACTTAAGTCCTCCTGGACTTCGTGG
T (AflII) 
PgapA-fw 
CTAGCGGCCGCATGTGTCTGTATGATT
TTGC (NotI) 
Amplification of the gapA promoter 
fragment of C. glutamicum for 
chromosomal integration into the Δgdh 
locus PgapA-rv 
CTACTTAAGTCTCCTCTAAAGATTGTA
GGA (AflII) 
Ptac-fw 
CTAGCGGCCGCGAGCTGTTGACAATT
AATCATC (NotI) 
Amplification of the tac promoter 
fragment from the plasmid pEKEx2 for 
chromosomal integration into the Δgdh 
locus Ptac-rv 
CTACTTAAGATCTATATCCTCCTTTCTC
TAG (AflII) 
lys20-gdh-fw 
CTACTTAAGATGACTGCTGCTAAACC 
(AflII) 
Amplification of the homocitrate 
synthase gene lys20 of S. cerevisiae for 
chromosomal integration into the Δgdh 
locus lys20-gdh-rv 
AGACCCGGGTTAGGCGGATGGCTTAG
TC (XmaI) 
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Name 
 
5'-3' sequence and properties Application 
lys4, lys12 integration   
ΔaceA-1 
CTAAAGCTTCTACCTCTGGAATCTAGG
TG (HindIII) Amplification of overlapping fragment 
aceA-1 for in-frame deletion of the 
aceA gene (isocitrate lyase) in 
C. glutamicum ΔaceA-2 
TCCCGGGATCCTAGGTGAGCGGCCG
CATTATTATTATTATGGCTTTCCAAC
GTTTGACAT (XmaI, AvrII, NotI) 
ΔaceA-3 
TGCGGCCGCTCACCTAGGATCCCGG
GATCTACCACCGCTTTGAAGGG (NotI, 
AvrII, XmaI) 
Amplification of overlapping fragment 
aceA-2 for in-frame deletion of the 
aceA gene (isocitrate lyase) in 
C. glutamicum ΔaceA-4 AGAGAATTCCAACGCTGCTGGTGAAA
CAA (EcoRI) 
ΔaceA-control-fw GCCTAAACCAGAAGAATGCG Checking of in-frame deletion of the 
aceA gene and chromosomal 
integration of lys4-lys12 ΔaceA-control-rv CGCTACGGAATCGCAGATC 
Ptuf-aceA-rv 
CTACCTAGGTGTATGTCCTCCTGGACT
TC (AvrII) 
Amplification of the tuf promoter 
fragment of C. glutamicum for 
chromosomal integration into the 
ΔaceA locus 
lys4-aceA-fw 
CTACCTAGGATGCTACGATCAACCAC
ATTTA (AvrII) 
Amplification of the homoaconitase 
gene lys4 of S. cerevisiae for 
chromosomal integration into the 
ΔaceA locus 
lys12-aceA-rv 
AGACCCGGGCTATAATCTCGACAAAA
CGTCG (XmaI) 
Amplification of the homoisocitrate 
dehydrogenase gene lys12 of 
S. cerevisiae for chromosomal 
integration into the ΔaceA locus 
 
 
3.2 Chemicals and culture media 
All chemicals used in the course of this work were obtained by Merck AG (Darmstadt, 
Germany), Fluka (Steinheim, Germany), Sigma-Aldrich (Taufkirchen, Germany), Roth 
GmbH & Co. (Karlsruhe, Germany) and Roche Diagnostics GmbH (Mannheim, Germany). 
The components of complex media were used from Difco Laboratories (Detroit, USA). 
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The following media were used for cultivation 
LB medium: yeast extract (5 g l-1), tryptone (10 g l-1), NaCl (10 g l-1) 
BHI medium: brain heart infusion (37 g l-1)  
BHIS medium: brain heart infusion (37 g l-1), sorbitol (91 g l-1) 
CGXII medium: MOPS (42 g l-1), (NH4)2SO4 (20 g l-1), urea (5 g l-1), KH2PO4 (1 g l-1), 
K2HPO4 (1 g l-1), MgSO4 x 7 H2O (0.25 g l-1), CaCl2 (10 mg l-1), the pH 
was adjusted to 7 with KOH. After autoclaving, biotin (0.2 mg l-1), 
protocatechuate (30 mg l-1), glucose (4 g l-1) and supplementary salts 
containing FeSO4 x 7 H2O (10 mg l-1), MnSO4 x H2O (0.1 mg l-1), 
ZnSO4 x 7 H2O (1 mg l-1), CuSO4 x 5 H2O (0.2 mg l-1) NiCl2 x 6 H2O 
(20 µg l-1) were added to the medium 
SD medium: YNB (yeast nitrogen base) supplemented with NH4+ (6.7 g l-1), glucose 
(20 g l-1) and 10 ml l-1 100x amino acid solution (4 g l-1 tryptophan, 
4 g l-1 alanine, 2 g l-1 histidine, 2 g l-1 methionine, 6 g l-1 leucine, 3 g l-1 
lysine, 2 g l-1 uracil); before autoclaving the pH was adjusted to 6 with 
KOH     
M63 medium: KH2PO4 (3 g l-1), K2HPO4 (7 g l-1), (NH4)2SO4 (2 g l-1), FeSO4 
(0.5 mg l-1); pH adjusted to 7 with KOH. After autoclaving thiamine 
(100 mg l-1), MgSO4 x 7 H2O (0.16 g l-1) and glucose (2 g l-1) were 
added to the media. 
For agar plates, 18 g l-1 agar was added to the media. When appropriate, kanamycin (25 µg 
ml-1 for C. glutamicum or 50 µg ml-1 for E. coli) or tetracycline (5 µg ml-1 for C. glutamicum) 
were added to the culture medium or the agar plates. 
 
3.3 Cultivation and conservation of bacteria 
3.3.1 Cultivation of E. coli for plasmid isolation 
For plasmid isolation E. coli DH5α was routinely cultivated in 5 ml LB medium, 
supplemented with the appropriate antibiotics (kanamycin or tetracycline), for 12-24 h at 
37°C and 170 rpm. 
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3.3.2 Cultivation of C. glutamicum in shake flaks 
C. glutamicum was routinely cultivated at 30°C. For cultivation of C. glutamicum strains 
5 ml BHIS medium was inoculated with a single colony from a fresh BHIS agar plate and 
incubated for 8 h. 100 µl of the first preculture were used to inoculate a 100 ml baffled shake 
flask containing 20 ml BHIS medium and cultivated overnight at 30°C. The cells were 
washed with 0.9% NaCl. The 60 ml main culture (500 ml shake flask) was inoculated to an 
OD600 of 1 and cultivated on a rotary shaker (120 rpm). For all main cultures of 
C. glutamicum CGXII medium containing glucose (111 mM or 222 mM) as carbon and 
energy source was used. Strains harbouring an expression plasmid with a tac promoter were 
induced with 0.7 mM IPTG at an OD600 of 1. For modified CGXII medium with nitrogen 
limitation, urea (1.67 g l-1, 6.4%) was used as sole nitrogen source. Phosphate limitation was 
performed by reducing the phosphate concentration in the medium from 2 g l-1 to 0.15 g l-1, 
using KH2PO4. Cultivation with additional feeding in the stationary phase was performed by 
adding 222 mM glucose and 204 mM potassium acetate dissolved in standard CGXII 
medium. To test whether C. glutamicum was able to consume adipate, 2-oxoadipate or 
homocitrate, growth experiments were performed by adding various concentrations (50 mM 
to 500 mM) of these compounds to the glucose minimal medium of the main culture. The pH 
value of the various organic acid solutions was adjusted with NaOH or KOH to pH 7 before 
addition to the culture media.  
For DNA microarray analysis of the transcriptional response to the presence of adipate and 
2-oxoadipate, C. glutamicum cells were pregrown in CGXII minimal medium with 222 mM 
glucose and 50 mM of the respective dicarboxylate and then used to inoculate the main 
culture with the same medium composition to an OD600 of 1. Cells of the main culture were 
harvested in the exponential phase at an OD600 of 6 for RNA preparation. 
 
3.3.3  Conservation of bacteria  
For long-term conservation of E. coli and C. glutamicum strains, 2 ml of an overnight 
culture (12-15 h) were centrifuged at room temperature for 2 min at 5,000 x g. The cell pellet 
was resuspended in 0.75 ml of appropriate media (LB or BHIS) and mixed with 0.75 ml of 
sterile glycerol. The strains were stored in cryovials at -70°C. 
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3.3.4  Cultivation of C. glutamicum in a bioreactor 
For cultivating C. glutamicum strains in a bioreactor, a starter culture with 5 ml BHIS 
medium in a test tube was inoculated with a single colony of a fresh BHIS agar plate and 
incubated for 10-12 h on a rotary shaker a 30°C. A second preculture in a 100 ml baffled 
shake flask containing 60 ml CGXII minimal medium with 4% (222 mM) glucose as sole 
carbon source was inoculated to an OD600 of 0.25. After overnight cultivation at 30°C and 
120 rpm a 1.4 l bioreactor (Multifors multi fermenter system with six independent 
controllable bioreactors, Infors, Einsbach, Germany) was inoculated with cells of the 
preculture to an OD600 of 1. Each bioreactor contained 500 ml of modified CGXII minimal 
medium with 4% (222 mM) glucose as sole carbon source omitting the buffer substance 
MOPS. If required 25 µg ml-1 kanamycin and 0.7 mM IPTG were added. The bioreactor was 
fumigated with 0.9 l min-1 air. The flow rate was controlled by a mass flow regulator. Oxygen 
saturation during the experiment was measured online using a polarimetric oxygen electrode 
(Mettler Toledo, Giessen, Germany). To prevent dropping of oxygen saturation below 30%, 
oxygen was permanently held above 30% by stepwise increasing stirrer speed from 500 rpm 
to 800 rpm and increasing molecular oxygen in the inflow gas mix by 5% to a maximal value 
of 30%. The pH was also measured online using a standard electrode (Mettler Toledo) and 
automatically adjusted to pH 7 with 3 M sodium hydroxide and 3 M hydrochloric acid. Foam 
formation was prevented by automatic addition of 25% (v/v) Antifoam 204 suspension in 
water (Sigma Aldrich, Steinheim, Germany). Carbon dioxide and oxygen was measured in a 
partial flow of exhaust air with an Off-gas analyser (Infors). Determination of CO2 and O2 
concentration was performed via near-infrared absorption. Feeding of additional carbon 
sources (glucose and acetate) was automatically performed by either continuous feeding a 
solution of 25% (w/v) glucose and 12.5% (w/v) acetate in modified CGXII medium or by 
feeding the solution in dependency of oxygen saturation. When oxygen saturation was above 
80%, indicating that the cells did not further consume oxygen and thus were limited by carbon 
supply, glucose and potassium acetate were added to final concentrations of 20 mM and 
10 mM, respectively.  Another strategy was to add manually one pulse of a 25% glucose and 
12.5% acetate solution to final concentrations of 222 mM glucose and 204 mM potassium 
acetate. 
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3.3.5  Cultivation of S. cerevisiae  
For cultivation of S. cerevisiae strains a 5 ml culture in a test tube containing SD minimal 
medium was inoculated with a single colony from a fresh SD agar plate. This starter culture 
was incubated over night at 30°C and 170 rpm. Main cultures of S. cerevisiae were performed 
in shake flasks in 60 ml SD minimal medium at 30°C and 120 rpm, inoculated to an OD600 of 
0.25 with cells from the starter culture.     
 
3.4  Determination of growth parameters 
Cell growth in liquid culture was followed by measuring the optical density at 600 nm 
against a blank sample with an UV-1800 spectrophotometer (Shimadzu, Duisburg, Germany). 
For measuring in the linear detection range (OD600 0.05-0.75), the samples were diluted in 
water. The C. glutamicum biomass was calculated from the OD600 values using an 
experimentally determined correlation factor of 0.25 g (cell dry weight) l-1 for an OD600 of 1 
(Kabus et al., 2007). 
 
3.5 Molecular biology methods 
3.5.1 Isolation of nucleic acid 
3.5.1.1 Isolation of plasmid DNA 
E. coli or C. glutamicum strains harbouring a plasmid were cultivated overnight in 5 ml LB 
or BHIS media containing the appropriate antibiotics at 37°C or 30°C, respectively. The cells 
were harvested at room temperature by centrifugation at 5,000 x g for 2 min. For isolation of 
plasmid DNA of E. coli or C. glutamicum the QIAprep Spin Miniprep Kit (Qiagen, Hilden, 
Germany) or GeneJET Plasmid Miniprep Kit (Fermentas) were used according to the 
corresponding manual. The isolation procedure is based on alkaline cell lysis (Bimboim & 
Doly, 1979). Membrane-bound DNA was eluted with sterile water. The complex cell wall of 
C. glutamicum requires cell disruption for isolation of plasmid DNA, either by beat-beating 
three to four times for 20 s with silica beats (300 mg Ø 0.1 mm, Roth) using the Silamat® S5 
(Ivoclar Vivadent) or by shaking the cell suspension for 2 hours at 37°C in buffer P1 (Qiagen) 
or Resuspension solution (Fermentas) with 15 mg lysozyme (Schwarzer & Puhler, 1991). 
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3.5.1.2 Isolation of total RNA 
To isolate total RNA of C. glutamicum the strains were cultivated as described above (3.2 
and 3.3). 25 ml of the cultures were harvested by centrifugation at 5,000 x g and 4°C for 
5 min in prechilled falcon tubes, filled with 15 g of ice. The collected cells were either frozen 
in liquid nitrogen and stored at –20°C or directly used for RNA isolation. The cell pellets 
were resuspended in 700 µl RLT buffer supplemented with 10 mM dithiothreitol and 
transferred to a 1.5 ml reaction tube, loaded with ~300 mg silica beats (Ø 0.1 mm, Roth). The 
cells were disrupted by beat-beating three to four times for 20 s using the Silamat® S5 
(Ivoclar Vivadent). The isolation of total RNA of C. glutamicum was performed using the 
RNeasy Mini Kit (Qiagen) with on-column digestion of DNA. This method is based on cell 
lysis in the presence of dithiothreitol and guanidine isothiocyanate, which leads to inactivation 
of RNAses and allows the isolation of intact RNA. Afterwards the RNA was absorbed in the 
presence of ethanol and a specific salt solution (RNeasy Kit) to a silica-gel membrane which 
binds selectively single-stranded RNA molecules. Isolation steps were carried out according 
to the RNeasy Kit manual. The membrane-bound RNA was eluted with sterile water and 
stored at -20°C. 
 
3.5.1.3 Isolation of genomic DNA of S. cerevisiae 
Isolation of genomic DNA of the baker’s yeast S. cerevisiae was performed using the 
DNeasy Kit (Qiagen). 5 ml LB medium supplemented with glucose (20 g l-1) and casein (10 g 
l-1) was inoculated with 10 µl S. cerevisiae cell suspension to and incubated for 24 h at 30°C. 
3 ml of the culture was centrifuged at 6,000 x g for 2 min at room temperature. The cell pellet 
was resuspended in 180 µl ATL (DNeasy Kit, Qiagen) and transferred to a 1.5 ml reaction 
tube containing 200 mg silica beats (∅ 0.5 mm, ROTH). The cells were disrupted by beat-
beating two times for 30 s using the Silamat® S5 (Ivoclar Vivadent). The cell debris were 
separated by centrifugation at 6,000 x g for 2 min at room temperature. The supernatant was 
used for the isolation of genomic DNA according to the DNeasy Kit manual. The genomic 
DNA was eluted with sterile water and stored at 4°C.  
 
3.5.1.4 Purification of DNA fragments 
Purification of DNA fragments to remove residual nucleotides and enzymes after PCR and 
restriction digestion was performed using the PCR Purification Kit (Qiagen) according to the 
manual. The DNA was eluted with sterile water and stored at -20°C. 
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3.5.1.5 Isolation of DNA fragments from agarose gels 
To separate DNA fragments of PCR or restriction digests, agarose gel electrophoresis was 
performed. After electrophoresis the DNA fragment of interest was carefully excised. 
Extraction of the DNA fragments was done with the QIAquick Gel Extraction Kit (Qiagen) or 
Omnipure-OLS®-Kit (OMNI Life Sciences) according to the respective manual. The DNA 
fragments were eluted with sterile water and stored at -20°C. 
 
3.5.2  DNA gel electrophoresis 
Separation of DNA fragments by size in an electric field is based on the negatively charged 
DNA molecules. Electrophoresis was performed using 0.7% - 2% (w/v) agarose gels 
depending on the size of the fragment of interest in 1x TAE buffer. The samples were mixed 
with 6x loading buffer and loaded onto the gel, which contained one lane with GeneRuler™ 
(Thermo Scientific) 1 kb DNA marker. Electrophoresis was carried out in 1x TAE buffer at 
80-100 V for 1 hour. After electrophoresis the gel was stained with an ethidium bromide 
solution (2 μg/mL) for 10 min. Before gel documentation was done with an Image Master 
VDS System (Amersham Biosciences) the gel was destained for 10 min in a water bath.  
 
6x DNA loading buffer 4 M urea, 1 mM EDTA, 50% (w/v) sucrose, 0.1% (w/v) 
bromophenol blue 
 
50x TAE buffer   242 g Tris, 57.1 ml acetic acid, 14.7 g EDTA 
 
3.5.3  RNA gel electrophoresis 
RNA gel electrophoresis was used to check the quality and purity of isolated total RNA. 
Therefore 1.2% (w/v) formaldehyde gels were prepared adding 0.6 g agarose to 5 ml 10x FA 
buffer and 45 ml double autoclaved water. After heating in the microwave to dissolve the 
agarose 4 μl GelRed® solution was added. The solution was cooled to 60°C before 900 µl 
37% formaldehyde was added. The gel was polymerised and equilibrated for 30 min in 1x FA 
running buffer. The RNA samples were mixed with 5x RNA loading buffer and incubated for 
5 min at 65°C. The samples were chilled on ice and loaded onto the gel. RNA was separated 
by electrophoresis at 70-80 V for 75-90 min. Gel documentation was done with an Image 
Master VDS System (Amersham Biosciences). 
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FA buffer (10x) 200 mM MOPS, 50 mM sodium acetate, 20 mM EDTA,            
pH 7.0 (NaOH) 
FA running buffer (1x) 100 ml FA buffer (10x), 20 ml formaldehyde (37%), 880 ml 
H2O, pH 7.0 
RNA loading buffer (5x)  60 μl saturated bromophenol blue solution, 80 μl 0.5 M EDTA 
(pH 8.0), 720 μl formaldehyde (37%), 2 ml glycerol (100%), 
4 ml FA buffer (10 x), 3 ml formamide 
 
3.5.4 Determination of nucleic acid concentrations 
The concentration of nucleic acids was determined by measuring the extinction at 260 nm 
with a spectrophotometer (Nanodrop® ND-1000, PeqLab Biotechnologie GmbH, Erlangen). 
The following conversion factors were used to calculate the DNA or RNA concentration 
(Sambrook et al., 2001): 
Single-strand RNA: OD260 = 1 corresponds to a concentration of 40 μg/ml 
Double-strand DNA: OD260 = 1 corresponds to a concentration of 50 μg/ml 
The purity of DNA and RNA was determined by the ratio of OD260/OD280, which should be 
between 1.8 and 2.0 for DNA and at 2.0 for RNA. 
 
3.5.5 Recombinant DNA work 
3.5.5.1 Restriction of DNA 
Restriction of DNA fragments was performed using type II restriction endonucleases at 
37°C. The enzymes were obtained from Fermentas or New England Biolabs. Restriction with 
the “Fast Digest Enzymes” of Fermentas was performed for 45 min using the “Fast Digest 
buffer”. When using the enzymes of New England Biolabs the recommended “NEBuffer” was 
used and digestion was performed for 2 h. Restriction of PCR products or plasmids was 
performed in a total volume of 100 µl, containing 1-2 U of the enzymes per µg of DNA and 
1-2 µg of digested DNA. The buffer for double digests with enzymes of New England Biolabs 
was chosen according to the recommendations of the manufacturer.  
 
3.5.5.2 Dephosphorylation of restricted plasmid DNA  
Alkaline phosphatase catalyses hydrolytic elimination of a phosphate group at the 5’-end 
of DNA and was used to prevent recircularisation of plasmid DNA during ligation. For 
dephosphorylation of restricted plasmid DNA the “shrimp alkaline phosphatase” from Roche 
Material and methods  31 
Diagnostics was used. The plasmid was incubated with 1 U of the phosphatase for 1 h at 
37°C. Afterwards the phosphatase was inactivated by heating to 65°C for 15 min. 
 
3.5.5.3 Ligation 
The T4 DNA ligase catalyses the formation of a phosphodiester bond between 
5’-phosphate and 3’-hydroxy groups in double-stranded DNA. For ligation of PCR products 
with appropriate plasmids the “DNA Rapid Ligation” Kit of Fermentas was used. The ligase 
catalyses both, ligation of sticky- and blunt-ended DNA fragments. Ligation was carried out 
in 20 µl mixtures containing 100 ng plasmid DNA and a 2-3 times molar excess of the PCR 
product. The reaction was incubated for 1 h at room temperature or overnight at 4°C. 
 
3.5.6 Generation and transformation of competent E. coli cells 
Generation of competent, logarithmic grown E. coli cells were performed by RbCl2 
treatment to introduce free DNA into the cell. The preparation of competent cells was 
performed according to Hanahan (Hanahan, 1985). 5 ml LB medium in a test tube was 
inoculated with a single colony from a fresh agar plate and cultivated overnight at 37°C and 
170 rpm. 200 µl of this culture was inoculated into 70 ml LB medium and cultivated to an 
OD600 of 0.6 at 37°C and 120 rpm. The culture was transferred to a precooled 50 ml falcon 
tube and chilled on ice for 15 min. The cells were harvested by centrifugation for 10 min at 
4°C and 5,000 x g. Afterwards the cell pellet was resuspended in 25 ml RF1 solution and 
incubated on ice for 10 min, followed by centrifugation for 10 min at 4°C and 5,000 x g. The 
pellet was resuspended in 2 ml RF2 solution and dispensed in 150 µl aliquots, which were 
frozen in liquid nitrogen and stored at -70°C.  
 
RF1 solution  100 mM RbCl, 50 mM MnCl2, 30 mM potassium acetate, 10 mM 
CaCl2, pH 5.8 (acetic acid) 
The solution was filter-sterilized before use. 
 
RF2 solution  10 mM RbCl, 10 mM MOPS, 75 mM CaCl2 x 6 H2O, 15% (v/v) 
glycerol, pH 5.8 (NaOH) 
The solution was autoclaved before use. 
 
Transformation of chemically competent E. coli cells was carried out by a heat shock 
protocol. 10-100 ng of plasmid DNA or 10 µl of ligation mixture was mixed with 150 µl of 
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competent cells and incubated for 20 min on ice. To transfer the DNA into the cells a heat 
shock at 42°C for 1 min was performed. Subsequently, the cells were regenerated by adding 
500 µl of LB medium to the cells and by incubation for 1 h at 37°C and 300 rpm. The cell 
suspension was plated on LB agar plates containing the appropriate antibiotics and incubated 
overnight at 37°C. 
 
3.5.7 Generation and transformation of competent C. glutamicum cells 
Generation of electro-competent C. glutamicum cells was performed according to the 
protocol of Tauch et al., 2002. A 20 ml BHIS starter culture (100 ml shake flask) was 
inoculated with a single colony from a fresh BHIS agar plate and incubated overnight at 30°C 
and 120 rpm. The 50 ml BHIS main culture (500 ml shake flask) was inoculated to an OD600 
of 0.5 and cultivated at 30°C and 120 rpm to an OD600 of 1.75. The cells were transferred to a 
50 ml falcon tube and harvested by centrifugation at 4°C and 5,000 x g for 20 min. After the 
supernatant had been completely removed, the pellet was resuspended in 8 ml ice-cold TG 
buffer and centrifuged for 10 min at 4°C and 5,000 x g. This washing step was repeated two 
times. Afterwards the cell pellet was resuspended in 8 ml ice-cold 10% (v/v) glycerol and 
centrifuged for 10 min at 4°C and 5,000 x g. This washing step was repeated two times. Then 
the supernatant was completely removed, the cell pellet was resuspended in 2 ml ice-cold 
10% glycerol and dispensed in 150 µl aliquots. The aliquots were frozen in liquid nitrogen 
and stored at -70°C.  
 
TG buffer   1 mM Tris-HCl pH 7.5, 10% (v/v) glycerol 
 
The transformation of C. glutamicum was performed by electroporation. Initially, 4 ml BHIS 
medium was pre-warmed to 46°C in a water bath. Competent C. glutamicum cells were gently 
thawed on ice and mixed with 0.1-2 µg plasmid DNA. The mixture was transferred to a 
0.2 cm Gene Pulser cuvette (BioRad) and carefully covered with 0.8 ml 10% (v/v) glycerol. 
Electroporation was performed at 2.5 kV, 25 μF and 200 Ω, at which the time constant should 
be between 3.5 ms and 4 ms. Subsequently, the cell suspension was transferred into a 15 ml 
falcon tube containing pre-warmed BHIS medium for heat-shocking the cells at 46°C for 
6 min. Then the cells were regenerated for 50 min at 30°C and 170 rpm. The cell suspension 
was plated onto BHIS agar plates containing the appropriate antibiotics and incubated over 
night at 30°C. 
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3.5.8 Polymerase chain reaction (PCR) 
The polymerase chain reaction is a method for amplification of DNA fragments (Mullis et 
al., 1986). PCR was performed either in a PCR Gene Amp PCR System 9700 (Applied 
Biosystems) or in a Mastercycler Personal (Eppendorf) according to standard set up (see 
below). Amplification for preparative procedures was done with KOD Hot Start Polymerase 
(Novagen, Darmstadt, Germany), Advantage HD Polymerase (Clontech) or Phusion® High-
Fidelity DNA Polymerase (New England Biolabs, Frankfurt am Main, Germany). For 
analytical procedures or checking transformed cells Taq DNA polymerase from Fermentas 
was used. Colony PCR was performed by transferring cell material of a colony to the PCR 
reaction tube. An initial denaturation step for 10 min at 95°C was used to disrupt the cells. 
The annealing temperature was chosen 2-4°C below the melting temperature of the 
oligonucleotides. The melting temperature was calculated using the formula TM [°C] = [(G + 
C) x 4] + [(A + T) x 2]. The extension time of the PCR was chosen according to the size of 
the DNA fragment to be amplified (1 min for 1,000 bp). Amplification using the Advantage 
HD Polymerase (Clontech) was performed lacking the annealing step. For overlap extension 
PCR both preliminary amplified PCR products were used in equal molar ratio. This method is 
based on identical 15-30 bp at the 3’-end of the first DNA fragment and the 5’-end of the 
second fragment. In contrast to the standard PCR set up, the overlap extension PCR set up 
contained 20-50 ng of each DNA fragment, the forward primer of the first fragment and the 
reverse primer of the second fragment. The oligonucleotides used in the course of this work 
are listed in Tab. 3. 
 
50 μl standard PCR set up 
PCR buffer according to manufacture manual 
dNTP mix (10 mM each, Roche Diagnostics) 1 μl 
MgSO4 (25 mM) (only in case of KOD) 3 μl 
forward (5’) primer (10 μM) 2 µl 
reverse (3’) primer (10 μM) 2 µl 
Template DNA 0.5-50 ng 
DNA polymerase 0.02 U 
Sterile water to 50 µl total volume 
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3.5.9 Construction of expression plasmids 
For expression of heterologous genes in E. coli and C. glutamicum the plasmids pEKEx2 
and pVWEx2 were used (Tab. 2). The genes were amplified from chromosomal DNA of 
S. cerevisiae (provided by Prof. Hegemann, Heinrich Heine University Duesseldorf, 
Germany), T. thermophilus (DSMZ, Braunschweig, Germany) or A. vinelandii (DSMZ, 
Braunschweig, Germany) using the oligonucleotides listed in Tab. 3. In front of each gene an 
artificial ribosomal binding site (GAAAGGAGG) was cloned, with the last “G” located 9 bp 
in front of the start codon. After amplification the DNA fragments were purified and restricted 
with appropriate enzymes (Tab. 3). The restricted DNA fragments were purified and ligated 
with the appropriately restricted vector DNA, followed by transformation of E. coli DH5α 
cells. E. coli colonies grown on the selective agar plates were chosen to test for the desired 
recombinant plasmid by colony PCR with plasmid or target gene specific oligonucleotides 
(Tab. 3).  
 
3.5.10 Construction of chromosomal gene replacements using the pK19mobsabB system 
The gdh gene was replaced by the HCS gene lys20. Three different promoters (Ptuf, PgapA, 
Ptac) have been fused to lys20 to test their ability for HCS expression. For this purpose the 
three plasmids pK19mobsacB-Δgdh::Ptuf-lys20, pK19mobsacB-Δgdh::PgapA-lys20, 
pK19mobsacB-Δgdh::Ptac-lys20 were constructed. Therefore, the up- and downstream regions 
(approximately 500 bp each) of the gdh gene, containing codons for the first 7 and the last 17 
amino acids of the gdh sequence, were amplified from chromosomal DNA of C. glutamicum 
using the oligonucleotides pairs designated Δgdh-1/Δgdh-2 and Δgdh-3/Δgdh-4 (Tab. 3). The 
resulting PCR products served as templates for an overlap extension PCR using the 
oligonucleotides Δgdh-1 and Δgdh-4. This overlap PCR product, named Δgdh-olf 
(overlapping fragment), contained a multiple cloning site harbouring the restriction sites NotI, 
AflII and XmaI as well as seven in-frame stop codons terminating the translation of Gdh. The 
overlap PCR product Δgdh-olf (approximately 1,000 bp) was digested with the enzymes 
HindIII and EcoRI and cloned into the vector pK19mobsacB, designated pK19mobsacB-
Δgdh. The promoters Ptuf and PgapA were amplified from chromosomal DNA of C. glutamicum 
using the oligonucleotides Ptuf-fw/Ptuf-rv and PgapA-fw/PgapA-rv, respectively (Tab. 3). The 
plasmid pVWEx1 served as template for the amplification of the promoter Ptac with the 
oligonucleotides Ptac-fw and Ptac-rv (Tab. 3). The PCR products of the three different 
promoters were digested with the enzymes NotI and AflII and cloned into the plasmid 
pK19mobsacB-Δgdh. The resulting plasmids were named pK19mobsacB-Δgdh::Ppromoter name. 
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For the cloning of the homocitrate synthase the gene lys20 was amplified from chromosomal 
DNA of S. cerevisiae using the oligonucleotides lys20-Δgdh-fw and lys20-Δgdh-rv (Tab. 3), 
digested with the enzymes AflII and XmaI and cloned into the plasmid pK19mobsacB-
Δgdh::Ppromoter name, designated  pK19mobsacB-Δgdh::Ppromoter name-lys20. For gene expression 
an artificial ribosomal binding site (AGGAGGA) was cloned in front of the lys20 gene, with 
the last “A” located 7 bp in front of the start codon.   
The construction of the plasmid for the gene replacement of the gene aceA by the fused 
genes lys4-lys12 was performed as described above. The oligonucleotides used for the ΔaceA 
overlap fragment were named ΔaceA-1/ΔaceA-2 and ΔaceA-3/ΔaceA-4 (Tab. 3). The multiple 
cloning site within the ΔaceA-olf contained the restriction sites for the enzymes NotI, AvrII 
and XmaI as well as seven in-frame stop codons terminating the translation of aceA. 
Amplification of the Ptuf-promoter was performed using the oligonucleotides Ptuf-fw and 
Ptuf-aceA-rv. The genes lys4 and lys12 were amplified from plasmid pVWEx2-lys4-lys12 
using the oligonucleotide lys4-aceA-fw/lys12-aceA-rv (Tab. 3). The PCR product was 
digested with the enzymes AvrII and XmaI and cloned into the vector pK19mobsacB-
Δace::Ptuf resulting in the plasmid pK19mobsacB-ΔaceA::Ptuf-lys4-lys12. The deletion/ 
integration of the genes was performed with a two-step homologous recombination technique 
as described by Niebisch & Bott, 2001. Kanamycin-sensitive and sucrose-resistant clones 
were analysed via colony PCR with the corresponding oligonucleotides Δgene-control-fw and 
Δgene-control-rv (Tab. 3). 
 
3.5.11  Site-directed mutagenesis  
Site-directed mutagenesis of the homocitrate synthase of S. cerevisiae was performed using 
the QuikChange XL Site-Directed Mutagenesis Kit (Agilent Technologies, Waldbronn, 
Germany). Replacement of a single base from G to A caused a change in the amino acid 
sequence from L-arginine to L-lysine (Feller et al., 1999). The plasmid pEKEx2-lys20 served 
as template for the amplification with the oligonucleotides lys20R276K-fw and lys20R276K-rv 
(Tab. 3) which were used to incorporate the point mutation. Further steps were carried out 
according to the manufacturer’s manual with the exception that E. coli DH5α was used for 
transformation. The obtained point mutation was checked via DNA sequencing.  
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3.5.12 DNA sequencing 
DNA sequencing was performed using the single read sequencing service of Eurofins 
MWG Operon. The samples were premixed with gene-specific primers or primers binding to 
the plasmid backbone according to the sequencing guidelines of the company. The received 
sequences were compared to the in-silico sequences using the freeware tool BioEdit (Ibis 
Biosciences, Carlsbad, USA). 
 
3.6 Quantification of glucose and organic acids in the cell culture supernatant 
For the quantification of substrate consumption and product formation, 1 ml samples were 
taken from cultures and centrifuged at room temperature at 6,000 x g for 5 min. The 
supernatant was transferred to a new 1.5 ml reaction tube and centrifuged at room temperature 
at 15,000 x g for 10 min. The supernatant was diluted 4 times in pure water and analysed via 
HPLC. Determination of glucose and organic acids in the cell-free culture supernatant was 
performed using an Agilent 1100 LC-system (Agilent Technologies, Waldbronn, Germany). 
Organic acids were detected with an Agilent 1100 Diode Array Detector and glucose with an 
Agilent 1100 Refractive Index Detector. Separation was carried out on a 300 x 8 mm organic 
acid column (polystyrol-divinylbenzol resin) and a guard column loaded with the same 
material (CS Chromatographie Service GmbH, Langerwehe, Germany). Isocratic elution was 
performed for 38 min at 40°C with 100 mM sulphuric acid as mobile phase at a flow rate of 
0.4 ml/min. Quantification was done using calibration curves obtained from external 
standards dissolved in pure water. 
 
3.7 GC-ToF-MS analysis of metabolites in the cell culture supernatant 
For detection and analysis of metabolites in cell culture supernatants by GC-coupled mass 
spectrometry, 500 µl samples were taken from the culture at various time points during 
cultivation and centrifuged for 5 min at 13,000 x g and room temperature. 130 µl of the 
supernatant were shock-frozen in liquid nitrogen, lyophilised overnight in a Christ LT-105 
freeze drier and then stored at -20 °C. The dried samples were consecutively derivatised with 
50 µL MeOX (20 mg/mL O-methylhydroxylamine in pyridine) for 90 min at 30 °C and 
600 rpm in a Thermomixer followed by an incubation with additionally 80 µL of MSTFA (N-
acetyl-N-(trimethylsilyl)-trifuoroacetamide) for 90 min at 40 °C and 600 rpm. 1 µl of the 
samples was used for analyses. For the determination of the derivatised metabolites an 
Agilent 6890N gas chromatograph, equipped with a 30 m Varian FactorFour Vf-5ms column 
and a 10 m guard column was used coupled to a Waters Micromass GCT Premier high 
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resolution time of flight mass spectrometer. The system was controlled with the software 
Waters MassLynx 4.1. Under constant helium flux of 1 ml min-1 a temperature of 60°C was 
hold for 2 min and then increased gradually by 12°C min-1 to 300°C, which was hold for 
8 min. The ToF-MS was performed in [EI]+ modus with an energy of 70 eV and an ionisation 
temperature of 180°C. The MS was calibrated by the fragmentation pattern of 
Heptacosafluoro-tributylamin and the obtained masses were adjusted by Chloropentafluoro-
benzene as an external standard.  To identify the metabolites, masses were compared to the 
databases JuPoD (in-house database), NIST (National Institute of Standards and Technology) 
and GMD (Golm Metabolome Database). The GC-ToF-MS measurements and subsequent 
data analysis were performed by Jochem Gätgens (IBG-1: Biotechnology, Systems 
Biotechnology, Forschungszentrum Jülich GmbH, Germany). 
 
3.8 Protein analysis 
3.8.1 Determination of protein concentration 
Protein concentrations of crude extracts were measured using the Bradford assay. This 
method is based on the formation of a complex between the dye Coomassie brilliant blue G 
and proteins. The unbound dye shows peak absorption at 465 nm, whereas the absorption 
shifts to 595 nm when a dye-protein complex is formed. 100 µl of appropriately diluted 
protein samples were mixed with 900 µl Bradford reagent (Sigma-Aldrich, Taufkirchen, 
Germany) and incubated for 10 min at room temperature in the dark. After incubation the 
absorption was measured at 595 nm. The calculation of the protein concentration was based 
on a calibration curve with bovine serum albumin (BSA) in the range of 20-100 µg/ml. 
 
3.8.2 Homocitrate synthase enzyme assay 
C. glutamicum strains containing either plasmid- or chromosomal-encoded homocitrate 
synthase were grown on BHIS agar plate and 5 ml BHIS liquid medium containing 
kanamycin if necessary were inoculated with a single colony. After cultivation for 9 h at 30°C 
100 µl of the preculture were inoculated into 20 ml BHIS medium and cultivated overnight at 
30°C. This preculture was then used to inoculate the main culture containing 60 ml CGXII 
minimal medium with 222 mM glucose to an OD600 of 1. Heterologous gene expression of 
plasmid-containing strains was induced with 1 mM IPTG at an OD600 of 1. Cells were 
harvested by centrifugation (15 min, 4,000 x g, 4°C) during the exponential phase after 6 h of 
growth and in the stationary phase after 24 h of cultivation, respectively. The supernatant was 
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completely removed and the cell pellet was either immediately used for the enzyme assay or 
frozen in liquid nitrogen. The enzyme activity assay was performed using the photo-
colorimetric DCPIP (dichlorophenol indophenol) method as described previously (Quezada et 
al., 2011). In the oxidised state DCPIP is blue and colourless when it is reduced. In this assay, 
homocitrate synthase activity was determined by measuring the reduction of DCPIP at 
600 nm (ε600nm = 20,600 cm-1 M-1), which oxidise free CoASH that is released during the 
condensation of acetyl-CoA and 2-oxoglutarate (Armstrong, 1964, Schöbel et al., 2010). 
Calculation of homocitrate synthase activity is based on a stoichiometry of 1:1 between 
CoASH and DCPIP (Andi et al., 2004). For the enzyme assay the cells were washed with 50 
mM MOPS pH 7.0 and 0.1% Triton X-100. The crude extract was obtained by disrupting the 
cells by bead-beating with silica beads (Ø 0.1 mm, Roth) three to four times for 20 s using the 
Silamat® S5 (Ivoclar Vivadent). The crude extract was separated from the cell debris by 
centrifugation (25 min, 13,000 x g, 4°C) and used for the enzyme assay. The assay was 
performed in a 1 ml mixture containing 50 mM HEPES pH 7.2, 100 mM 2-oxoglutarate, 
0.1 mM DCPIP and 0.25 mM acetyl-CoA. After equilibration (5 min, 30°C) the assay was 
started by adding variable amounts of the crude extract. The decreasing absorption was 
measured for 10 min at 600 nm. 
 
3.9 Global gene expression analysis using DNA microarrays 
DNA microarray technology permits the comparison of genome-wide mRNA 
concentration of two independent samples, by using two differently fluorescence-labelled 
cDNA samples (Frunzke et al., 2008). The used arrays were glass slides spotted with 
synthetic oligonucleotides. Analysis of global gene expression of C. glutamicum was 
performed with custom-made whole genome DNA microarrays (Operon Biotechnologies, 
Cologne, Germany) containing sequence-specific 70mer oligonucleotides of the 
C. glutamicum genome (Kalinowski et al., 2003). The spotted oligonucleotides represented 
3057 protein coding genes, 1294 intergenic regions, 50 tRNA genes, 15 rRNA genes and 140 
oligonucleotides for positive and negative controls.  
 
3.9.1 cDNA synthesis 
For DNA microarray analysis of C. glutamicum, fluorescently labelled cDNA was 
synthesised from RNA isolated from cells harvested in the exponential growth phase. 
Fluorescence labelling was performed by using the dUTP analogues Cy3-dUTP (λabsorption max 
550 nm, λfluorescence max 570 nm, green, Amersham Biosciences) and Cy5-dUTP (λabsorption max 
649 nm, λfluorescence max 670 nm, red, Amersham Biosciences). For cDNA synthesis equal 
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amounts of isolated RNA samples (20-25 µg) were mixed with 1 µl (500 ng) of pdND6 
random hexamer primer (Amersham Biosciences) and filled up to 15 µl with RNase free 
water. The mixtures were incubated for 10 min at 65°C followed by incubation on ice for 
2 min. Afterwards 3 μl of the 1 mM dUTP analogues were added and the reverse transcription 
of the RNA was performed by adding the following reaction mixture (components obtained 
from Life Technologies GmbH, Darmstadt, Germany): 
 
First Strand buffer (5x)      6 μl 
DTT (0.1 M)       3 μl 
dNTPs (25 mM dATP, dCTP, dGTP and 10 mM dTTP)  0.6 μl 
Superscript® II (200 U/ml)      2 μl 
 
Reverse transcription was performed at room temperature for 10 min and afterwards for 110 
min at 42°C. The cDNA reaction was stopped by adding 10 µl 0.1 N NaOH and incubation 
for 10 min at 70°C. 10 µl of 0.1 N HCl was added to neutralise the mixture. To remove 
oligonucleotides and enzyme components and to concentrate the cDNA, ultrafiltration using 
Microcon YM-30 (Millipore) was performed. The reaction mixtures were transferred to 
Microcons containing 450 µl RNase-free water and centrifuged for 10 min at room 
temperature and 16,100 x g. The cDNA samples were pooled and the washing step (480 µl 
RNase-free water) was repeated two times. The concentrated cDNA (10 µl) was directly used 
for DNA microarray hybridisation.  
 
3.9.2 C. glutamicum DNA microarray hybridisation 
3.9.2.1 Array pre-hybridisation 
To check the spotting and the background the DNA microarray was pre-scanned at 
wavelengths of 532 nm and 635 nm at 600 PMT with a GenepixTM 4000B Laser Scanner 
(Axon Instruments). Pre-hybridisation was performed to saturate unspecific binding sites. The 
SDS-containing OpArray Pre-Hyb solution (Operon Biotechnologies) was heated to 42°C and 
50 ml were filtrated with a 0.2 µm syringe filter (Sarstedt) into a 50 ml falcon tube to remove 
undissolved SDS. The DNA microarray was gently slewed in this solution at 42°C for 1 h. 
Afterwards the microarray was slewed for 5 min at 37°C in Wash A solution (1.25 ml 
Wash B, Operon Biotechnologies, 48.75 ml H2Obidest) and washed twice with water. 
Subsequently, the slide was transferred to a new falcon tube and dried by centrifugation at 
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1,300 x g for 5 min. To determine the background after pre-hybridisation the slide was 
scanned at 532 nm and 635 nm at 600 PMT.  
 
3.9.2.2 DNA microarray hybridisation 
The concentrated Cy3- and Cy5-labeled cDNA samples (5 µl) were mixed with 50 µl 
OpArray Hyb Solution (Operon Biotechnologies), denatured at 95°C for 3 min and cooled to 
42°C. For hybridisation, a mixer (MAUI®Mixer AO, BioMicro® Systems) was fixed via 
adhesive strips at the frame to the slide which generates a space between mixer and slide. The 
denatured cDNA samples were transferred into the fillport of the DNA microarray. To avoid 
evaporation during the hybridisation the fillports were sealed with adhesive strips. 
Hybridisation was performed using the pre-heated MAUI® hybridisation system (BioMicro® 
Systems) for 14-16 h at 42°C. 
 
3.9.2.3 Post-hybridisation  
Before starting post-hybridisation of the DNA microarray, Wash 2, 3, and 4 solutions had 
to be prepared in 50 ml falcon tubes. All washing steps were performed in the dark to avoid 
damage of the fluorescent dyes. Initially, Wash 2 solution was filtered and heated to 42°C. In 
Wash 2 solution the DNA microarray was quickly removed from the mixer to avoid drying. 
The slide was gently slewed in Wash 2 solution for 10 min at 42°C. Afterwards the 
microarray was slewed in Wash 3 solution for 10 min at 37°C and in Wash 4 solution for 
5 min at room temperature. Subsequently, the microarray was quickly transferred to a 50 ml 
falcon tube and dried by centrifugation at 1,300 x g for 5 min. After post-hybridisation, 
scanning of the DNA microarray was performed using the GenepixTM 4000B Laser Scanner. 
 
Wash 2  5 ml Wash A, 2.5 ml Wash B, 42.5 ml H2O 
Wash 3  5 ml Wash A, 45 ml H2O 
Wash 4  1 ml Wash A, 49 ml H2O 
 
Wash A and Wash B were ordered from Operon Biotechnologies. 
3.9.3 Measurement and analysis of the fluorescence signals 
For determination of the relative mRNA level of the samples to be compared, the surface 
of the DNA microarrays was irradiated with monochromatic light at wavelengths of 532 nm 
and 635 nm to stimulate the fluorescent dyes Cy3-dUTP and Cy5-dUTP, respectively. The 
ratio of Cy3- and Cy5- fluorescence correlates to the relative number of mRNA molecules in 
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the samples and therefore it is a dimension for the relative mRNA level. The emitted 
fluorescence was registered by light sensitive cathodes at 570 nm (Cy3 fluorescence) and at 
670 nm (Cy5 fluorescence) that convert the emitted fluorescence into electrical current, which 
was further amplified. The determined electric current correlates directly with the Cy3 and 
Cy5 fluorescence. The fluorescence of each spot was converted to a numerical value and 
assigned to the appropriate genes of C. glutamicum (gene array lists) using the Genepix Pro 
6.0 software. The calculation of signal to noise ratios of Cy3- and Cy5-fluorescent signals 
resulted from the quotient signal intensityspot/signal intensitybackground. Fluorescent signals 
exhibiting a signal to noise ratio less than 3 were not included in the further analysis. The 
numerical values of the fluorescent signals were normalised by using R-packages limma and 
marray (http://www.bioconductor.org/). Normalised data were uploaded to an in-house 
database for further analyses. Genes showing up- or down-regulation (ratio of Cy3/Cy5) less 
than 2-fold were not considered as “regulated” in the further analysis.  
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4  Results 
4.1 Influence of 2-oxoadipate and adipate on growth parameters of C. glutamicum 
For an industrial scale production process of 2-oxoadipate and later on of adipate the 
impact of the intermediates, occurring during the production process, on the host organism is 
of great interest. In case of C. glutamicum adipate is no biological intermediate of the 
metabolism and thus not characterised concerning toxicity or inhibitory effects. In contrast, 
2-oxoadipate occurred naturally in C. glutamicum as an intermediate of the tryptophan 
degradation pathway (Kegg Map 00380). The tricarboxylate homocitrate is structurally 
related to citrate and occurs naturally not only as an intermediate of the α-aminoadipate 
pathway but also as a component (organic ligand) of the iron-molybdenum cofactor of 
nitrogenases in nitrogen fixing bacteria (Durrant et al., 2006). Cultivation experiments to 
analyse the influence of the available α-aminoadipate pathway intermediates homocitrate and 
2-oxoadipate as well as of adipate on growth parameters of C. glutamicum were performed. 
Furthermore, it was investigated whether C. glutamicum possesses the ability to metabolise 
these substances. The remaining intermediates of the AAA pathway were not commercially 
available and were not tested.  
To analyse the growth behaviour of C. glutamicum in response to adipate, 2-oxoadipate 
and homocitrate, the wild-type strain was cultivated in the presence of various concentrations 
of these substances. The cultivations were performed in medium-scale shake flasks (60 ml 
medium) and in the micro-scale BioLector cultivation system (750 µl medium). The CGXII 
minimal medium contained 2% (111 mM) glucose as carbon source and were supplemented 
with adipate in concentrations of 0 mM (control), 50 mM (7.3 g l-1), 150 mM (21.9 g l-1), 
250 mM (36.5 g l-1) and 500 mM (73.1 g l-1) or with 50 mM (8 g l-1) 2-oxoadipate. The pH 
value of the adipate and 2-oxoadipate solutions was adjusted with NaOH to pH 7 before 
added to the cultivation media. The main culture was inoculated with C. glutamicum wild-
type cells to an OD600 of 0.5. Growth was observed for 30 h (Fig. 4A). Concentrations of up 
to 50 mM adipate did not significantly affect the growth of C. glutamicum wild-type cells, as 
similar growth rates of 0.41 ± 0.03 h-1 and 0.4 ± 0.02 h-1 were observed in the absence and 
presence of 50 mM adipate. Cultivation in the presence of 250 mM adipate caused a 37% 
decrease of the growth rate (µ = 0.29 ± 0.002 h-1), compared to the control culture, whereas 
the final OD600 was only slightly decreased from 30.1 ± 1.6 to 28.6 ± 2.0. C. glutamicum cells 
cultivated in the presence of 500 mM adipate showed a strong growth defect with a growth 
rate of 0.08 ± 0.01 h-1and reached only 10% of the maximal OD600 of the control culture 
(OD600 = 2.96 after 30 h). Cells growing in the presence of 50 mM 2-oxoadipate showed a 
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similar growth rate (µ = 0.37 ± 0.04 h-1) and maximal OD600 (32.5 ± 5.8) as the control culture 
(µ = 0.37 ± 0.03 h-1, maximal OD600 = 34.1 ± 0.7).  
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Fig. 4: Growth and concentrations of organic acids during shake flask cultivations in the presence of 
adipate and 2-oxoadipate. (A) Growth of C. glutamicum wild type in CGXII minimal medium with 2% (w/v) 
glucose and either no supplement ( ) or supplemented with 50 mM ( ), 250 mM ( ) or 500 mM ( ) 
adipate or with 50 mM 2-oxoadipate ( ). (B) Concentrations in the supernatant of adipate and 2-oxoadipate in 
cultures supplemented with either 50 mM ( ) or 500 mM ( ) adipate or with 50 mM 2-oxoadipate (50 mM 
( ). Medium supplemented with 50 mM 2-oxoadipate but without cells was used as a control to check for 
chemical degradation of this compound ( ). Mean values from three independent experiments were shown. 
HPLC measurements of adipate and 2-oxoadipate in the control culture were performed only in single analyses. 
Besides the growth of C. glutamicum in the presence of 2-oxoadipate and adipate, the 
metabolisation of the substances by C. glutamicum was tested (Fig. 4B). The quantification of 
the organic acids was performed by HPLC analysis of the cell-free supernatant of samples 
taken during the cultivation. No significant concentration changes were detected over 30 h in 
the cultures containing 50 mM and 500 mM adipate. The determined average of 45.7 mM and 
467.9 mM showed a variation of 8.6% and 6.6%, respectively. In contrast 2-oxoadipate 
continuously decreased over 30 h from 34 ± 3.7 mM to 16 ± 2.7 mM. Surprisingly, only 
34 mM 2-oxoadiapte was found at the beginning of the cultivation instead of the expected 
50 mM. In the control culture without cells an initial concentration of 54 mM was found, in 
good agreement with the expectation. An explanation for this could be the immediate binding 
of 2-oxoadipate to the cells directly after inoculation leading to extraction of 2-oxoadipate 
from the media. Further it is possible that 2-oxoadipate enters the cell and C. glutamicum can 
metabolise 2-oxoadipate via the tryptophan metabolism to some extent. Since it is reported 
that 2-oxoadipate can be converted to glutaryl-CoA by 2-oxoglutarate dehydrogenase within 
the tryptophan metabolism (http://www.genome.jp/kegg-bin/show_pathway?org_name=cgb& 
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mapno=00380&mapscale=&show_description=hide) this might be a reason for the 
continuous decrease during cultivation. 
Further, the impact of homocitrate, the first intermediate of the AAA pathway, on 
C. glutamicum wild-type cells was tested. Since homocitrate is an expensive substance, 
cultivation experiments were performed in 750-µl-scale using the BioLector system. In 
addition, 2-oxoadipate and adipate growth experiments were performed under these 
conditions. The experiments were done in 48-well plates at 30°C and 1200 rpm. The main 
culture containing 750 µl CGXII minimal medium with 4% glucose (222 mM) was 
supplemented with 50 mM of either homocitrate, 2-oxoadipate or adipate and inoculated to an 
OD600 of 1. As controls, cultures containing C. glutamicum cells without supplements and 
media with supplements but without cells were used. Growth was automatically monitored by 
the BioLector System over 47 h (Fig. 5), measuring the absorption seven times per hour. 
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Fig. 5: Growth of C. glutamicum wild type in the presence of adipate, 2-oxoadipate and homocitrate in a 
micro-scale BioLector system. C. glutamicum wild type was cultivated in CGXII minimal medium with 4% 
(w/v) glucose and either no supplement ( ) or supplemented with 50 mM homocitrate ( ), 50 mM 
2-oxoadipate ( ), or 50 mM adipate ( ). The control culture containing 50 mM 2-oxoadipate without cells is 
indicated by ( ). Data of representative experiments are shown and two independent replicates gave 
comparable results.   
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After 0 h, 24 h and 47 h samples were taken to determine the concentrations of the organic 
acid in the supernatant. The cultivation of C. glutamicum in the presence of 2-oxoadipate and 
adipate under these conditions showed similar results to the experiments in shake flasks: In 
comparison to the control culture without additives, no growth retardation was observed. The 
addition of 50 mM homocitrate also revealed no growth inhibition. In contrast to the similar 
growth rates observed for all tested conditions, a difference in the maximal OD600 was 
observed for the culture supplemented with 50 mM 2-oxoadipate. The cells reached 94% of 
the maximal OD600 compared to supplementation with adipate or homocitrate. The results of 
the organic acid quantifications in the cell-free culture supernatants revealed constant 
concentration over 47 h for all three tested metabolites, with and without cells (control) in the 
culture (Tab. 4), indicating that none of the substances was metabolised by C. glutamicum or 
degraded in the media.     
 
Tab. 4: Concentrations of adipate, 2-oxoadipate and homocitrate during the cultivation of C. glutamicum 
in 750 µl micro scale. Concentrations of homocitrate (HC), 2-oxoadipate (2-OA) and adipate (AA) in the cell 
free supernatant of the cultivation with and without C. glutamicum cells using the BioLector system were 
determined via HPLC measurements after 0 h, 24 h and 47 h. 
 CGXII + additives + C. glutamicum CGXII + additives 
Time HC [mM] 2-OA [mM] AA [mM] HC [mM] 2-OA [mM] AA [mM] 
0 43.0 67.6 48.1 43.6 68.1 49.0 
24 44.9 65.9 49.6 44.9 70.6 50.5 
47 49.4 66.9 52.7 49.8 71.1 52.2 
 
In the case of 2-oxoadipate this result was unexpected, since the data of the shake flask 
experiments revealed a continuous decrease to about the half of the initial 2-oxoadipate 
concentration during growth (Fig. 4). The reason for this difference is not clear yet, however, 
as all these experiments were performed in triplicate, an experimental error seems unlikely. 
Possibly, the difference is related to the different cultivation condition. For example, it is 
know that cultivation in shake flasks leads to oxygen limitation at higher cell densities (Koch-
Koerfges et al., 2012), which is probably not the case in the BioLector cultivations.  
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4.2 Improved growth in the presence of growth-inhibiting adipate concentrations 
As shown before, no relevant growth of C. glutamicum occurred in the presence of 
500 mM adipate when using NaOH to adjust adipate solution to pH 7 (Fig. 6A). To examine a 
possible inhibitory effect of Na+ ions, C. glutamicum wild-type cells were cultivated in CGXII 
minimal medium with 4% glucose supplemented with 500 mM adipate, adjusted to pH 7 
using KOH instead of NaOH. This condition allowed slow growth of the cells (µ = 0.09 h-1) 
and the culture finally reached a similar maximal OD600nm as the control culture (µ = 0.41 h-1) 
after 50 h of cultivation (Fig. 6A). In a further control experiment, cells were cultivated in the 
presence of 500 mM KCl to test adipate-independent osmotic stress. Under these conditions, 
cells grew with a rate of 0.27 h-1, corresponding to a 34% decrease compared to the control 
culture (Fig. 6A). This result indicates that growth retardation in the presence of 500 mM 
adipate, neutralised with KOH, is due to the high concentrations of both, adipate and 
potassium ions.  
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Fig. 6: Studies to test the influence of modified cultivation conditions (A) and the impact of the 
chromosomal deletions of dctA and dccT (B) on growth in the presence of adipate. C. glutamicum wild type 
was cultivated in standard CGXII medium without supplements ( ),with 500 mM KCl ( ), with 500 mM 
adipate adjusted to pH 7 with KOH ( ), with 500 mM adipate adjusted to pH 7 with NaOH ( ), and with 
500 mM adipate adjusted to pH 7 with KOH and 5 mM L-proline and 5 mM L-glutamate ( ). Furthermore, the 
strain C. glutamicum ΔdctAΔdccT was cultivated under standard CGXII conditions ( ) or supplemented with 
500 mM adipate adjusted to pH 7 with KOH ( ). Data were obtained from a single experiment.  
 
Regarding the influence of osmotic stress, it has been previously described that the 
accumulation of osmoprotective solutes such as betaine, ectoine or proline reduces 
hyperosmotic stress (Peter et al., 1998). Thus, C. glutamicum was cultivated in the presence 
of 500 mM adipate (pH adjusted with KOH) supplemented with 5 mM proline. Besides 
proline, 5 mM glutamate was added to analyse a possible inhibitory effect of adipate towards 
citrate synthase, which is based on the structural similarity of adipate to citrate. Addition of 
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glutamate prevent a limitation of amino acid supply, which could be caused by inhibition of 
the citrate synthase (Van Ooyen, 2011). The cultivation in the presence of proline and 
glutamate resulted in a growth rate of µ = 0.16 h-1 and thus 44% increase in comparison to the 
experiment without proline and glutamate supplementation (Fig. 6A).  
It was shown above that adipate is not consumed in measurable amounts by C. glutamicum 
during cultivation (Fig. 4B). However, it might be possible that some adipate enters the cell 
via transport systems and, as it cannot be degraded, it could act inhibitory. Two known 
possible candidates for adipate import in C. glutamicum are the dicarboxylate transporters 
DctA and DccT. To analyse the influence of the dicarboxylate transporters in adipate uptake, 
growth of a double deletion mutant of dctA and dccT (provided by Volker F. Wendisch, 
University of Muenster) was analysed in the presence of adipate (Youn et al., 2008, Youn et 
al., 2009). Cultivation of C. glutamicum ΔdctAΔdccT in CGXII medium with 4% glucose and 
500 mM adipate revealed a similar growth rate  (µ = 0.08 h-1) compared to wild type 
(µ = 0.08 h-1) cultivated under the same conditions (Fig. 6B). The deletion of both 
dicarboxylate transporters did not affect growth in the presence of 500 mM adipate.  
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4.3 Impact of 2-oxoadipate and adipate on global gene expression of C. glutamicum 
Since it was shown that adipate causes growth retardation of C. glutamicum, DNA 
microarray analyses were performed to determine global gene expression changes in response 
to the presence of adipate. Furthermore, global gene expression experiments were also carried 
out in the presence of 2-oxoadipate. To investigate the specific impact of adipate on 
C. glutamicum gene expression, secondary effects such as a reduced growth rate, should be 
avoided. Therefore, a concentration of 50 mM adipate was selected for the DNA microarray 
experiments, as this concentration had no significant effect on growth in glucose minimal 
medium (section 4.1). On the other hand global gene expression in the presence of 150 mM 
adipate was investigated to gain information about the mechanism how adipate impacts 
growth (performed by Olga Valdau during her internship in May 2010).  
The gene expression in the presence of either adipate or 2-oxoadipate was compared to that 
of cells grown without these supplements. In contrast to standard cultivation conditions, 
precultures in CGXII medium with 2% glucose (111 mM) as carbon source and supplemented 
with either 50 mM adipate or 50 mM 2-oxoadipate were performed to adapt the cells to these 
conditions. The main culture was carried out under the same conditions and inoculated to an 
OD600 of 0.5 with cells of the preculture at the end of the exponential growth phase. For DNA 
microarray analyses the cells were harvested in the mid-exponential phase (OD600 = 5-6). 
After RNA isolation, the RNA of both samples was transcribed into fluorescently labelled 
cDNA, which were then mixed in a 1:1 ratio and hybridised to the DNA microarray. The data 
of at least two independent replicate experiments were filtered for evaluation. Only genes 
exhibiting an average mRNA level change of more than two-fold (red fluorescence signal 
divided by green fluorescence signal) and a signal-to-noise ratio >3 for the red and the green 
fluorescence signal were considered in the further analysis.  
In the presence of 50 mM adipate, the mRNA levels of 23 genes were more than two-fold 
increased and that of 4 genes were more than two-fold decreased. DNA microarray 
experiments with cells exposed to 150 mM adipate resulted in 41 genes with increased and 22 
genes with decreased mRNA levels. The genes regulated under both conditions are listed in 
Tables 5 and 6. 
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Tab. 5: Overview of genes, which showed an increased mRNA level in the presence of adipate. 
Transcriptome comparison of C. glutamicum wild type grown in glucose minimal medium either in the absence 
or in the presence of 50 mM or 150 mM adipate (AA). Cells were harvested during the mid-exponential growth 
phase. Genes which fulfil the criteria of an average mRNA ratio (+ adipate/- adipate) of ≥2 in at least two 
independent experiments, a signal-to-noise ratio >3 for Cy3 or Cy5, and a p-value ≤0.05 in one or both of the 
comparisons are listed. Genes changed in both comparisons are shaded in grey. Genome annotation, literature 
and database searches (http://www.coryneregnet.de/ and http://www.genome.jp/kegg/kegg2.html) were 
performed to assign the function of the corresponding proteins. 
Gene  Annotation mRNA ratio (150 mM AA) 
mRNA ratio 
(50 mM AA) 
cg0005 recF, recombination  protein F 2.01 1.1 
cg0340 putative integral membrane transport protein 17.19 13.38 
cg0341 fadD1, putative fatty-acid-CoA ligase transmembrane protein 38.13 15.91 
cg0344 fabG1, 3-oxoacyl-(acyl-carrier protein) reductase 27.72 12.61 
cg0345 metal-dependent hydrolase of the TIM-barrel fold 19.69 11.62 
cg0346 fadE, glutaryl-CoA dehydrogenase 16.64 10.49 
cg0347 hdtZ, 3-hydroxyacyl-thioester dehydratase 18.04 11.64 
cg0444 ramB, transcriptional regulator, involved in acetate metabolism 3.11 0.92 
cg0645 cytP, cytochrome P450 3.38 1.22 
cg0759 prpD2, propionate catabolism protein PRPD 4.20 2.13 
cg0760 prpB2, probable methylisocitric acid lyase 3.19 2.19 
cg0762 prpC2, 2-methylcitrate synthase 3.37 2.35 
cg0998 trypsin-like serine protease 2.40 1.11 
cg1016 betP, glycine betaine transporter 2.31 1.4 
cg1129 aroF, 3-deoxy-7-phosphoheptulonate synthase 2.34 1.14 
cg1214 cysteine sulfinate desulfinase/cysteine desulfurase or related 
enzyme 
2.46 1.27 
cg1215 nadC, nicotinate-nucleotide pyrophosphorylase 2.85 1.43 
cg1216 nadA, quinolinate synthetase 4.32 1.46 
cg1218 ADP-ribose pyrophosphatase 3.52 1.35 
cg1224 phnB2, similarity to alkylphosphonate uptake operon protein 
PhnB of Escherichia coli 
2.24 1.05 
cg1226 pobB, 4-hydroxybenzoate 3-monooxygenase 3.22 1.07 
cg1292 flavin-containing monooxygenase 3 2.70 1.29 
cg1616 cmk, cytidylate kinase 2.37 1.03 
cg2234 ABC-type cobalamin/Fe3+-siderophores transport system, 
secreted component 
2.73 1.09 
cg2622 pcaJ, β-ketoadipate succinyl-CoA transferase subunit 48.28 10.55 
cg2623 pcaI, β-ketoadipate succinyl-CoA transferase subunit 85.59 11.96 
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Gene Annotation mRNA ratio (150 mM AA) 
mRNA ratio 
(50 mM AA) 
cg2624 pcaR, transcriptional regulator of 4-hydroxybenzoate, 
protocatechuate,  p-cresol pathway 
33.45 7.82 
cg2625 pcaF, β-ketoadipyl CoA thiolase 26.59 8.15 
cg2626 pcaD, β-ketoadipate enol-lactone hydrolase 23.14 7.51 
cg2627 pcaO, transcriptional regulator of 4-hydroxybenzoate, 
protocatechuate, p-cresol pathway 
4.75 2.39 
cg2634 catC, muconolactone isomerase 3.82 3.5 
cg2635 catB, chloromuconate cycloismerase 4.57 3.86 
cg2636 catA1, catechol 1,2-dioxygenase 15.30 5.70 
cg2637 benA, benzoate 1,2-dioxygenase alpha subunit (aromatic ring 
hydroxylation dioxygenase A) 
22.22 13.43 
cg2638 benB, benzoate dioxygenase small subunit 15.08 13.42 
cg2642 benK1, putative benzoate transport protein 5.87 3.72 
cg2888 phoR, two component response regulator 2.89 0.98 
cg3240 permease of the major facilitator superfamily 6.69 3.80 
cg3335 malE, malic enzyme 3.01 2.40 
cg3389 oxiC, myo-inositol dehydrogenase 3.24 1.10 
cg3395 proP, proline/ectoine carrier 2.72 1.38 
 
 
Tab. 5 shows several genes with increased mRNA level regulated under both, 50 mM and 
150 mM adipate. The data of the global gene expression experiments revealed increased 
mRNA levels for several genes involved in the metabolism of the aromatic compounds 
benzoate and protocatechuate. Changes of mRNA levels of genes belonging to the ben operon 
(benA, benB, benK1) or to the cat operon (catA1, catB, catC) were observed. With exception 
of catA1 and benB (15-fold increased mRNA levels), the other genes showed only slightly 
changed mRNA levels (3-5-fold). Enzymes of the ben operon are involved in benzoate 
degradation to catechol, whereas enzymes of the cat operon are part of the catechol branch of 
the β-ketoadipate pathway (Brinkrolf et al., 2006). The highest mRNA level change (up to 85-
fold) was observed for genes (pcaIJFDO) of the pca operon, which is part of the 
protocatechuate branch of the β-ketoadipate pathway in C. glutamicum (Brinkrolf et al., 
2006). Interestingly, mRNA levels of both regulator genes of the pca gene cluster were also 
increased, namely pcaR (33-fold) and pcaO (5-fold). Adipate might act as an activator 
molecule of PcaR and PcaO.  
Further, several genes belonging to the fatty acid metabolism were highly up-regulated in 
the presence of adipate: the four genes fabG1, cg0345, fadE, hdtZ of the predicted operon 
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OP_cg0344 as well as cg0340 and fadD1 revealed elevated mRNA levels of 10-fold and 
20-fold due to the addition of 50 mM and 150 mM adipate, respectively (Tab. 5). These 
results indicate that adipate is involved in gene regulation of fatty acid metabolism, maybe by 
its structural similarity to fatty acids. The mRNA levels of genes of the prp2 operon (prpB2, 
prpC2, prpD2), which are involved in the propionate catabolism, were two-fold increased in 
the presence of 50 mM and three to four-fold increased in the presence of 150 mM adipate. 
Further, in response to 150 mM adipate genes involved in the stress response of 
C. glutamicum displayed increased mRNA levels: The genes proP (2.7-fold) and betP 
(2.3-fold), which encode osmoregulatory proteins (ProP and BetP), obtained slightly elevated 
mRNA levels in the presence of 150 mM adipate. Both proteins function as osmoregulated 
secondary transporter systems for compatible solutes and were described to be beneficial for 
C. glutamicum to cope with hyperosmotic stress conditions (Peter et al., 1998).    
Table 6 shows the genes with decreased mRNA levels in the presence of 50 mM and 
150 mM adipate. Only two genes were found to have a decreased mRNA level at both, 
50 mM and 150 mM adipate (Tab. 6), which are cg1384 coding for putative NUDIX 
hydrolase and cg3405 coding for an NADPH quinone reductase or Zn-dependent 
oxidoreductase. The latter one seems to be down regulated as a stress response of 
C. glutamicum in the presence of adipate, since it is associated in the global stress response of 
C. glutamicum (Busche et al., 2012). In the presence of 150 mM adipate several genes of 
central metabolism enzymes showed decreased mRNA levels: the mRNA levels of pyk (8.9-
fold) and ldh (7.7-fold), coding for pyruvate kinase and lactate dehydrogenase, respectively, 
were strongly decreased. Furthermore, the genes mdh (2.9-fold) coding for malate 
dehydrogenase and ackA (2.4-fold) coding for acetate kinase showed a reduced expression 
level. A 2.3-fold reduced mRNA level was observed for ramA, coding for global regulator of 
metabolism in C. glutamicum (Auchter et al., 2011). Since down-regulation of these genes 
occurred only in the presence of 150 mM adipate, a stress-related response seems to be the 
most likely explanation for these results. 
In the presence of 50 mM adipate, the mRNA level of the gene dctA coding for a Na+/H+ 
dicarboxylate symporter (Youn et al., 2009), was 2.1-fold decreased. Besides dctA, the 
mRNA level of the second dicarboxylate uptake system in C. glutamicum (DccT) was also 
decreased (1.9-fold). Both, DctA and DccT are known to enable C. glutamicum to grow on 
the TCA cycle intermediates succinate, fumarate and malate as sole carbon source. Since the 
native expression levels of dctA or dccT are not sufficient to allow growth on these 
dicarboxylates as sole carbon source in minimal medium, (high) plasmid-borne expression 
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levels of dctA or dccT or promoter up-mutations are required (Youn et al., 2008, Youn et al., 
2009).  
Tab. 6: Overview of genes exhibiting decreased mRNA levels in the presence of adipate. Transcriptome 
comparison of C. glutamicum wild type grown in glucose minimal medium either in the absence or in the 
presence of 50 mM or 150 mM adipate (AA). Cells were harvested during the mid-exponential growth phase. 
Genes which fulfil the criteria of an average mRNA ratio (+ adipate/- adipate) of ≤ 2 in at least two independent 
experiments, a signal-to-noise ratio >3 for Cy3 or Cy5, and a p-value ≤0.05 in one or both of the comparisons are 
listed. The genes showing altered expression in both comparisons are shaded in grey. Genome annotation, 
literature and database searches (http://www.coryneregnet.de/ and http://www.genome.jp/kegg/kegg2.html) were 
performed to assign the function of the corresponding proteins. 
Gene Annotation  Average ratio (150 mM AA) 
 Average ratio 
(50 mM AA) 
cg0238 L-gulonolactone oxidase 0.46 1.03 
cg0260 moaC, molybdenum cofactor biosynthesis protein C 0.44 0.97 
cg0277 dccT, dicarboxylate uptake system (succinate, fumarate or L-
malate) 
0.52 0.51 
cg1384 putative NUDIX hydrolase 0.35 0.49 
cg1647 ABC-type multidrug transport system, permease component 0.30 0.96 
cg1744 pacL, cation-transporting ATPase 0.28 0.85 
cg1769 ctaA, cytochrome oxidase assembly protein 0.31 1.05 
cg2030 hypothetical protein predicted by Glimmer 0.63 0.45 
cg2114 lexA, LexA repressor 0.39 0.97 
cg2613 mdh, malate dehydrogenase 0.34 0.99 
cg2831 ramA, transcriptional regulator, acetate metabolism 0.44 0.91 
cg2845 pstC, ABC-type phosphate transport system, permease 
component 
0.26 1.06 
cg2846 pstS, ABC-type phosphate transport system, secreted 
component 
0.10 1.02 
cg2870 dctA, Na+/H+-dicarboxylate symporter 0.78 0.47 
cg3047 ackA, acetate/propionate kinase 0.40 0.62 
cg3099 grpE, molecular chaperone GrpE (heat shock protein) 0.31 0.8 
cg3100 dnaK, molecular chaperone DnaK 0.39 1.02 
cg3107 adhA, Zn-dependent alcohol dehydrogenase 0.39 0.75 
cg3218 pyk, pyruvate kinase 0.11 0.87 
cg3219 ldh, L-lactate dehydrogenase 0.13 1.23 
cg3227 lldD, quinone-dependent L-lactate dehydrogenase LldD 0.21 0.88 
cg3255 uspA3, universal stress protein family 0.35 1.03 
cg3367 ABC-type multidrug transport system, ATPase component 0.28 0.86 
cg3368 ABC-transporter permease protein 0.28 0.93 
cg3405 NADPH quinone reductase or Zn-dependent oxidoreductase 0.09 0.08 
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As mentioned above, transcriptome analyses of C. glutamicum wild type were also 
performed with RNA from cells grown in the presence and absence of 50 mM 2-oxoadipate 
(Tab. 7). With such RNA samples also one experiment was performed by Nadine Dobler 
using an Agilent tiling array to test something else, however, the results can be additionally 
used here. The results of the data analyses showed up to 5-fold increased mRNA levels of the 
genes hemL, cg0519, cg0520, ccsA, cg0523 and ccsB belonging to the predicted operon 
OP_cg0516. This operon is described to be involved in metal homeostasis. Further, mRNA 
level changes (up to 10-fold increased) of genes, which are part of the metal homeostasis in 
C. glutamicum, were observed for components of an ABC-type cobalamin/Fe3+-siderophore 
transport system. In only one of the experiments the genes benA (2.8-fold) and benB (3.8-
fold) coding for subunits of benzoate 1,2-dioxygenase showed elevated mRNA levels 
(Tab. 7). Both genes showed also increased mRNA levels in the presence of adipate (Tab. 5). 
Among the regulated genes in response to 50 mM 2-oxoadipate, no one was identified, which 
could be directly linked to the possible metabolisation of 2-oxoadipate observed in the 
cultivation experiments described above.  
 
Tab. 7: Overview of genes exhibiting altered mRNA levels in the presence of 2-oxoadipate. Transcriptome 
comparison of C. glutamicum wild type grown in glucose minimal medium either in the absence or in the 
presence of 50 mM 2-oxoadipate. Cells were harvested during the mid-exponential growth phase. Genes which 
fulfil the criteria of an mRNA ratio (+ 2-oxoadipate/- 2-oxoadipate) of ≤ 2 or ≥2 in at least one of three 
independent experiments, a signal-to-noise ratio >3 for Cy3 or Cy5, and a p-value ≤0.05 are listed. Two 
experiments (Array I and II) were performed using a standard microarray (Operon Biotechnology) and one 
experiment was performed with a tilling array (TA). Genome annotation, literature and database searches 
(http://www.coryneregnet.de/ and http://www.genome.jp/kegg/kegg2.html) were performed to assign the 
function of the corresponding proteins. 
Gene Annotation 
mRNA 
ratio 
Array I 
mRNA 
ratio 
Array II 
mRNA 
ratio 
TA 
Average 
cg0518 hemL, glutamate-1-semialdehyde 
aminotransferase 
3.76 1.84 4.45 3.35 
cg0519 putative phosphoglycerate mutase 2.97 1.80 3.90 2.89 
cg0520 secreted thiol-disulfide isomerase or 
thioredoxin 
n.d 1.59 4.00 2.79 
cg0522 ccsA, cytochrome c biogenesis protein 
transmembrane protein 
4.61 2.03 4.37 3.67 
cg0523 membrane protein required for cytochrome c 
biosynthesis 
5.05 2.42 4.09 3.85 
cg0524 ccsB, cytochrome c assembly membrane protein n.d 1.56 4.25 2.91 
cg0569 cation-transporting ATPase 0.68 0.40 0.63 0.57 
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Gene Annotation 
mRNA 
ratio 
Array I 
mRNA 
ratio 
Array II 
mRNA 
ratio 
TA 
Average 
cg1494 putative secreted protein 0.50 0.49 n.d 0.49 
cg1551 uspA1, universal stress protein UspA and 
related nucleotide-binding proteins 
0.67 0.44 0.88 0.66 
cg1832 ABC-type cobalamin/Fe3+-siderophores 
transport system, permease component 
11.50 3.32 9.77 8.20 
cg1833 ABC-type cobalamin/Fe3+-siderophores 
transport system, secreted component 
12.98 4.31 12.93 10.07 
cg2637 benA, benzoate 1,2-dioxygenase alpha subunit 
(aromatic ring hydroxylation dioxygenase A) 
n.d 2.77 n.d 2.77 
cg2638 benB, benzoate dioxygenase small subunit n.d 3.79 n.d 3.79 
cg3240 permease of the major facilitator superfamily 2.65 2.68 1.88 2.40 
 
 
 
4.4 Selection of enzymes for the conversion of 2-oxoglutarate to 2-oxoadipate 
The main focus of this work was to introduce the enzymes of the α-aminoadipate (AAA) 
pathway necessary for 2-oxoadipate production into C. glutamicum in order to produce 
2-oxoadipate as precursor of adipate. In a first step, enzyme characteristics were analysed 
based on literature and databases (http://www.brenda-enzymes.info) especially regarding their 
substrate affinity and turnover number (Tab. 8). Additional selection criteria were the 
knowledge of the corresponding gene sequences as well as experimental experience in 
expressing the homocitrate synthase (HCS) gene in a heterologous host organism. The HCS 
enzymes of Thermus thermophilus (Wulandari et al., 2002), Azotobacter vinelandii (Zheng et 
al., 1997) and S. cerevisiae (Andi et al., 2004) with the corresponding genes ttc1550, nifV, 
lys20 were selected for heterologous expression in C. glutamicum. T. thermophilus is an 
extremely thermophilic, Gram-negative bacterium containing as an interesting feature an 
AAA-like pathway for the biosynthesis of L-lysine (Andi et al., 2004). The Gram-negative 
bacterium A. vinelandii is an aerobic model organism, which is capable of fixing molecular 
nitrogen and thus playing an important role in the nitrogen cycle of the nature (Hamilton et 
al., 2011). HCS of A. vinelandii is not required for lysine formation, but for synthesis of 
homocitrate, which is required as organic constituent of the FeMo cofactor (Zheng et al., 
1997). The gene lys20 coding for HCS of S. cerevisiae was the only one selected from a 
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eukaryotic organism, as it represent the best characterised enzyme among the homocitrate 
synthases.   
The gene lys4 coding for homoaconitase (HA), also known as homoaconitate hydratase, 
was selected from S. cerevisiae. At the beginning of this project little was known about 
enzyme characteristics and mechanism, except its membership to the aconitase superfamily. 
Recently it was reported that the homoaconitase of S. cerevisiae only catalyses the hydration 
of homoaconitate to homoisocitrate, but not the dehydration of homocitrate to homoaconitate 
(Fazius et al., 2012). For the conversion of homoisocitrate to 2-oxoadipate the homoisocitrate 
dehydrogenase (HICDH) with the corresponding gene lys12 was used from S. cerevisiae. 
 
Tab. 8: Characteristics of the enzymes selected for establishment of 2-oxoadipate production in 
C. glutamicum. Homocitrate synthase (HCS) was chosen from T. thermophilus (Okada et al., 2010), 
A. vinelandii (Zheng et al., 1997) and S. cerevisiae (Andi et al., 2004). Homoaconitase (HA) and homoisocitrate 
dehydrogenase (HICDH) were selected from S. cerevisiae (Yamamoto et al., 2007). N.a., value was not 
available in literature. 
Enzyme 
(gene) 
Organism Substrate 1 
(S1) 
Substrate 2 
or cofactor 
Spec. 
activity 
(mU/mg) 
KM 
(mM) 
(S1) 
kcat (s-1) 
(S1) 
HCS 
(ttc1550) T. thermophilus 2-Oxoglutarate Acetyl-CoA 
41 
(50°C) 
0.0054 
(50°C) 
0.18 
(50°C) 
HCS 
(nifV) 
A. vinelandii 2-Oxoglutarate Acetyl-CoA 657 2.24 n.a 
HCS 
(lys20) S. cerevisiae 2-Oxoglutarate Acetyl-CoA 730 4.6 0.62 
HA 
(lys4) S. cerevisiae Homocitrate n.a n.a n.a n.a 
HICDH 
(lys12) S. cerevisiae Homoisocitrate NAD
+ n.a 0.018 17 
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4.5 Homocitrate production with C. glutamicum 
The aim of this project was to show the feasibility of C. glutamicum for the production of 
homocitrate and 2-oxoadipate with the use of the selected enzymes (Tab. 8). For homocitrate 
production, HCS activity was introduced into C. glutamicum by plasmid-based expression as 
well as chromosomal integration of the HCS genes. To establish HCS activity in 
C. glutamicum, each of the genes ttc1550, nifV and lys20 were cloned into the vector pEKEx2 
with the ribosomal binding site GAAAGGAGG for C. glutamicum located 8 bp in front of the 
start codon. Gene expression was controlled by the Ptac promoter already present in pEKEx2. 
C. glutamicum wild-type cells were transformed with one of the constructs, resulting in the 
strains C. glutamicum/pEKEx2-ttc1550, C. glutamicum/pEKEx2-nifV and C. glutamicum/ 
pEKEx2-lys20 (Fig. 7). 
 
Fig. 7: Schematic overview of first generation homocitrate producer strains originating from the 
C. glutamicum wild-type strain. For plasmid-based expression of the homocitrate synthases the genes lys20 
(S. cerevisiae), ttc1550 (T. thermophilus) and nifV (A. vinelandii) were cloned into the vector pEKEx2. Plasmid-
free expression was established by in-frame deletion of gdh encoding glutamate dehydrogenase and 
simultaneous integration of lys20 either under control of the promoter Ptuf, PgapA or Ptac.  
Besides the plasmid-based introduction of the HCS genes, chromosomal integration of 
lys20 was also tested. The benefits of plasmid-free production are the avoidance of selection 
markers, e.g. antibiotics, plasmid-borne expression stress and plasmid instability. Thus, for 
the chromosomal establishment of the relevant genes, suitable integration loci were selected 
and tested. Recently it was shown, that the disruption of the genes gdh and aceA, coding for 
glutamate dehydrogenase and isocitrate lyase in C. glutamicum, enhance the production of 
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2-oxoglutarate up to 12 g l-1 by directing the carbon flux from isocitrate to 2-oxoglutarate (Jo 
et al., 2012). Both enzymes are involved in pathways competing with 2-oxoglutarate (Fig. 
11): gdh represents the key enzyme in the conversion of 2-oxoglutarate to L-glutamate and 
the deletion of aceA leads to the blocking of the glyoxylate cycle. In case of aceA it has to be 
mentioned that the glyoxylate shunt is only active under acetate overflow metabolism, but not 
under aerobic growth on glucose (Wendisch et al., 1997). Since 2-oxoglutarate is the direct 
precursor for homocitrate, deletion of both genes should promote enhanced precursor supply 
for homocitrate and later on for 2-oxoadipate production.  
The gene lys20 of S. cerevisiae was selected to establish plasmid-free HCS activity. In-
frame deletion of gdh with simultaneous integration of lys20 under the control of either the 
Ptac, PgapA or Ptuf promoter was tested. PgapA and Ptuf are native promoters of C. glutamicum 
controlling the expression of the genes for glyceraldehyde-3-phosphate dehydrogenase and of 
the elongation factor TU, respectively. The synthetic promoter Ptac is derived from sequences 
of the lac and trp promoter of E. coli (de Boer et al., 1983). Deletion of gdh and simultaneous 
integration of lys20 in C. glutamicum wild type was performed via homologous 
recombination using the suicide vector pK19mobsacB (section 3.5.10). All three variants were 
successfully constructed, resulting in the strains C. glutamicum Δgdh::Ptuf-lys20, 
C. glutamicum Δgdh::PgapA-lys20 and C. glutamicum Δgdh::Ptac-lys20 (Fig. 7). To characterise 
the strains with respect to homocitrate production, cultivation experiments in standard CGXII 
minimal medium with 4% (w/v) glucose as sole carbon source were carried out. Samples of 
the cultures were taken over 72 h. The identification and quantification of extracellular 
metabolites was performed via HPLC measurements. The HPLC method for quantification 
was established by using external standards of the substances. In addition to the HPLC 
measurements, qualitative analyses using GC-ToF-MS measurements were performed to 
verify the identity of homocitrate and 2-oxoadipate as well as to identify accumulated by-
products. 
Growth of the homocitrate producer strains was compared to a control culture of 
C. glutamicum wild-type cells (Fig. 8A, B). The growth rate of C. glutamicum/pEKEx2-
ttc1550 (µ = 0.37 ± 0.01 h-1) was very similar to that of the control culture (0.39 ± 0.01 h-1), 
whereas the growth rate of C. glutamicum/pEKEx2-lys20 (µ=0.30 ± 0.01 h-1) revealed a 30% 
decreased growth rate. Further, it was noticed that the maximum OD600 of the producer strains 
(OD600 = 40) was about 23% lowered in comparison to the wild-type strain (OD600 = 52), 
indicating that available carbon is not completely utilised for cell growth. In accordance with 
the results of the growth, the strain C. glutamicum/pEKEx2-lys20 showed a slightly slower 
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glucose uptake (consumption within 14 h), compared to the strains C. glutamicum wild type 
and C. glutamicum/pEKEx2-ttc1550 (consumption within 12 h) (Fig. 8C). In comparison to 
the wild-type strain (µ = 0.39 ± 0.01 h-1) and also to the plasmid-based strain 
C. glutamicum/pEKEx2-lys20 (µ = 0.3 ± 0.01 h-1), the three plasmid-free strains showed a 
strong growth retardation (Fig. 8B), most likely in consequence of the gdh-knock out.  
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Fig. 8: Analyses of homocitrate production by plasmid-based (A, C, E) and chromosomal (B, D, F) 
expression of HCS genes under standard conditions. Growth (A, B), glucose consumption (C, D), and 
accumulation of homocitrate (E, F) of the strains C. glutamicum wild type ( ), C. glutamicum pEKEx2-lys20 
( ), C. glutamicum pEKEx2-ttc1550 ( ), C. glutamicum Δgdh::Ptuf-lys20 ( ), C. glutamicum Δgdh::PgapA-
lys20 ( ) and C. glutamicum Δgdh::Ptac-lys20 ( ). The curves shown here are mean values including 
standard deviation of three independent cultivation experiments.  
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Fig. 9: Analyses of lactate (A, B) and acetate (C, D) formation during cultivation of homocitrate producer 
strains. Lactate and acetate accumulation of the strains C. glutamicum wild type ( ), C. glutamicum 
pEKEx2-lys20 ( ), C. glutamicum pEKEx2-ttc1550 ( ), C. glutamicum Δgdh::Ptuf-lys20 ( ), 
C. glutamicum Δgdh::PgapA-lys20 ( ) and C. glutamicum Δgdh::Ptac-lys20 ( ) was observed under standard 
conditions. The curves shown here are mean values including standard deviation of three independent cultivation 
experiments. 
The growth rates of the plasmid-free strains were determined to be 0.22 h-1 for 
C. glutamicum Δgdh::PgapA-lys20 as well as C. glutamicum Δgdh::Ptac-lys20, and 0.18 ± 
0.02 h-1 for C. glutamicum Δgdh::Ptuf-lys20, which represents a decrease of about 30% 
compared to C. glutamicum/pEKEx2-lys20 . Also, decelerated glucose consumption was 
observed (Fig. 8D). The glucose uptake rates of the two faster growing strains were 6.0 mmol 
gcdw-1 h-1, whereas 4.84 ± 0.4 mmol gcdw-1 h-1was calculated for C. glutamicum Δgdh::Ptuf-
lys20, compared to 8.1 mmol gcdw-1 h-1for C. glutamicum/pEKEx-lys20. 
Besides glucose, the cell culture supernatant was analysed towards accumulated 
metabolites, especially towards homocitrate. After 72 h the strains C. glutamicum pEKEx2-
lys20 and C. glutamicum/pEKEx2-ttc1550 accumulated up to 2.6 mM homocitrate (HC) with 
a yield of 0.009 mol CHC/mol Cglucose and 1.8 mM homocitrate corresponding to 
0.006 mol CHC/mol Cglucose, respectively (Fig. 8E), whereas no homocitrate could be detected 
at all by the strain containing the HCS of A. vinelandii (data not shown). The carbon yield was 
calculated based on the amount of glucose consumed during the cultivation. Cultivation of the 
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negative controls C. glutamicum wild type and C. glutamicum/pEKEx2 (data not shown) 
exhibited no homocitrate accumulation. Homocitrate accumulation was also observed for all 
three strains harbouring a chromosomally integrated gene of the HCS (Fig. 8F, Tab. 9). After 
72 h, the strain containing the lys20 gene controlled by the Ptuf promoter showed the highest 
accumulation with a final titer of 4.1 mM, corresponding to a yield of 0.014 mol CHC/ 
mol Cglucose. This corresponds to a doubled production yield compared to the plasmid-based 
strain cultivated under the same conditions. At the same time, the strains C. glutamicum 
Δgdh::PgapA-lys20 and C. glutamicum Δgdh::Ptac-lys20 produced up to 2.3 mM and 2 mM 
homocitrate (0.007 mol CHC/ mol Cglucose), respectively. The most promising strain 
C. glutamicum Δgdh::Ptuf-lys20 was chosen for further experiments and renamed 
C. glutamicum MS-1 (Fig. 7). It is worthwhile to notice that extracellular accumulation of 
homocitrate was first detectable after about 10-12 h. At this time point glucose as required 
carbon source was almost completely consumed indicating that homocitrate production seems 
to be somehow coupled to the stationary growth phase or the metabolic state of growth-
limited cells. 
Further analyses of the cell culture supernatant revealed accumulation of the homocitrate 
precursor 2-oxoglutarate. Surprisingly, also 2-hydroxyglutarate was accumulated in the cell 
culture supernatant of the homocitrate producers (Tab. 9). Both metabolites were not detected 
in the control culture. Since no enzyme reaction for the formation of 2-hydroxyglutarate is 
described in C. glutamicum, it seems feasible that 2-oxoglutarate serves as substrate for an 
uncharacterised dehydrogenase activity. Due to extensive overlapping of HPLC signals of 
2-hydroxyglutarate and 2-oxoglutarate an appropriate quantification was not possible (section 
4.6.3). At the beginning of the stationary growth phase when glucose was almost completely 
consumed, accumulation of lactate (Fig. 9G, H) and acetate (Fig. 9I, J) was observed. All 
tested strains showed high accumulation of lactate (30 – 70 mM), whereas acetate was 
accumulated up to 12 mM during the cultivation. An exception was C. glutamicum 
Δgdh::Ptac-lys20 which accumulated only 5 mM lactate and no acetate. In further course of the 
cultivation acetate and lactate were completely consumed again. In summary, this was the 
first time homocitrate production was demonstrated with C. glutamicum. This formed the 
basis for the improvement of homocitrate production as well as the establishment of 
2-oxoadipate production in C. glutamicum.     
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Tab. 9: Growth parameters and product formation of plasmid-based and plasmid-free homocitrate 
production with C. glutamicum. The C. glutamicum strains were cultivated in standard CGXII minimal 
medium with 4% (w/v) glucose. The final titers of the products were determined after 72 h. Product 
concentrations were determined via HPLC measurements of the cell-free supernatants. Product titers of 
2-oxoglutarate and 2-hydroxyglutarate could not be determined (n.d.) via the HPLC measurements. 
C. glutamicum 
strains 
Growth rate [h-1] Biomass     
[gcdw-1 h-1] 
Glucose uptake rate 
[mmol gcdw-1 h-1] 
Final homocitrate 
titer [mM] 
2-OG + 2-HG 
[mAU*s] 
pEKEx2-lys20 0.30 ± 0.01 8.2 ± 0.2 8.1 ± 0.1 2.6 ± 0.3 2,801 
pEKEx2-ttc1550 0.37 ± 0.01 9.0 ± 0.4 9.1 ± 0.6 1.8 ± 0.6 715 
Δgdh::Ptuf-lys20 0.18 ± 0.02 7.4 ± 0.4 4.8 ± 0.5 4.1 ± 1.4 2,134 
Δgdh::PgapA-lys20 0.22 ± 0.003 8.1 ± 0.4 6.0 ± 0.4 2.3 ± 0.4 1,277 
Δgdh::Ptac-lys20 0.22 ± 0.009 8.2 ± 0.8 6.0 ± 0.7 2.0 ± 0.5 730 
 
 
4.6 Enhancement of homocitrate production 
4.6.1 Influence of modified cultivation conditions 
Recently, it was shown that limitation of the nitrogen supply during the cultivation of 
C. glutamicum is also beneficial for succinate production. This limitation bypasses a part of 
the carbon from biomass production to product formation and results in a lower OD (Litsanov 
et al., 2012a). To test the effect of nitrogen limitation on homocitrate production, the 
corresponding C. glutamicum strains were cultivated in CGXII minimal medium with 222 
mM glucose as sole carbon source and under limited nitrogen conditions (Tab. 9). Nitrogen 
supply was limited by omitting ammonium sulfate from the standard medium and reducing 
urea from 5 g l-1 to 1.67 g l-1. The applied amount of nitrogen (59.6 mM corresponding to 
6.7% of standard nitrogen amount) was calculated to limit the cell growth at an OD of 30. The 
homocitrate producer strains C. glutamicum/pEKEx2-ttc1550 (µ = 0.27 ± 0.005 h-1) and 
C. glutamicum/ pEKEx2-lys20 (µ = 0.24 ± 0.01 h-1) as well as the wild-type strain 
(µ = 0.3 ± 0.03 h-1) showed reduced growth rates of 20-27% under nitrogen limitation (Fig. 
10A). In addition, decelerated glucose consumption was observed for all strains (Fig. 10C). 
Glucose was consumed within 26 h by the wild-type strain, whereas the homocitrate 
producers depleted the glucose within 34 h. Determination of homocitrate production under 
nitrogen limitation revealed a positive effect of the final product titers (Fig. 10E). The 
homocitrate production was increased up to 8.2 mM with C. glutamicum/pEKEx2-lys20 and 
up to 7 mM with C. glutamicum/pEKEx2-ttc1550, corresponding to yields of 0.03 and 
0.02 mol CHC/mol Cglucose, respectively. The homocitrate production under nitrogen limitation 
62  Results 
was also detectable only after 10 h as under nitrogen excess conditions, but homocitrate 
accumulates constantly for 50 h instead of 30 h. This effect can be explained by glucose 
availability over a longer period of time in consequence of limited and slowed growth.  
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Fig. 10: Homocitrate production with C. glutamicum under standard and modified cultivation conditions. 
Growth (A), glucose consumption (C), and formation of homocitrate (E) of the strains C. glutamicum wild type 
( / ) and C. glutamicum/pEKEx2-lys20 ( / ) were tested in CGXII medium with 222 mM glucose 
under nitrogen excess (892 mM N, filled symbols) and nitrogen limitation (59.6 mM N, open symbols). Mean 
values and standard deviations of three independent experiments are shown. Further growth (B), glucose (D, 
filled symbols) and acetate consumption (D, open symbols), and formation of homocitrate (F) of the strain 
C. glutamicum MS-1 was analysed in “fed-batch” cultivation experiments. Cultivation was performed in GCXII 
medium with 222 mM glucose as starting carbon source ( / ), at the beginning of the stationary growth 
phase 222 mM glucose ( ), 204 mM potassium acetate ( ) and 222 mM glucose + 204 mM potassium 
acetate ( ) were added. Data represent a single experiment.     
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Tab. 10: Growth parameters and product formation of plasmid-based and plasmid-free homocitrate 
production with C. glutamicum under nitrogen excess and nitrogen limitation. The C. glutamicum 
homocitrate producer strains were cultivated in standard CGXII medium with 4% (w/v) glucose under nitrogen 
excess (892 mM N) and nitrogen limitation (59.6 mM N). The final titer of homocitrate was determined after 
72 h. Product concentrations were determined via HPLC measurements of the cell free supernatant. Product 
titers of 2-oxoglutarate and 2-hydroxyglutarate could not be determined from the HPLC measurements and are 
given as sum of the peak area 
C. glutamicum 
strains 
Condition 
Growth rate 
[h-1] 
Biomass            
[gcdw-1 h-1] 
Glucose uptake 
rate [mmol    
gcdw-1 h-1] 
Final homo-
citrate titer [mM] 
2-OG + 2-HG 
[mAU*s] 
pEKEx2-lys20 
892 mM 
nitrogen 
0.30 ± 0.01 8.2 ± 0.2 8.1 ± 0.1 2.6 ± 0.3 2,801 
pEKEx2-lys20 
59.6 mM 
nitrogen 
0.24 ± 0.0 6.0 ± 0.6 8.8 ± 1.1 8.2 ± 0.9 5,966 
pEKEx2-ttc1550 
892 mM 
nitrogen 
0.37 ± 0.01 9.0 ± 0.4 9.1 ± 0.6 1.8 ± 0.6 715 
pEKEx2-ttc1550 
59.6 mM 
nitrogen 
0.27 ± 0.01 7.1 ± 0.4 8.3 ± 0.6 7.0 ± 1.06 9,558 
Δgdh::Ptuf-lys20 
(MS-1) 
892 mM 
nitrogen 
0.18 ± 0.02 7.4 ± 0.4 4.8 ± 0.5 4.1 ± 1.4 2,134 
Δgdh::Ptuf-lys20 
(MS-1) 
59.6 mM 
nitrogen 
0.14 6.0 5.2 3.1 4,935 
 
Interestingly, cultivation of C. glutamicum MS-1 revealed decreased homocitrate 
accumulation (3.1 mM, data not shown) under same conditions, indicating that the 
inactivation of the Gdh negatively influence homocitrate production under nitrogen limitation. 
Furthermore, nitrogen limitation increased by-product formation of 2-hydroxyglutarate and 
2-oxoglutarate by a factor of 2 or more (Tab. 10). The excess of the precursor 2-oxoglutarate 
indicates that homocitrate production is either limited by acetyl-CoA supply or by HCS 
activity.   
Further experiments were performed to overcome a possible precursor limitation of 
2-oxoglutarate and/or acetyl-CoA towards homocitrate production. Therefore, the strain 
C. glutamicum MS-1 (C. glutamicum Δgdh::Ptuf-lys20) was tested under standard conditions 
with additional feeding of several carbon sources at the beginning of the stationary growth 
phase. The additional carbon sources (222 mM glucose, 204 mM potassium acetate, 222 mM 
glucose + 204 mM potassium acetate and 222 mM glucose + 20 mM 2-oxoglutarate (data of 
the cultivation experiments not shown)) were dissolved in standard CGXII medium without 
carbon source and added to the cultures after 22 h. The additional carbon supply led to 
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increased maximal OD, compared to standard conditions (Fig. 10B). In case of separately 
added glucose and acetate a maximal OD of 40 represents an increase of 12.5%, whereas the 
addition of glucose plus acetate revealed an increased OD of 56 (37.5%). The consumption of 
the additional carbon source was slight different (Fig. 10D): Acetate was consumed within 
24 h within addition, whereas glucose was depleted within 72 h. Simultaneous metabolisation 
was observed when glucose and acetate were added together and completely consumed within  
72 h. Concerning homocitrate production, every tested condition resulted in increased 
homocitrate titers (Fig. 10F). Before addition of the carbon sources, homocitrate 
concentration was about 1 mM. Feeding of additional glucose at the beginning of the 
stationary growth phase yielded 13 mM homocitrate, which represents an increase of 9 mM or 
about 225% (compared to 4 mM under standard conditions) with a corresponding yield of 
0.03 mol CHC/mol Cglucose. The carbon yield of the second production phase (after addition of 
carbon supply) was calculated on the basis of additionally added and consumed amount of 
substances (glucose, acetate, 2-oxoglutarate). The addition of acetate resulted in the 
accumulation of 9.8 mM homocitrate, whereas a combination of glucose and acetate increased 
the homocitrate titer to 27.5 mM, representing yields of 0.04 mol CHC/mol Cacetate and 
0.06 mol CHC/mol Cglucose+acetate, respectively. Additional glucose in combination with 
2-oxoglutarate was also tested and yielded 12.2 mM homocitrate (0.026 mol CHC/ mol 
Cglucose+2-oxoglutarate), which was very similar to the results obtained for additional glucose alone. 
In summary, the combination of glucose and acetate showed the strongest positive effect on 
homocitrate production. This clearly shows that homocitrate production is limited by 
precursor supply at the early stationary growth phase. However, the concentration of 
homocitrate reached about 1 mM before adding the additional carbon supply, giving further 
evidence for a coupling of production to the stationary growth phase or the metabolic status of 
the cells.  
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4.6.2  Characterisation of the homocitrate synthase mutein Lys20R276K 
Several working groups have reported that homocitrate synthase is subject to complex 
regulation by different components and mechanisms (Andi et al., 2005). One of them is the 
feedback inhibition by L-lysine, the end product of the AAA pathway, representing the key 
point for limiting the metabolic flux through the AAA pathway in S. cerevisiae (Bulfer et al., 
2010). From previous studies it is known that the native Lys20 enzyme is 50% inhibited in the 
presence of 1 mM L-lysine. An amino acid exchange of arginine to lysine at position 276 
(R276K) led to a decrease of sensitivity towards L-lysine up to 100 mM (Feller et al., 1999). 
Since it is known that the intracellular concentration of L-lysine in the mid-exponential 
growth phase of C. glutamicum wild-type cells is about 5 mM (Binder et al., 2012), inhibition 
of HCS activity might be a limiting factor for homocitrate production in C. glutamicum. In 
order to circumvent this possible limitation the R276K amino acid exchange of the HCS 
might be beneficial for homocitrate production in C. glutamicum. Thus, the base pair mutation 
AGA  AAA which leads to the amino acid exchange R276K was inserted into the lys20 
sequence (section 3.5.11). The effect of the mutein Lys20R276K on homocitrate production was 
tested in strains containing the gene chromosomally integrated as well as plasmid-based. The 
strains were cultivated in CGXII minimal media with glucose as sole carbon source. 
Homocitrate accumulation was analysed after 6 h, 24 h and 52 h (Tab. 11). In case of the 
plasmid-based strains, up to 2.5 mM homocitrate was produced after 52 h with Lys20 and 
Lys20R276K. A slight difference was observed for the strains containing the chromosomally 
integrated genes: The strain expressing the native enzyme accumulated up to 4.1 mM 
compared to 3.6 mM homocitrate produced by the strain with the mutein described to be 
L-lysine-insensitive.  
Additionally, the HCS enzyme activities of the mutein and the native enzyme were 
measured at various time points (Tab. 11). HCS activity was determined in crude extracts 
using the DCPIP method. At the time points, at which homocitrate was already present in the 
supernatant (24 h, 52 h), the amino acid exchange in Lys20 led to lower enzyme activity for 
both, the chromosomally encoded variant and the plasmid-encoded variant, compared to the 
wild-type Lys20 (Tab. 11). 
Moreover, the enzyme assay was performed with addition of 10 mM L-lysine to test the 
feedback inhibition. In case of both plasmid-encoded variants, the enzyme activity was 2-4 
fold decreased in the presence of the inhibitor L-lysine, but the native enzyme showed a 3-
fold higher activity compared to the claimed L-lysine insensitive variant (Tab. 11). For the 
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two chromosomally encoded Lys20 variants no HCS activity was detectable in the presence 
of the inhibitor.  
 
Tab. 11: Homocitrate accumulation and homocitrate synthase activities of Lys20 and Lys20R276K. The 
native enzyme Lys20 was compared to the L-lysine insensitive variant Lys20R276K after 6 h, 24 h and 52 h 
cultivation in standard CGXII minimal medium. Both, the plasmid-based as well as the chromosomally 
integrated variants were tested in C. glutamicum wild type. The enzyme assay was performed with crude extracts 
with and without addition of 10 mM L-lysine. 
 Strains 
Time 
C. glutamicum 
pEKEx2-lys20 
C. glutamicum  
pEKEx2-lys20R276K 
C. glutamicum 
Δgdh::Ptuf-lys20 
C. glutamicum 
Δgdh::Ptuf-lys20R276K 
 
Spec. activity 
[mU/mg] 
HC 
[mM] 
Spec. activity 
[mU/mg] 
HC 
[mM] 
Spec. activity 
[mU/mg] 
HC 
[mM] 
Spec. activity 
[mU/mg] 
HC 
[mM] 
6 h 5 0 17 0 14 0 0 0 
24 h 53 1.9 8 1.9 21 2.1 11 1.8 
24 h + 
10 mM 
Lys 
12 1.9 4 1.9 0 2.1 0 1.8 
52 h 36 2.5 9 2.4 29 4.1 2 3.6 
 
These results indicate that the amino acid exchange R276K is not beneficial for HCS 
enzyme activity in the presence of L-lysine and HCSR276K appears to be still sensitive to 
L-lysine. In addition, it was observed that on the one hand the strains containing the plasmid 
pEKEx2-lys20 exhibited a higher HCS enzyme activity, but on the other hand accumulated 
only about one half of homocitrate in comparison to the strain harbouring the HCS gene 
within the genome. In summary, intracellular L-lysine levels could be a limiting factor for 
homocitrate production as HCS is inhibited and homocitrate titers could not be increased by 
using the mutein Lys20R276K. 
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4.6.3  Metabolic engineering to improve precursor supply 
The previous results showed that homocitrate production in C. glutamicum under standard 
conditions is relatively low and coupled to the stationary growth phase. To improve 
homocitrate production the best producer strain C. glutamicum MS-1 was selected for further 
genetic modifications, which increase the supply of the homocitrate precursors 2-oxoglutarate 
and acetyl-CoA (Fig. 11). In previous studies it has been reported for strain C. glutamicum R 
that overexpression of the native pyruvate carboxylase gene (pyc), catalysing the 
carboxylation of pyruvate to oxaloacetate, enhanced the rate of succinate production (Okino et 
al., 2008). In this context it was further demonstrated that the amino acid exchange P458S in 
pyruvate carboxylase (pycP458S) is beneficial for the formation of oxaloacetate (Ikeda et al., 
2006). 
 
Fig. 11: Schematic overview of the central carbon metabolism of C. glutamicum and the genetic 
modifications applied to enhance the production of homocitrate and 2-oxoadipate. An enzymatic reaction 
(arrow) marked with an “X” indicates the deletion of the corresponding gene. Enzymes whose genes were 
overexpressed are displayed in grey boxes and their corresponding reactions are highlighted in bold arrows. 
Abbreviations: PDHC, pyruvate dehydrogenase; PC, pyruvate carboxylase; CoAT, CoA transferase; PTA, 
phosphotransacetylase; AK, acetate kinase; CS, citrate synthase; ACN, aconitase; ICD, isocitrate dehydrogenase; 
ODHC, 2-oxoglutarate dehydrogenase; SCS, succinyl-CoA synthetase; SDH, succinate dehydrogenase; FUM, 
fumarase; MDH, malate dehydrogenase; ICL, isocitrate lyase; MS, malate synthase; GDH, glutamate 
dehydrogenase; HCS, homocitrate synthase; HA, homoaconitase; HICDH, homoisocitrate dehydrogenase   
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To test the influence of PycP458S on homocitrate production, C. glutamicum MS-1 was 
transformed with plasmid pAN6-pycP458S. In addition, pycP458S controlled by the Ptuf promoter 
was chromosomally integrated into the pta-ackA locus in C. glutamicum MS-1, thereby 
simultaneously inactivating pta-ackA by deletion. Deletion of the acetate activating genes pta 
and ackA, coding for phosphotransacetylase and acetate kinase was described to prevent 
acetate formation from acetyl-CoA (Reinscheid et al., 1999). The emerging strains (Fig. 12) 
were named C. glutamicum MS-2 (C. glutamicum MS-1 pAN6-pycP458S) and C. glutamicum 
MS-3 (C. glutamicum MS-1 Δpta-ackA::Ptuf-pycP458S).  
 
Fig. 12: Overview of second generation homocitrate producer strains derived from C. glutamicum MS-1. 
C. glutamicum MS-1 was transformed with the plasmids pEKEx2-lys20, encoding HCS of S. cerevisiae and 
pAN6-pycP458S, encoding a pyruvate carboxylase variant of C. glutamicum R, resulting in the strains C. 
glutamicum MS-1-pHCS and C. glutamicum MS-2, respectively. To generate C. glutamicum MS-3 gene 
deletions of pta-ackA (encoding phosphotransacetylase and acetate kinase) and simultaneous integration of 
pycP458S, controlled by the promoter Ptuf, was performed.  C. glutamicum MS-3 was transformed with the plasmid 
pEKEx2-lys20 to generate C. glutamicum MS-pHCS. Gene deletion of pknG (encoding serine/threonine protein 
kinase) in C. glutamicum MS-1 leads the strain C. glutamicum MS-4  
A further strategy tested to increase the product titer of homocitrate was the enhancement 
of the gene dosage of the homocitrate synthase. Therefore the strains C. glutamicum MS-1 
and C. glutamicum MS-3 were transformed with the plasmid pEKEx2-lys20, resulting in the 
strains C. glutamicum MS-1-pHCS (C. glutamicum MS-1/pEKEx2-lys20) and C. glutamicum 
MS-3-pHCS (C. glutamicum MS-3/pEKEx2-lys20). By this, both strains contained a plasmid-
encoded Lys20 in addition to the chromosomally integrated one. In a further approach the Ptuf-
lys20 fragment was integrated in the gdh locus of the strain C. glutamicum ΔpknG (Niebisch 
et al., 2006), resulting in C. glutamicum MS-4. Deletion of the serine/threonine protein kinase 
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(PknG) prevents phosphorylation of OdhI. Unphosphorylated OdhI binds with high affinity to 
OdhA, the E1-component of the 2-oxoglutarate dehydrogenase complex (ODH) in 
C. glutamicum, and leads to inhibition of OdhA (Schultz et al., 2007). In consequence of the 
OdhA inhibition, the homocitrate precursor 2-oxoglutarate accumulates, which should be 
beneficial for homocitrate formation.  
To evaluate whether the genetically modified strains show increased product formation, 
cultivation experiments in shake flasks in CGXII medium was performed. Standard 
conditions with 4% glucose as starting carbon source as well as “fed-batch” conditions with 
addition of 4% glucose and 2% acetate at the beginning of the stationary growth phase were 
tested. Growth and product formation was observed over 72 h (Fig. 13).  
In comparison to the parental strain C. glutamicum MS-1 (µ = 0.18 ± 0.02 h-1), the plasmid-
based expression stress further reduced the growth rate of strain MS-1-pHCS to 0.07 ± 
0.007 h-1, which means a decrease of about 53%. The slowed growth correlates with 
decelerated glucose consumption of MS-1-pHCS, showing complete consumption within 60 h 
to 72 h. Analyses of homocitrate concentration revealed up to 2.5 mM after 72 h, 
corresponding to a yield of 0.009 mol CHC/ mol Cglucose. This means a decrease of 37.5% in 
comparison to the parental strain MS-1 (4 mM homocitrate). Since MS-1-pHCS had strong 
growth retardation, the additional pulse of glucose and acetate was added after 54 h, yielding 
in increased biomass formation of about 22%. 
After 72 h approximately 45% (92 mM) of the added acetate and 44% (98 mM) of the added 
glucose were still present in the cell culture supernatant of MS-1-pHCS. In consequence of 
minor glucose and acetate uptake rate the strain C glutamicum MS-1-pHCS showed a 
decreased homocitrate accumulation (15.4 mM) and a slightly decreased yield of 
0.058 mol CHC/ mol Cglucose+acetate. Strain C. glutamicum MS-2, harbouring a plasmid encoded 
copy of the pycP458S gene, showed an enhanced growth rate (µ = of 0.22 ± 0.008 h-1). This 
indicates that the expression of the pyruvate carboxylase variant positively effects the growth 
of this strain compared to C. glutamicum MS-1. Under standard conditions the glucose in the 
culture of MS-2 was completely consumed within 24 h. Similar to C. glutamicum MS-1-
pHCS the plasmid encoded overexpression of PycP458S in the strain MS-2 was not beneficial 
for homocitrate production: After 72 h a maximal concentration of  2.5 mM, corresponding to 
a yield of 0.009 mol CHC/ mol Cglucose, was measured. 
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Fig. 13: Effect of various genetic modifications in C. glutamicum on homocitrate formation. Growth (A, B), 
glucose (C, D) and acetate consumption (D, grey) as well as homocitrate production (E, F) of the strains 
C. glutamicum MS-1 ( / ), C. glutamicum MS-3 ( / ) and C. glutamicum MS-3-pHCS ( / ) was 
analysed in standard CGXII minimal medium with 4% (w/v) glucose (A, C, E) and under “fed-batch” conditions 
with addition of 222 mM glucose and 204 mM acetate at the beginning of the stationary growth phase (B, D, F) 
for 72 h. Data represent mean values with standard deviation from three independent experiments, except for the 
“fed-batch” cultivation of C. glutamicum MS-1, which was performed in a single experiment.  
In the second experiment glucose and acetate were added after 28 h to the culture of MS-2, 
which led to an increased biomass formation of about 30% compared to standard conditions. 
Glucose was completely consumed within 56 h, whereas 10 mM acetate was present at the 
end of the cultivation. The strain, containing the plasmid-based pyruvate carboxylase gene 
pycP458S accumulated up to 31 mM homocitrate in 72 h, which corresponds to a yield of 
0.069 mol CHC/ mol Cglucose+acetate. Compared to the parental strain C. glutamicum MS-1, 
homocitrate production with MS-2 is increased by 11%. 
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In comparison to the parental strain, C. glutamicum MS-3 exhibited also an increased 
growth rate (µ = 0.23 ± 0.03 h-1, Fig. 13A). Similar to C. glutamicum MS-2, MS-3 fully 
consumed the glucose within 24 h (Fig. 13C) and reached a decreased homocitrate titer 
(2.5 mM) under standard conditions (Fig. 13E). At the beginning of the stationary growth 
phase (26 h) of C. glutamicum MS-3, a 222 mM glucose plus 204 mM pulse was added (Fig. 
13D), which led to a maximal OD of 56, representing a 30% increase in comparison to 
standard conditions. Analyses of the supernatant revealed that glucose was depleted within 
56 h, whereas a remaining concentration of 10 mM acetate was measured after 72 h. 
Cultivation of C. glutamicum MS-3 under “fed-batch” conditions yielded in a maximal 
homocitrate concentration of 41.1 mM with a corresponding yield of 0.092 mol CHC/ mol 
Cglucose+acetate (Fig. 13F). This result indicates that deletion of pta-ackA and/or chromosomal 
expression of pycP458S are beneficial for homocitrate production. 
Strain MS-3-pHCS (µ = 0.13 ± 0.002 h-1) harbouring the additional plasmid encoded copy 
of the HCS gene exhibited strong growth retardation of about 44% in comparison to the strain 
without plasmid (MS-3) (Fig. 13A). Glucose was more slowly consumed by MS-3-pHCS and 
depleted within 48 h (Fig. 13C). Interestingly, increased homocitrate titers were observed with 
the strain C. glutamicum MS-3-pHCS (Fig. 13E). At the end of the cultivation homocitrate 
was accumulated up to 6.6 mM with a corresponding yield of 0.023 mol CHC/mol Cglucose. To 
test this strain under “fed-batch” conditions glucose and acetate was added after 54 h, which 
led to a 34% increase of biomass after 72 h (Fig. 13B). HPLC measurements of the cell 
culture supernatant showed that 70 mM glucose and 158 mM were not metabolised within 
72 h (Fig. 13D). An accumulation of up to 52.1 mM homocitrate was measured after 72 h, 
representing a yield of 0.21 mol CHC/ mol Cglucose+acetate (Fig. 13F). 
Taken together, homocitrate production could be increased from 4 mM with C. glutamicum 
MS-1 under standard conditions to 52 mM with C. glutamicum MS-3-pHCS under “fed-
batch” conditions by metabolic engineering and modification of the cultivation conditions.    
The strain C. glutamicum MS-4, containing the deletion of the pknG gene encoding 
serine/threonine protein kinase, was tested independently of the other experiments under 
standard and “fed-batch” conditions in single experiments (data not shown). Cultivation under 
standard conditions revealed a diminished growth rate of µ = 0.11 h-1 and slowed glucose 
consumption (within 48 h), compared to the parental strain MS-1. Addition of glucose and 
acetate at the beginning of the stationary growth phase led to increased biomass formation by 
about 28%. Both, glucose and acetate were completely consumed within 120 h. Analyses of 
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the cell culture supernatant resulted in homocitrate titers similar to that of the parental strain 
C. glutamicum MS-1 under standard (4.1 mM) or “additional feeding” conditions (27.1 mM).  
 
Tab. 12: Summarised results of the genetically modified strains cultivated under “fed-batch” conditions. 
Cultivation of the strains C. glutamicum MS-1, MS-1-pHCS, MS-2, MS-3, MS-3-pHCS and MS-4 (Fig. 12) 
were performed in standard CGXII minimal medium with 4% (w/v) glucose as growth substrate. At the 
beginning of the stationary growth phase 4% (w/v) glucose (glu) and 2% (w/v) acetate (ac) dissolved in CGXII 
stock solution were added to the culture. Final product titers of homocitrate (HC) were determined via HPLC 
analyses after 72 h. Average data are calculated from three independent experiments, except for MS-1 and MS-4, 
where data from single experiments were obtained. 
Strains Genetic background Growth 
rate [h-1] 
Final product 
titer HC 
[mM] 
Consumed 
carbon source 
[mM] 
HC yield [mol 
CHC/ mol 
Cglucose+acetate] 
MS-1 Δgdh::Ptuf-lys20 0.18  27.5 222 glu 
194 ac 
 
0.06 
MS-1-
pHCS 
Δgdh::Ptuf-lys20/ 
pEKEx2-lys20 
0.07 ± 
0.006 
15.4  
± 6.6 
124 glu 
112 ac 
 
0.058 
MS-2 Δgdh::Ptuf-lys20/ 
pAN6-pycP458S 
0.22 ± 
0.008 
 
31.0 
± 3.9 
222 glu 
194 ac 
0.069 
MS-3 Δgdh::Ptuf-lys20 
Δpta-ackA::Ptuf-pycP458S 
0.24 ± 
0.01 
 
41.1 
± 2.6 
222 glu 
194 ac 
0.092 
 
MS-3-
pHCS 
Δgdh::Ptuf-lys20 
Δpta-ackA::Ptuf-pycP458S/ 
pEKEx2-lys20 
0.13 ± 
0.002 
 
 
52.1 
± 12.5 
152 glu 
46 ac 
0.21 
MS-4 Δgdh::Ptuf-lys20 
ΔpknG 
0.11 27.1 222 glu 
204 ac 
0.052 
 
Besides the main product homocitrate, several by-products were accumulated by the 
genetically engineered strains during cultivation. To identify the by-products as well as to 
verify the formation of homocitrate, GC-ToF-MS measurements of the cell culture 
supernatants were performed. Therefore, samples of the supernatant of the homocitrate 
producer strain MS-3 cultivated under standard conditions and with additional feeding of 
glucose and acetate, respectively, were taken after 48 h of cultivation. The GC-ToF-MS 
analysis confirmed homocitrate formation under both tested conditions. Furthermore, 
accumulation of 2-oxoglutarate, 2-hydroxyglutarate, malate and succinate were detected 
under both growth conditions. In addition lactate, citrate, 2-oxoisocaproate, 
2-hydroxyisocaproate and glycerol were identified in samples of the “fed-batch” approach. 
None of these substances was detected in samples of the strains C. glutamicum wild type and 
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C. glutamicum/pAN6-pycP458S which were used as negative controls. Those metabolites which 
were detectable via HPLC measurements were quantified in samples after 72 h of cultivation 
of the genetically modified strains (Tab. 13). In general, it was observed that the concentration 
of each metabolite was higher if the respective strain was cultivated under the condition of 
additional glucose and acetate feeding.  
The citrate cycle intermediates citrate, fumarate and malate were accumulated in the low 
mill molar range, whereas succinate was produced up to 21.7 mM with the strain 
C. glutamicum MS-3-pHCS. The accumulation of succinate might be an effect of the 
chromosomally encoded pyruvate carboxylase and the deletion of the pta-ackA genes, which 
have been described to be beneficial for succinate production in C. glutamicum (Litsanov et 
al., 2012a, Litsanov et al., 2012b).  
 
Tab. 13:  Comparison of the by-product formation of the plasmid-free homocitrate and 2-oxoadipate 
producer strains. Cell culture supernatants of the strains C. glutamicum MS-1-pHCS, MS-2, MS-3, MS-3-
pHCS and MS-4 grown under standard conditions (-) and grown under “fed-batch” with additional feeding of 
glucose and acetate (+) were analysed via HPLC to determine formation of malate, fumarate, succinate and 
citrate. For 2-hydroxyglutarate (2-HG) and 2-oxoglutarate (2-OG) the integrated area of the HPLC peaks were 
taken. 
 MS-1-pHCS MS-2 MS-3 MS-3-pHCS MS-4 
Carbon 
supply 
- + - + - + - + - + 
Malate 
[mM] 
0 2.2 0.6 3.5 0.3 3.3 0.3 5.4 0 0 
Fumarate 
[mM] 
0 0.1 0.1 0.2 0.1 0 0.1 0.3 0 0.01 
Succinate 
[mM] 
1.8 10.4 1.1 13.1 2.2 10.9 4.5 21.7 0 6.7 
Citrate 
[mM] 
0 0.1 0.5 1.1 0.3 0.6 0.8 0 1.0 2.1 
2-OG/        
2-HG 
[mAU*s] 
2701 13957 3049 30100 2951 44283 9488 52085 4880 19617 
 
The concentration of 2-oxoglutarate, which represents the direct precursor of homocitrate, 
could not be determined quantitatively for the homocitrate producer strains. The accumulation 
of 2-oxoglutarate and 2-hydroxyglutarate caused an extensive overlap of the respective peaks 
in the HPLC measurements. Manual reintegration of peak areas for the sample of 
C. glutamicum MS-3-pHCS after 72 h would indicate concentrations of 27 mM and 484 mM 
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for 2-oxoglutarate and 2-hydroxyglutarate, respectively. Based on the supplied amount of 
carbon, a concentration of 484 mM 2-hydroxyglutarate is theoretically not possible, 
demonstrating that even the manual reintegration of partly separated signals could not be used 
to get reliable data. For this reason, only the summed up peak areas of 2-hydroxyglutarate and 
2-oxoglutarate were analysed. For all homocitrate producer strains tested under “fed-batch” 
conditions a drastically increased peak area of 2-oxoglutarate and 2-hydroxyglutarate was 
observed (Tab. 13). The largest peak areas for 2-oxoglutarate and 2-hydroxyglutarate were 
detected in samples of the most promising homocitrate producer MS-3-pHCS under standard 
(9488 mAU*s) and much higher under “fed-batch” conditions (52085 mAU*s). The other 
tested strains obtained peak areas from 2700 to 4800 mAU*s under standard conditions and 
showed increased 2-oxoglutarate/2-hydroxyglutarate accumulation of 5-15-fold when 
cultivated under “fed-batch” conditions. However these results indicate that homocitrate 
production under “fed-batch” conditions is rather limited by acetyl-CoA than by 
2-oxoglutarate supply. Since the highest homocitrate titers under “fed-batch” conditions were 
reached at different time points (Fig. 13F), e.g. MS-3 after 48 h and MS-3-pHCS after 72 h, 
loss of HCS activity can likely be excluded. This observation gives further evidence of a 
limitation of acetyl-CoA supply.  
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4.7 Establishment of 2-oxoadipate production with C. glutamicum 
In the previous experiments of this thesis the establishment and enhancement of 
homocitrate production with C. glutamicum were demonstrated. These results form the basis 
for the development of a 2-oxoadipate producer strain. For the conversion of homocitrate to 
2-oxoadipate enzyme activities for homoaconitase (HA) and homoisocitrate dehydrogenase 
(HICDH) are necessary. Similar to the strain development of the homocitrate producers, the 
genes encoding HA (lys4) and HICDH (lys12) of S. cerevisiae were introduced 
chromosomally and plasmid-encoded into the homocitrate producer strains. To provide the 
enzymes for the plasmid-based 2-oxoadipate production, the homocitrate producer strains 
C. glutamicum/pEKEx2-ttc1550 and C. glutamicum/pEKEx2-lys20 were transformed with the 
plasmid pVWEx2-lys4-lys12, encoding HA and HICDH, respectively. 
For plasmid-free production of 2-oxoadipate the most promising strain MS-1 (C. glutamicum 
Δgdh::Ptuf-lys20) of the first generation of homocitrate producers was selected as parental 
strain. The gene aceA was chosen as integration locus in strain MS-1 for the S. cerevisiae 
genes lys4 and lys12 controlled by Ptuf. The resulting strain containing all three genes (MS-1 
ΔaceA::Ptuf-lys4-lys12) relevant for 2-oxoadipate production was named C. glutamicum MS-5 
(Fig. 14).  
 
Fig. 14: Establishment of the 2-oxoadipate production in C. glutamicum. For plasmid-based expression of 
the AAA pathway genes, relevant for 2-oxoadipate production, the C. glutamicum wild type was transformed 
with the plasmids pEKEx2-lys20 and pEKEx2-ttc1550 encoding homocitrate synthases as well as with the 
plasmid pVWEx2-lys4-lys12 encoding homoaconitase and homoisocitrate dehydrogenase. Gene deletion of aceA 
and simultaneous integration of lys4-lys12, controlled by the Ptuf promoter in C. glutamicum MS-1 leads to the 
plasmid-free 2-oxoadipate producer C. glutamicum MS-5. C. glutamicum MS-5 was transformed with the 
plasmid pEKEx2-lys20, resulting in the strain C. glutamicum MS-5-pHCS. 
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To test the effect of the gene dosage for the rate-limiting step in the AAA pathway 
catalysed by homocitrate synthase, the strain C. glutamicum MS-5 was transformed with the 
plasmid pEKEx2-lys20, resulting in the strain C. glutamicum MS-5-pHCS (Fig. 14). 
To test the plasmid-based 2-oxoadipate production (Tab. 14), the strains C. glutamicum/ 
pEKEx2-lys20/pVWEx2-lys4-lys12 (Fig. 15) and C. glutamicum/pEKEx2-ttc1550/pVWEx2-
lys4-lys12 (data not shown), were cultivated in standard CGXII medium (892 mM nitrogen) 
and under nitrogen limitation (59.6 mM nitrogen) with 4% (w/v)) glucose as sole carbon 
source. C. glutamicum/pEKEx2/pVWEx2 was used as a control. Evaluation of the growth 
behaviour under nitrogen excess (Fig. 15A) revealed growth rates of µ = 0.18 ± 0.02 h-1 
(C. glutamicum/pEKEx2-ttc1550/pVWEx2-lys4-lys12), µ = 0.16 ± 0.02 h-1 (C. glutamicum/ 
pEKEx2-lys20/pVWEx2-lys4-lys12) and µ = 0.16 ± 0.01 h-1 (control). This strong growth 
retardation in comparison to the wild-type strain (µ = 0.41 h-1) is a result of the two plasmid-
borne selections and expression stress.  
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Fig. 15: Comparison of plasmid based 2-oxoadipate production with C. glutamicum producer strains 
under standard conditions and nitrogen limitation. Growth (A), glucose consumption (B) and formation of 
2-oxoadipate (C) and homocitrate (D) in CGXII minimal medium with 4% glucose under nitrogen excess 
(892 mM N, black symbols) and nitrogen limitation (59.6 mM N, white symbols) of the strains C. glutamicum/ 
pEKEx2-lys20/ pVWEx2-lys4-lys12 ( / ) and the control strain C. glutamicum/pEKEx2/pVWEx2 ( / ) 
were tested. Mean values and standard deviation of three independent experiments are shown 
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As shown before for the homocitrate producer strains, cultivation of 2-oxoadipate strains 
under nitrogen limitation led to a strong decrease of the growth rates of about 56%, resulting 
in growth rates of 0.07 ± 0.005 h-1 and 0.08 ± 0.01 h-1 for C. glutamicum/pEKEx2-
lys20/pVWEx2-lys4-lys12 (Fig. 15A) and C. glutamicum/pEKEx2-ttc1550/pVWEx2-lys4-
lys12 (data not shown), respectively. In contrast, the growth rate of the control culture was not 
significantly affected under nitrogen limitation (µ = 0.15 h-1).  
Under nitrogen excess the 2-oxoadipate producer strains completely consumed glucose 
within 28 h, whereas glucose was consumed within 24 h by the control strain (Fig. 15B). 
Cultivation of the 2-oxoadipate strains under nitrogen limitation led to retarded glucose 
consumption: C. glutamicum/pEKEx2-lys20/pVWEx2-lys4-lys12 completely consumed the 
glucose within 72 h, whereas the glucose was still not fully consumed within 130 h by the 
strain C. glutamicum/pEKEx2-ttc1550/pVWEx2-lys4-lys12. Interestingly, the control strain 
did not fully consumed the glucose within 48 h under conditions of nitrogen limitation, 
although no difference in growth behaviour was observed compared to nitrogen excess (Fig. 
15B). 
Analyses of the cell culture supernatant revealed, that 2-oxoadipate was produced by both 
strains under standard conditions and under nitrogen limitation (Fig. 15C). Under standard 
conditions both strains accumulated up to approximately 2.2 mM 2-oxoadipate after 130 h, 
corresponding to a yield of 0.013 mol C2-OA/mol Cglucose. As shown for homocitrate 
production, nitrogen limitation also positively influenced 2-oxoadipate formation: Product 
titer increased up to 5 mM (0.03 mol C2-OA/mol Cglucose) for C. glutamicum/pEKEx2-
lys20/pVWEx2-lys4-lys12 and up to 9 mM (0.05 mol C2-OA/mol Cglucose) for C. glutamicum/ 
pEKEx2-ttc1550/pVWEx2-lys4-lys12, respectively. Further, analyses of the cell culture 
supernatant revealed a homocitrate accumulation for both strains of about 2 mM and 6.5 mM 
under standard and nitrogen limitation conditions, respectively (Fig. 15D, Tab. 14). Besides 
homocitrate, 2-oxoglutarate was also detected in the cell culture supernatant (Tab. 16), which 
leads to the assumption that neither homocitrate nor 2-oxoglutarate is limiting the 
2-oxoadipate production.  
It is worthwhile to notice that 2-oxoadipate and homocitrate were first detectable in the cell 
culture supernatant between 12 h and 22 h under standard conditions (Fig. 15C, D). In 
comparison, under nitrogen limitation homocitrate is present at the same time point, whereas 
2-oxoadipate is first detectable between 32 h and 48 h. This observation further indicates that 
2-oxoadipate production is limited by enzyme activity of homoaconitase or homoisocitrate 
dehydrogenase. Since the intermediates homoaconitate and homoisocitrate were not available 
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commercially, quantification of these substances in the cell culture supernatant by HPLC 
analyses was not possible. 
In summary, the feasibility of heterologous, plasmid-based 2-oxoadipate production in 
C. glutamicum, using the enzymes HCS, HA and HICDH of the AAA pathway of 
S. cerevisiae and T. thermophilus, was demonstrated. 
 
Tab. 14: Growth parameters and product formation of plasmid-based 2-oxoadipate production with 
C. glutamicum under nitrogen excess and nitrogen limitation conditions. The C. glutamicum strains were 
cultivated in standard CGXII minimal medium with 4% (w/v) glucose under nitrogen excess (892 mM N) and 
nitrogen limitation (59.6 mM N). The final titers of the products were determined after 130 h via HPLC 
measurements of the cell free supernatant. Product titers of 2-oxoglutarate and 2-hydroxyglutarate could not be 
determined from the HPLC measurements and are given as peak area. 
C. glutamicum 
strains 
Nitrogen 
supply 
Growth 
rate [h-1] 
Biomass     
[gcdw-1 h-1]    
Glucose uptake 
rate [mmol 
gcdw-1 h-1] 
Final homo-
citrate titer 
[mM] 
Final 2-oxo-
adipate titer 
[mM] 
2-OG/ 2-HG 
[mAU*s] 
pEKEx2-lys20/ 
pVWEx2-lys4-lys12 
892 mM 
0.16 ± 
0.02 
8.6 ± 2.6 4.6 ± 1.9 2.2 ± 0.3 2.1 ± 0.8 293 
pEKEx2-lys20/ 
pVWEx2-lys4-lys12 
59.6 mM 
0.07 ± 
0.005 
5.8 ± 0.6 2.5 ± 0.5 6.7 ± 1.6 5.6 ± 0.4 1516 
pEKEx2-ttc1550/ 
pVWEx2-lys4-lys12 
892 mM 
0.18 ± 
0.02 
7.9 ± 0.7 4.9 ± 0.9 1.9 ± 0.3 2.3 ± 0.6 489 
pEKEx2-ttc1550/ 
pVWEx2-lys4-lys12 
59.6 mM 
0.08 ± 
0.01 
5.9 ± 0.4 2.4 ± 0.5 6.6 ± 0.9 9.1 ± 1.7 3032 
 
In addition to the plasmid-based 2-oxoadipate production, the strains C. glutamicum MS-5 
and MS-5-pHCS having the genes for HA and HICDH chromosomally integrated were also 
analysed. These strains were cultivated in CGXII minimal medium under standard conditions 
with 4% (w/v) glucose as starting carbon source and under “fed-batch” conditions with 
addition of 4% (w/v) glucose and 2% (w/v) acetate at the beginning of the stationary growth 
phase. Analyses of the growth behaviour of C. glutamicum MS-5 (Fig. 16A) under standard 
conditions showed a slightly increased growth rate (µ = 0.22 ± 0.003 h-1) in comparison to the 
parental strain MS-1 (µ = 0.18 ± 0.02 h-1), and exhibited a 23% increased biomass formation. 
On the contrary, a stronger growth retardation was observed for the strain C. glutamicum MS-
5-pHCS (µ = 0.1 ± 0.003 h-1), likely induced by the expression stress of the plasmid encoded 
HCS gene. In correlation with the results obtained for growth behaviour, the glucose 
consumption rate of MS-5-pHCS (2.4 ± 0.04 mmol gcdw-1 h-1) was significantly lower 
compared to MS-5 (3.6 ± 0.3 mmol gcdw-1 h-1) (Fig. 16B). Determination of 2-oxoadipate in 
Results  79 
the cell culture supernatant of C. glutamicum MS-5 under standard conditions revealed a 
maximal production titer of up to 3.6 mM after 72 h, corresponding to a yield of 0.018 mol 
C2-OA/mol Cglucose (Fig. 16C). The second lys20 copy had a positive effect on 2-oxoadipate 
production (Fig. 16C): The strain C. glutamicum MS-5-pHCS accumulated up to 7.2 mM 
2-oxoadipate after 72 h, which represents a yield of 0.037 mol C2-OA/mol Cglucose and an 
increase of 100% compared to the strain C. glutamicum MS-5. Surprisingly, extracellular 
accumulation of 2-oxoadipate was detected after 8 h for both strains. This might be an 
indication that the chromosomally encoded genes were earlier expressed than the plasmid-
encoded genes or deletion of gdh with integrated lys20 has an effect on the time-course of 
product formation by influencing the precursor supply.  
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Fig. 16: Parameters of 2-oxoadipate production with C. glutamicum producer strains under standard and 
“fed-batch” conditions. Growth (A), glucose (B, black) and acetate (B, grey) consumption and product 
formation of 2-oxoadipate (C) and homocitrate (D) was analysed in standard CGXII minimal medium with 4% 
(w/v) glucose (black symbols) and under “fed-batch” conditions with addition of 222 mM glucose and 204 mM 
acetate at the beginning of the stationary growth phase (white symbols)  for 72 h. The strains C. glutamicum MS-
5 ( / ) and C. glutamicum MS-5-pHCS ( / ) were tested in this experiment. Mean values and standard 
deviation of three independent experiments are shown.   
Further analyses revealed that the precursor homocitrate was not present in the supernatant 
of the strain C. glutamicum MS-5 and was accumulated up to 2.3 mM by the strain 
C. glutamicum MS-5-pHCS after 72 h. Increased carbon availability in consequence of the 
reduced growth of MS-5-pHCS might explain the homocitrate accumulation. Alternatively, 
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the second HCS gene copy increases formation of homocitrate and the further conversion to 
homoaconitate is limited. 
For cultivation under “fed-batch” conditions, 222 mM glucose and 204 mM acetate were 
added after 26 h to the culture of the strain C. glutamicum MS-5, and in consequence of 
retarded growth after 54 h to the strain C. glutamicum MS-5-pHCS (Fig. 16B). An increased 
biomass formation of 30% and 22% for MS-5 and MS-5-pHCS, respectively, after additional 
carbon supply was observed (Fig. 16A). The additionally added glucose was completely 
consumed within 56 h by the C. glutamicum strain MS-5, whereas 10 mM acetate was present 
after 72h. In comparison, remaining concentrations of 20 mM glucose and of 92 mM acetate 
were measured in the supernatant of the strain MS-5-pHCS after 72 h.  
Similar to the results obtained for homocitrate production, 2-oxoadipate accumulation was 
significantly enhanced by adding the additional carbon sources (Fig. 16C, Tab. 15). The strain 
C. glutamicum MS-5 accumulated up to 19.6 mM after 72 h cultivation, representing a carbon 
yield of 0.065 mol C2-OA/mol Cglucose+acetate. Additionally, 10.4 mM (Fig. 16D) of the precursor 
homocitrate was present in the supernatant at the end of the cultivation. 2-Oxoadipate 
production was further enhanced by the strain MS-5-pHCS, yielding a final product titer of 
29.3 mM 2-oxoadipate with a yield of 0.13 mol C2-OA/mol Cglucose+acetate. Quantification of the 
precursor homocitrate revealed an accumulation of 15.7 mM after 72 h. Similar to the results 
of the plasmid based 2-oxoadipate production, the accumulation of the precursor homocitrate 
indicates that 2-oxoadipate production is limited either by the conversion of homocitrate to 
homoisocitrate or by the conversion of homoisocitrate to 2-oxoadipate.  
Tab. 15: Summarised results of the plasmid free 2-oxoadipate strains cultivated under standard and “fed-
batch” conditions. Cultivation of the strains C. glutamicum MS-5 and MS-5-pHCS were performed in standard 
CGXII minimal medium with 4% (w/v) glucose as growth substrate. At the beginning of the stationary growth 
phase 4% (w/v) glucose (glu) and 2% (w/v) acetate (ac) dissolved in CGXII stock solution were added to the 
culture. Final product titers of homocitrate (HC) and 2-oxoadipate (2-OA) were determined via HPLC analyses 
after 72 h. Mean values are calculated from three independent experiments.    
Strains Cultivation 
condition 
Biomass    
[gcdw-1 h-1] 
Growth 
rate [h-1]  
Final 
product titer 
2-OA [mM] 
Titer HC 
[mM] 
Consumed 
carbon source 
[mM] 
Carbon yield 
[mol Cproduct/ 
mol Cglu+ac] 
MS-5 
Standard 
(222 mM glucose) 
10.7 ± 0.8 
0.16 ± 
0.004 
3.6 ± 0.6 0.0 222 glu 0.018 (2-OA) 
MS-5 
 
“fed-batch” 
(222 mM  glucose, 
204 mM acetate) 
16.0 ± 1.1 0.16 ± 
0.004 
19.6 ± 0.5 10.4 ± 0.2 222 glu 
194 ac 
0.065 (2-OA) 
0.023 (HC) 
MS-5-
pHCS 
Standard 
(222 mM glucose) 8.8 ± 0.4 
0.1 ± 
0.003 7.2 ± 1.3 2.6 ± 0.6 222 glu 
0.037 (2-OA) 
0.009 (HC) 
 
MS-5-
pHCS 
“fed-batch” 
(222 mM  glucose, 
204 mM acetate) 
13.8 ± 1.7 0.1 ± 
0.003 
27.2 ± 0.7 15.7 ± 7.2 202 glu 
112 ac 
0.13 (2-OA) 
0.048 (HC) 
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Furthermore, 2-oxoglutarate and 2-hydroxyglutarate were identified in the cell culture 
supernatants of MS-5 and MS-5-pHCS under “fed-batch” conditions and in low quantity in 
the supernatant of the strain MS-5-pHCS under standard conditions. Based on the HPLC peak 
areas of 2-oxoglutarate and 2-hydroxyglutarate (1411 mAU*s for MS-5, 7292 mAU*s for 
MS-5-pHCS) drastically decreased amounts under “fed-batch” conditions can be assumed in 
comparison to the homocitrate producer strains. That indicates that more of the carbon source 
was used for 2-oxoadipate formation. 
Additionally, the cell culture supernatants of the strain C. glutamicum MS-5 cultivated 
under standard as well as “fed-batch” conditions were analysed via GC-ToF-MS 
measurements after 48 h. Surprisingly, formation of 2-hydroxyadipate was observed under 
both tested conditions. 2-Hydroxyadipate is the product of the conversion of 2-oxoadipate in 
the proposed synthetic part of the pathway towards adipate (Fig. 3). Similar to the reduction 
of 2-oxoglutarate to 2-hydroxyglutarate, no enzyme activity in C. glutamicum is described, 
which naturally catalyse the reaction of 2-oxoadipate to 2-hydroxyadipate. However, it is 
likely that side-activities of enzymes are present which are capable of catalysing the described 
reductions. Furthermore, 2-oxoglutarate (under “fed-batch” conditions only), 
2-hydroxyglutarate and glutarate were present in the supernatants. Glutarate formation was 
observed under “fed-batch” conditions up to 3 mM. The citrate cycle intermediates malate 
and fumarate were detected in the low milli-molar range for both strains under “fed-batch” 
conditions, whereas succinate was accumulated up to 12.5 mM by the strain MS-5-pHCS.    
The most promising 2-oxoadipate producer strain C. glutamicum MS-5-pHCS was also 
tested under nitrogen-limited conditions. The experiment was performed in CGXII minimal 
medium, containing 59.6 mM nitrogen and 222 mM glucose as sole carbon source with and 
without “fed-batch” by additional feeding of glucose (222 mM) and acetate (204 mM) at the 
beginning of the stationary growth phase. Similar to the results of the homocitrate producer 
C. glutamicum MS-1, nitrogen limitation did not enhance the 2-oxoadipate titer (data not 
shown). Cultivation under standard conditions led to a final product titer of up to 5.2 mM 2-
oxoadipate, whereas the addition of extra carbon supply slightly increased the production to a 
value of 8.5 mM.  
In summary 2-oxoadipate production with C. glutamicum was demonstrated for the first 
time. The results obtained for 2-oxoadipate production further provide an excellent starting 
point for the development of an adipate producer strain.  
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4.8  2-Oxoadipate production under controlled conditions in a bioreactor 
In the previous experiments it was shown that homocitrate and 2-oxoadipate product titers 
were enhanced by genetic modifications, modified cultivation conditions, and combinations 
of both. All these experiments were performed in 500-ml shake flasks containing 60 ml 
medium. As a further step to test for improved production, the most promising 2-oxoadipate 
producer strain C. glutamicum MS-5-pHCS was cultivated in 700 ml-scale under controlled 
conditions in a Sixfors multi fermenter system (Infors), which allows simultaneous cultivation 
in six independent bioreactors. Since it has been demonstrated that additional carbon supply at 
the beginning of the stationary growth phase enhanced product formation, three different 
feeding strategies were tested in duplicates:  
The first strategy was the automatic feeding of glucose and acetate in dependency of the 
oxygen saturation. In previous experiments it was observed, that the oxygen saturation raised 
above 80% when glucose was completely depleted in the bioreactor. In accordance with this 
condition the threshold for addition of carbon supply was set to 80% oxygen saturation. When 
the threshold was exceeded, 20 mM glucose and 10 mM acetate were automatically added. In 
the second strategy, 222 mM glucose and 204 mM acetate were added by continuous feeding 
of a 25% glucose/12.5% acetate solution over 24 h. The third strategy was to add a single 
pulse of 4% (w/v) glucose and 2% (w/v) potassium acetate at the beginning of the stationary 
growth phase when glucose was depleted.  
Since in one experiment the strain MS-5-pHCS showed significantly slower growth, the 
results obtained from the performed duplicates with the third strategy exhibited considerable 
differences. Thus, only one experiment was considered for analyses (Fig. 17). In comparison 
to the shake flask experiments (µ = 0.1 ± 0.003 h-1) the growth rates under controlled 
conditions in the bioreactor were increased to values of 0.14 – 0.15 h-1. Furthermore, 
differences in biomass formation of the various conditions and of the duplicates were 
observed (Fig. 17A). The starting point of the three different feeding strategies was after 24 h, 
when the glucose, which was applied at the beginning of the experiment was completely 
consumed (Fig. 17B). 
After starting the feed in dependency of oxygen saturation, glucose was present during the 
whole cultivation and was accumulated at the end of cultivation (after 50 h) to 138 ± 24 mM. 
In contrast, acetate was only temporary detectable in dependency on the sample time point in 
relation to the time point of the feed (Fig. 17D). In case of the continuous feeding strategy, 
glucose accumulation in the medium started 13 h after the feed and ended up at a 
concentration of 51 ± 2 mM. Acetate accumulation was not observed during the whole 
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cultivation time. The approach of adding a single pulse revealed glucose consumption within 
13 h. In comparison acetate uptake occurred faster, resulting in complete uptake within 7 h. 
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Fig. 17: Parameters of bioreactor cultivations of the 2-oxoadipate producer strain C. glutamicum MS-5-
pHCS. Three different feeding strategies were tested and performed as duplicates in modified CGXII minimal 
medium with 4% (w/v) glucose omitting the buffer substance MOPS, except of the third strategy, for which only 
a single experiment is shown. Biomass formation (A), glucose (B) and acetate (D) consumption as well as 
2-oxoadipate production (C) were analysed for each strategy: (1) Addition of 20 mM glucose and 10 mM acetate 
in dependency of the oxygen saturation ( ), (2) continuous feed of 222 mM glucose and 204 mM acetate over 
24 h ( ) and (3) addition of 222 mM glucose and 204 mM acetate by a single pulse ( ). Average data with 
standard deviation are presented.  
Determination of 2-oxoadipate in the cell culture supernatant revealed a maximal final 
product titer of up to 6 mM after 50 h of cultivation (Fig. 17C), whereas the strain 
accumulated up to 29.3 mM 2-oxoadipate in the shake flask experiments (Fig. 16C). 
Compared to the shake flask experiments none of the feeding strategies resulted in an 
improvement of 2-oxoadipate production. Before starting the different feedings, up to 4 mM 
2-oxoadipate were accumulated, indicating that the additional carbon supply was mainly not 
converted to 2-oxoadipate. In contrast to the lowered 2-oxoadipate production, a high 
homocitrate concentration of up to 28 mM was obtained in the experiments with oxygen-
dependent feeding. In shake flask experiments with 2-oxoadipate producers the highest titer of 
the intermediate homocitrate was about 16 mM (Tab. 15). The analyses of homocitrate 
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accumulation of the other two bioreactor-approaches yielded in approximately 10 mM (Tab. 
16). 
Tab. 16: Overview of biomass and product formation during bioreactor cultivation of the strain 
C. glutamicum MS-5-pHCS. 2-Oxoadipate, homocitrate, 2-oxoglutarate/2-hydroxyglutarate and glutarate 
concentrations were determined in the cell culture supernatants of the samples after 50 h of cultivation. 
Bioreactor cultivation experiments were performed with three different feeding strategies: Addition of 20 mM 
glucose and 10 mM acetate in dependency of the oxygen saturation (1), continuous feed of 222 mM glucose and 
204 mM acetate over 24 h (2) and addition of 222 mM glucose and 204 mM acetate by a single pulse (3). 
 Feeding strategy 
 1 2 3 
Biomass [gcdw-1 h-1] 9.8 ± 0.5 12.8 ± 0.9 11.25 
2-Oxoadipate [mM] 5.0 ± 0.4 6.0 ± 0.1 4.5 
Homocitrate [mM] 28.3 ± 2.2 8.6 ± 2.5 9.5 
2-Oxoglutarate/ 
2-Hydroxyglutarate 
[mAU*s] 
9496 4506 9093 
Glutarate [mM] 1.8 ± 0.8 4.9 ± 0.7 3.8 
 
In case of feeding strategy 1 and 3 by-product formation of 2-oxoglutarate and 
2-hydroxyglutarate were similar compared to the shake flask cultivations of the strain 
C. glutamicum MS-5-pHCS. In contrast, only one half of 2-oxoglutarate and 
2-hydroxyglutarate were produced under feeding strategy 2. Glutarate was accumulated in 
low millimolar levels similar to the results of the shake flask cultivations. By-product 
formation of homocitrate and 2-oxoglutarate leads to the suggestion that 2-oxoadipate is 
limited by HA or HICDH.  
 In summary, all tested conditions in the Bioreactor revealed drastically decreased 
2-oxoadipate yields in comparison to the shake flask experiments. Besides the proposed 
limitation by HA and HICDH, the controlled conditions, in particular oxygen saturation, in 
the bioreactor might be unfavourable for 2-oxoadipate production, since 2-oxoadipate in 
shake flasks is mainly produced in the stationary growth phase under oxygen deprivation 
conditions. 
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5  Discussion 
The overall goal of this project is the generation of a new synthetic pathway for the 
complete bio-based production of adipate within a microbial cell. Adipate is the most 
important commercial aliphatic dicarboxylic acid in the chemical industry with an estimated 
production of 2.6 million tons in 2010 (Merchant Research & Consulting Ltd., 2011). The 
chemical production process of adipate is coupled to the oil price and is linked to 
environmental damage and harmful substances (Galbraith et al., 2010, Alini et al., 2007). 
Confronted with these points and with the exhaustion of the earth´s fossil energy resources, 
the bio-based production of bulk chemicals such as adipate from renewable sources is of 
growing interest.   
To this end, the primary aim of the studies presented here was the establishment of the 
production of the adipate precursor 2-oxoadipate in the biotechnologically relevant bacterium 
Corynebacterium glutamicum by heterologously expressed enzymes of the α-aminoadipate 
(AAA) pathway. Further aspects of this study were the analyses of growth parameters and the 
transcriptional response of C. glutamicum in the presence of adipate and 2-oxoadipate.   
 
5.1  Influence of 2-oxoadipate and adipate on growth and global gene expression of 
C. glutamicum.  
With respect to the desired production of 2-oxoadipate and finally adipate with 
C. glutamicum, their influence on growth and global gene expression of wild-type cells was 
analysed. The growth experiments in the presence of 50 mM (7.3 g l-1), 150 mM (21.9 g l-1) 
(data not shown), 250 mM (36.5 g l-1) and 500 mM (73 g l-1) adipate revealed increasing 
growth retardation at concentrations higher than 50 mM (Fig. 4). Similar to these results, no 
significant growth inhibition was obtained in the presence of 50 mM (8 g l-1) 2-oxoadipate 
and 50 mM trisodium homocitrate (13.6 g l-1). Experiments with using KOH instead of NaOH 
to adjust the adipate stock solution, revealed similar final biomass formation like the control, 
but did not completely restore the growth rate (Fig. 6). These results indicate an inhibitory 
effect on growth which is specifically linked to adipate and to some extent to osmotic stress in 
dependency of using sodium or potassium ions. In contrast to a low sodium concentration, 
C. glutamicum contains up to 800 mM potassium in the cytoplasm (Krämer et al., 1990). 
Thus, in comparison to potassium ions the influx of sodium ions to emerge a steady state 
between intra- and extracellular concentrations is higher and caused osmotic stress. 
Additionally, it was shown that high concentrations of sodium ions are harmful for proteins 
and membranes by disrupting their hydration shell (Liu & Bolen, 1995). In contrast, 
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accumulation of intracellular potassium is described as a first response of bacterial cells 
toward hyperosmotic stress and contributes to the global transcriptional regulation, which is 
activated under osmotic stress conditions (Follmann et al., 2009). In addition to potassium-
mediated mechanisms, the accumulation of compatible solutes is a general defense 
mechanism of C. glutamicum to overcome hyperosmotic stress conditions. For uptake of 
compatible solutes such as glycine, betaine, proline and ectoine five secondary uptake 
systems, named BetP, PutP, ProP, EctP and LcoP have been characterised in C. glutamicum 
so far (Steger et al., 2004, Peter et al., 1996, Peter et al., 1998). Since betP and proP showed 
elevated mRNA levels in the presence of 150 mM adipate (Tab. 5), cultivation experiments of 
C. glutamicum in the presence of 500 mM adipate supplemented with 5 mM proline and 
5 mM glutamate were performed. Glutamate was added to supplement a possible adipate-
mediated inhibition of the citrate synthase, which might be occurring due to some structural 
similarity of citrate and adipate. The growth rate in the presence of proline and glutamate was 
enhanced by 44% (µ = 0.16 h-1) and the lag-phase was strongly reduced compared to the 
experiment without supplementation, indicating the positive effect which is likely primarily 
mediated by the compatible solute proline. In summary, adipate-mediated growth retardation 
was to some extent caused by osmotic stress, which could be compensated by both, the 
adjusting the pH of the adipate stock solution with potassium instead of sodium as counter ion 
and the addition of the compatible solute proline. Nevertheless, the growth rate of 
C. glutamicum wild-type cells was not completely restored, suggesting further inhibitory 
effects mediated by adipate itself.  
To elucidate a possible adipate-mediated growth retardation on the transcriptional level, 
global gene expression experiments in the presence of 50 mM and 150 mM adipate (Tab. 5, 
Tab. 6) were performed. Interestingly, in the presence of 50 mM adipate, the genes dccT and 
dctA coding for the two dicarboxylate uptake systems in C. glutamicum were slightly down-
regulated. These transporters were classified as an anion/sodium-dependent symporter (DccT) 
and a dicarboxylate amino acid-cation symporter (DctA), catalysing the uptake of the C4-
dicarboxylates succinate, fumarate and L-malate (Youn et al., 2008, Youn et al., 2009). Since 
it was shown that cultivation of the wild type in the presence of adipate caused growth 
retardation the strain C. glutamicum ΔdccTΔdctA was cultivated in the presence of 500 mM 
adipate to test whether one or both of the transporters could be involved also in the uptake of 
adipate (Fig. 6B). The deletion of both dicarboxylate uptake systems was not beneficial for 
growth in the presence of 500 mM adipate, indicating that both uptake systems were not 
involved in transport of adipate into the cell under the conditions tested. Analyses of the data 
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of the global gene expression in the presence of 50 mM adipate exhibited no further obvious 
target genes, whose function could be linked to the growth retardation observed at higher 
adipate concentrations. In contrast, exposure to 150 mM adipate which clearly leads to some 
growth retardation, resulted in the down-regulation of further genes. Among these, several 
genes were identified whose corresponding proteins are participating in the central 
metabolism or are involved in its regulation (Tab. 6). For example, the genes ldh and cg3218 
encoding the L-lactate dehydrogenase and a pyruvate kinase-like protein, respectively, 
showed the strongest decrease in mRNA levels. Further, the gene coding for transcriptional 
regulator RamA, announced to have global regulatory functions and primary being a regulator 
of the acetate metabolism (Auchter et al., 2011), was slightly down-regulated under these 
conditions. RamA functions also as an activator of adhA (Zn-dependent alcohol 
dehydrogenase), which is down-regulated, too. This result is in agreement with the fact, that 
the second regulator of acetate metabolism RamB, which acts as repressor of adhA in the 
presence of glucose or acetate (Arndt & Eikmanns, 2007), is up-regulated under these 
conditions. The effectors of RamA and RamB were not identified so far and it seems unlikely 
that adipate acts as an effector of these regulators, since no further target genes of RamA and 
RamB were regulated in the presence of adipate. The genes which exhibited decreased mRNA 
levels in the presence of adipate were distributed among the central metabolism, which 
complicates the identification of direct target genes involved in adipate-mediated growth 
retardation from these data. In conclusion, the observed down-regulation of genes in response 
to adipate seems to be rather caused by secondary effects of the adipate-mediated growth 
retardation than to a direct effect of adipate. 
Analyses of the genes which are up-regulated in the presence of adipate revealed the 
regulation of whole operons or gene clusters. Most of the genes, which showed highly 
elevated mRNA levels in the presence of adipate, belong to the degradation pathway of 
aromatic compounds, especially to the β-ketoadipate pathway in C. glutamicum (Fig. 18). 
Almost all genes of the operons/clusters pca, ben and cat were up-regulated at both, 50 mM 
and 150 mM adipate. The pca gene cluster, which consists of 10 genes (Fig. 18B) and one 
transporter gene located upstream of the pca operon (not shown in Fig. 18), encode the 
enzymes of the protocatechuate (PCA) branch of the β-ketoadipate pathway. The regulation of 
the PCA branch has been intensively studied in several organisms, e.g. Pseudomonas putida 
and Acinetobacter baylyi (Zhao et al., 2010).  
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Fig. 18: Schematic overview of the β-ketoadipate pathway in C. glutamicum (Brinkrolf et al., 2006).         
(A) Metabolic pathway of the protocatechuate branch catalysing the conversion of 4-hydroxybenzoate to 
succinyl-CoA and acetyl-CoA. Abbreviations of the involved enzymes and metabolites: 4-HB, 
4-hydroxybenzoate; PC, protocatechuate; β-CM, β-carboxy-cis ,cis-muconate; γ-CM, γ-carboxy-muconolactone; 
β-KEL, β-ketoadipate enol-lactone; β-KA, β-ketoadipate; β-KA-CoA, β-ketoadipyl-CoA; PobA, 
4-hydroxybenzoate hydroxylase; PcaGH, protocatechuate-3,4-dioxygenase; PcaB, β-carboxy-cis, cis-muconate 
cycloisomerase; PcaC, γ-carboxy-muconolactone decarboxylase; PcaD, β-ketoadipate enol-lactone hydrolase; 
PcaIJ, β-ketoadipate succinyl-CoA transferase; PcaF, β-ketoadipyl-CoA thiolase. (B) Genetic organisation of the 
pca gene cluster in C. glutamicum. Boxed proteins show the two transcriptional regulators PcaR and PcaO and 
their respective target genes. (C) Metabolic pathway of the catechol branch of the β-ketoadipate pathway 
converting benzoate to β-ketoadipate enol-lactone. Abbreviations of the involved enzymes and metabolites: MA, 
cis,cis-muconate; ML, muconolactone; β-KEL, β-ketoadipate enol-lactone; BenAB, benzoate dioxygenase, 
BenC, benzoate dioxygenase reductase; BenD, 2-hydro-1,2-dihydroxybenzoate dehydrogenase; CatA, catechol-
1,2-dioxygenase; CatB, cis,cis-muconate cycloisomerase; CatC, muconolactone isomerase. 
 
In C. glutamicum the two regulators PcaR and PcaO were identified to regulate the PCA 
branch of the β-ketoadipate pathway. PcaR is a member of the IclR family of transcriptional 
regulators and is described to act as repressor of the genes pcaIJ and pcaFDO by binding to 
the DNA sequence motif GTTCGCATTGCGAAC (Molina-Henares et al., 2006, Brinkrolf et 
al., 2006). The second transcriptional regulator PcaO belongs to an ATP-binding LuxR 
(LAL)-type regulator and functions as an activator of the genes pcaG and pcaH. Transcription 
of pcaO is repressed by PcaR (Zhao et al., 2010). In P. putida PcaR and CatR show specific 
affinities to adipate, which is not metabolised and seems to be a gratuitous inducer molecule 
of both transcriptional regulators (Romero-Steiner et al., 1994). The transcriptome analyses of 
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C. glutamicum in the presence of adipate revealed high up-regulation of the genes pcaIJ and 
pcaFDO suggesting that the gene expression is no longer repressed under these conditions. 
Comparison of PcaR protein sequences of C. glutamicum and P. putida revealed 35.3% 
identity and 54.5% similarity. This result strongly indicates that adipate might also be an 
effector molecule for PcaR in C. glutamicum. In case of the second regulator PcaO it was 
reported, that PcaO binds only in response to protocatechuate and increased ADP level to its 
target sequence (Zhao et al., 2010). In the presence of adipate unchanged expression level of 
pcaH and pcaG was observed, indicating that PcaO did not function as a transcriptional 
activator of pcaH and pcaG under the tested conditions in C. glutamicum.  
Furthermore, up-regulation was observed for the genes benA and benB belonging to the 
ben operon and for the catCBA operon (Fig. 18C). The encoded proteins catalyse the reactions 
of benzoate to β-ketoadipate enol-lactone. This part of the β-ketoadipate pathway is named 
catechol branch (Brinkrolf et al., 2006). In case of C. glutamicum it was postulated that the 
putative transcriptional regulator BenR, which belongs to the LuxR-type family, positively 
regulates the expression of the ben and cat operons (Brinkrolf et al., 2006). BenR was 
described to be induced by benzoate in P. putida (Cowles et al., 2000) and it can be assumed 
that adipate activates BenR-mediated transcription of benAB and possibly of catCBA in 
C. glutamicum. In addition to that, the embedding of a second, currently unknown regulator of 
the catechol branch is conceivable. In conclusion, an influence of adipate on the regulatory 
network of aromatic compound degradation in C. glutamicum is obvious and was revealed for 
the first time by these experiments.  
Among the regulated operons, the genes fabG1, cg0345, fadE and hdtZ belonging to the 
predicted operon OP_cg0344 and the genes fadD1 and cg0340 were highly up-regulated (10-
38-fold) in the presence of adipate. The corresponding proteins are involved in fatty acid 
biosynthesis and metabolism. Furthermore it was predicted that the genes of the OP_cg0344 
operon were repressed by GlxR (Schröder & Tauch, 2010). Since no further genes, which 
were described to be regulated by GlxR, are (highly) regulated in the presence of adipate, it 
seems very unlikely that adipate acts as effector of GlxR. The results rather suggest that 
besides GlxR, at least one other regulator is involved in the transcriptional regulation of the 
OP_cg0344 operon as well as the divergently orientated genes fadD1 and cg0340 in the 
presence of adipate. 
Furthermore, exposure of C. glutamicum to adipate also resulted in slightly increased 
mRNA levels of the prpD2B2C2 cluster, which encodes proteins (2-methylcitrate 
dehydratase, 2-methylcitrate lyase, 2-methylcitrate synthase) of the 2-methylcitrate cycle and 
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enables C. glutamicum to grow on propionate as sole carbon source (Claes et al., 2002). In the 
presence of propionate as additional carbon source, the expression of the genes prpD2B2C2 is 
strongly induced (Claes et al., 2002). In case of Salmonella enterica it was shown, that PrpR 
acts as transcriptional regulator of the 2-methylcitrate cycle genes (Palacios & Escalante-
Semerena, 2004). Eventually, adipate functions as an effector molecule of PrpR in 
C. glutamicum leading to increased mRNA levels of the prpD2B2C2 gene cluster. Since 
adipate presumably acts as effector molecule for PcaR and maybe also for further 
transcriptional regulators (BenR, PrpR), the application of these regulators in a biosensor 
system for screening adipate producers should be tested. Recently, the design and application 
of metabolite sensors based on transcription factors was described for C. glutamicum (Binder 
et al., 2012): The transcriptional regulator LysG, which senses elevated concentrations of the 
basic amino acids L-lysine of L-arginine leading to the transcription of the LysG target gene 
lysE, was used for the design of an intracellular L-lysine detection system. For detection of 
increased intracellular L-lysine levels the lysG promoter was fused to a reporter gene (eyfp) 
(Binder et al., 2012). 
 
5.2  First generation of homocitrate and 2-oxoadipate producer strains 
In this work the chosen strategy for establishing the 2-oxoadipate production in 
C. glutamicum was the implementation of three heterologous genes coding for homocitrate 
synthase, homoaconitase and homoisocitrate dehydrogenase. These enzymes naturally 
catalyse reactions in the α-aminoadipate (AAA) pathway, which represents one of two distinct 
pathways for the L-lysine biosynthesis (Xu et al., 2006).  
The presence of the AAA pathway in the baker´s yeast S. cerevisiae has been demonstrated 
several decades ago (Bhattacharjee & Strassman, 1967). Therefore one might speculate the 
easiest way to produce 2-oxoadipate could be the use of S. cerevisiae as production organism. 
In the course of this thesis, the potential of S. cerevisiae as natural 2-oxoadipate producer was 
tested by analysing two commercially available strains (data not shown). These strains are 
defective either in the 2-oxoadipate converting enzyme 2-aminoadipate transferase (Yer152c) 
or in the aromatic amino acid transferase (Ygl202w). Cultivation of these strains in SD 
minimal medium with and without L-lysine supplementation revealed no accumulation of 
2-oxoadipate. The next step would be the construction and analyses of the double deletion 
strain S. cerevisiae Δyer152cΔygl202w expected to be L-lysine auxotrophic, which was not 
done in this study.  
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The microorganism C. glutamicum is firmly established as host organism in industrial 
biotechnological applications and is intensively studied regarding the metabolism and its 
regulation. For this reason it was selected as host organism for 2-oxoadipate production. Two 
different approaches for the establishment of homocitrate and 2-oxoadipate production have 
been performed in this thesis: Firstly, the plasmid-based establishment by expression and 
testing of homocitrate synthases. The respective genes were chosen from the organisms 
S. cerevisiae (lys20), T. thermophilus (ttc1550) and A. vinelandii (nifV). A second plasmid, 
which harbours the genes lys4 and lys12 of S. cerevisiae encoding homoaconitase and 
homoisocitrate dehydrogenase were used for 2-oxoadipate production. Secondly, the three 
relevant genes of S. cerevisiae (lys20, lys4, lys12) were integrated into the genome of 
C. glutamicum to test plasmid-free production. Thereby the genes gdh and aceA, coding for 
glutamate dehydrogenase and isocitrate lyase, respectively, were simultaneously deleted.  
Jo and co-workers (2012) reported that the deletion of gdh and aceA was beneficial for 
production of 2-oxoglutarate. The blocking of the glyoxylate shunt and biosynthesis of 
L-glutamate revealed a strong enhancement of 2-oxoglutarate production in a C. glutamicum 
strain engineered for L-glutamate production. Furthermore, the glutamate dehydrogenase was 
shown to be the key enzyme for converting 2-oxoglutarate to L-glutamate, whereas the 
production of 2-oxoglutarate was not influenced by the deletion of gltB, whose corresponding 
protein (glutamate synthase) is also participating in L-glutamate production (Jo et al., 2012).  
Based on glucose the maximal theoretical yield of homocitrate/2-oxoadipate is calculated 
to be 0.66 (66%) without considering the carbon consumed for biomass formation. 
Cultivation of the plasmid-based homocitrate producer strains under standard conditions 
revealed product formation up to 2.7 mM homocitrate (using Lys20) within 72 h, which 
corresponds to a yield of 0.009 mol CHC/mol Cglucose. In comparison the Ttc1550-mediated 
homocitrate production was slightly lower (1.8 mM homocitrate, 0.006 mol CHC/mol Cglucose). 
No homocitrate accumulation was detected when the homocitrate synthase of A. vinelandii 
(nifV) was tested. This was almost expected since HCS from the nitrogen-fixing A. vinelandii 
forms tiny amounts of homocitrate as cofactor for the nitrogenase. Heterologous expression of 
the nifV gene in E. coli showed in a proof of principle approach the extracellular accumulation 
of homocitrate, indicating that expression of nifV in C. glutamicum might be the limiting 
factor (Zheng et al., 1997). In case of E. coli it is reported that overexpression of a 
heterologous protein is often connected to problems dealing with toxicity of the protein, 
different codon usage, inclusion bodies or missfolded protein structures (Terpe, 2006). Thus, 
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the adaption of the nifV DNA sequence to the codon usage of C. glutamicum might result in 
better expression and homocitrate formation. 
As mentioned above, the plasmid-free establishment of the relevant AAA genes illustrates 
an important alternative in strain development for homocitrate and 2-oxoadipate production. 
Under standard conditions the strain MS-1 containing a single gene copy of lys20 under 
control of the Ptuf promoter revealed an increased homocitrate production titer of up to 
4.1 mM (0.014 mol CHC/ mol Cglucose), compared to the plasmid-based variants. An 
explanation for this increase might be the enhanced intracellular 2-oxoglutarate pool, which 
was shown to be a result of the gdh deletion (Müller et al., 2006). In consequence of the gdh 
deletion, a partially deregulated nitrogen starvation response was observed (Müller et al., 
2006), which might explain the decreased growth rate of C. glutamicum MS-1. This results in 
ammonium assimilation by the glutamate synthase instead of GDH. The glutamate synthase is 
not able to satisfy the glutamate demand of the cells completely (Rehm & Burkovski, 2011). 
Thus, the decreased growth rate is to some extent induced by a diminished L-glutamate pool 
and increased energy demand necessary for ammonium assimilation (Rehm & Burkovski, 
2011). On the contrary, in the strain MS-5 the deletion of aceA, coding for isocitrate lyase did 
not affect the growth behaviour. This is consistent with previous results which demonstrated 
an unaltered growth rate of a ΔaceA mutant on glucose, whereas isocitrate lyase (ICL) was 
essential for growth on acetate (Reinscheid et al., 1994). 
Nevertheless, the yield of homocitrate under standard conditions was quite low, indicating 
that the production process is somehow limited: Comparison of the affinities of the enzymes 
competing for 2-oxoglutarate showed especially for the enzyme of T. thermophilus a high 
affinity with a KM value between 5 and 24 µM, compared to the 2-oxoglutarate 
dehydrogenase complex (ODHC) of C. glutamicum, exhibiting a KM of 80 µM (Wulandari et 
al., 2002, Okada et al., 2010, Shiio & Ujigawa-Takeda, 1980). In contrast, a significantly 
lower affinity with a KM of 1.3 mM was determined for the HCS of S. cerevisiae (Andi et al., 
2004). The affinities of Lys20 and Ttc1550 toward the second substrate acetyl-CoA were 
almost identical (KM values of 2.4 µM and 3.2 µM, respectively). Furthermore, a specific 
activity of 730 mU (mg protein)-1 was measured for Lys20, compared to 41 mU (mg protein)-1 
for Ttc1550 (Okada et al., 2010, Andi et al., 2004). Since the temperature optimum of 
Ttc1550 is 60°C, cultivation at 30°C contributes to a loss of enzyme activity (Wulandari et 
al., 2002). Despite the differences in substrate affinity and specific activity similar amounts of 
homocitrate were produced, suggesting that the production process is not limited by HCS 
enzyme activity itself but e.g. by a low expression level of the HCS genes, by somehow 
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partially inactivated enzyme or by limited precursor supply. To test whether gene expression 
of homocitrate synthase genes is a limiting factor, quantification of transcriptional levels by 
using real-time PCR could be performed in the future. Increase of the HCS gene dosage and 
the adaption of the HCS genes to the codon usage of C. glutamicum could be a further 
strategy to enhance the level of HCS mRNA and HCS protein in the producer strains.  
Furthermore, it was shown that the homocitrate synthases are subject to complex 
regulation mechanisms. In organisms which contain an AAA (like) pathway almost all 
homocitrate synthases exhibit strong (feedback) inhibition by L-lysine, the end product of the 
AAA pathway (Xu et al., 2006). The enzymes of T. thermophilus and S. cerevisiae are 
inhibited at L-lysine concentrations of 70 µM and 0.5 to 1 mM, respectively (Okada et al., 
2010, Feller et al., 1999, Quezada et al., 2011). In the past, several approaches have been 
performed to decrease the sensitivity toward L-lysine: Based on crystal structure information 
single amino acids were identified as being essential for competitive inhibition of 
2-oxoglutarate binding by L-lysine. The exchange of those amino acids in T. thermophilus, 
S. cerevisiae and Schizosaccharomyces pombe HCS genes has been described to dramatically 
decrease the sensitivity toward L-lysine. In case of T. thermophilus the L-lysine insensitive 
variant showed comparable activity like the wild-type enzyme, whereas activity of the 
enzyme of S. pombe was strongly reduced (Okada et al., 2010, Bulfer et al., 2010). For the 
Lys20 of S. cerevisiae an impact of amino acids exchanges on activity was not directly tested, 
but a positive effect of the mutein (Lys20R276K) was shown by an increased intracellular 
concentration of L-lysine (Feller et al., 1999). Since the intracellular concentration of L-lysine 
at the mid-exponential phase of C. glutamicum was determined to be approximately 5 mM 
(Binder et al., 2012), a possible inhibition of Lys20 and Ttc1550 could result in a bottleneck 
for homocitrate production. Thus, the L-lysine-insensitive variant Lys20R276K, which was 
described to tolerate L-lysine concentrations up to 100 mM (Feller et al., 1999), was tested in 
C. glutamicum. Determination of HCS enzyme activities of Lys20 and Lys20R276K expressed 
in C. glutamicum (Tab. 11) revealed similar values for both compared to those measured for 
the native Lys20 (10 mU (mg protein)-1) in the mid-exponential phase of S. cerevisiae 
(Quezada et al., 2011). Further, the decreased enzyme activity in the presence of L-lysine of 
both, the native Lys20 variant and the Lys20R276K mutein confirms the inhibitory effect of 
L-lysine towards the native HCS (Feller et al., 1999). These results demonstrate that the 
mutation R276K did not decrease the sensitivity of S. cerevisiae HCS towards L-lysine. 
However, it is likely that the low homocitrate product titer was caused by L-lysine-mediated 
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HCS inhibition. To circumvent this “bottleneck” other L-lysine insensitive HCS variants (of 
S. pombe or T. thermophilus) could be tested.  
Similar to the results obtained for the homocitrate producer strains, 2-oxoadipate 
accumulation of the plasmid-free producer strain MS-5 was slightly enhanced (3.5 mM, 
0.018 mol C2-OA/ mol Cglucose) compared to the plasmid-based producer strains C. glutamicum/ 
pEKEx2-lys20/pVWEx2-lys4-lys12 and C. glutamicum/pEKEx2-ttc1550/pVWEx2-lys4-lys12 
which accumulated about 2 mM (0.013 mol C2-OA/ mol Cglucose).  
Accumulation of homocitrate by the plasmid-based 2-oxoadipate producer strains indicates 
a limitation of homoaconitase or homoisocitrate dehydrogenase enzyme activity. Very 
recently it was described that the homoaconitase Lys4 of S. cerevisiae, which were used in 
this work for the conversion of homocitrate to homoisocitrate, only catalyses the hydration of 
homoaconitate to homoisocitrate, but does not dehydrate homocitrate to homoaconitate. In 
case of S. cerevisiae aconitase Aco2p is not active on the citrate cycle intermediates, but 
specifically contributes to the dehydration of homocitrate to cis-homoaconitate (Fazius et al., 
2012). Since 2-oxoadipate production in C. glutamicum was proven by HPLC- and GC-ToF 
measurements it is suggested that the aconitase of C. glutamicum can also catalyse to some 
extent the formation of cis-homoaconitate from homocitrate. This has to be analysed and 
tested by in vitro enzyme assays and overexpression of acn in a 2-oxoadipate producer. 
Therefore, the dehydration of homocitrate is most likely a limiting factor for 2-oxoadipate 
production in the C. glutamicum strains constructed for 2-oxoadipate production. To 
overcome this, Aco2p from S. cerevisiae or other homoaconitase enzymes, e.g. of 
Methanocaldococcus jannaschii or of pig heart, should be tested. The enzyme of pig heart is 
described to complete the reaction of homocitrate to homoisocitrate by catalysing the 
dehydration of homocitrate to cis-homoaconitate (Jia et al., 2006). Only recently, the 
homoaconitase of M. jannaschii was the first one which has been characterised in detail and 
which can catalyse both reactions from homocitrate to homoisocitrate (Jeyakanthan et al., 
2010). In comparison, homoisocitrate dehydrogenase of S. cerevisiae and also of 
T. thermophilus are very well characterised (Yamamoto et al., 2007, Miyazaki et al., 2003). 
However, to test whether homoaconitase or homoisocitrate dehydrogenase is a bottleneck in 
the production process of 2-oxoadipate, enzyme activities have to be determined, which is 
hampered by the fact that the substrates homoaconitate and homoisocitrate are not easily 
available. 
Besides the selected strategy, conversion (degradation) of the end product of the AAA 
pathway, i.e. L-lysine, to 2-oxoadipate would provide a further opportunity for the production 
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of the adipate precursor. Therefore, the establishment of four enzymes, namely saccharopine 
dehydrogenase, saccharopine reductase, α-aminoadipate reductase and α-aminoadipate 
aminotransferase would be required (Xu et al., 2006).  
 
 
5.3  Improvement of production titers 
On the assumption that a major portion of the glucose is consumed for biomass production, 
resulting in low availability of acetyl-CoA and 2-oxoglutarate for homocitrate and 
2-oxoadipate production, modified cultivation conditions were tested. Recently, it has been 
shown that nitrogen limitation (59.6 mM) was beneficial for succinate production with 
C. glutamicum by redirecting the carbon used for biomass formation to product formation 
(Litsanov et al., 2012a). Compared to nitrogen excess conditions (892 mM N), production of 
homocitrate and 2-oxoadipate was 3-fold and 2.5-4 fold increased under N-limiting 
conditions, respectively, using the plasmid-based strains (Tab. 14, Fig. 19). The highest 
2-oxoadipate titer under nitrogen limitation was reached with the strain 
C. glutamicum/pEKEx2-ttc1550/pVWEx2-lys4-lys12, expressing the HCS gene of 
T. thermophilus. This indicates that chromosomal integration of ttc1550 (instead of lys20 of S. 
cerevisiae) could be tested for increased production. Surprisingly, a decreased product yield 
of homocitrate and 2-oxoadipate was observed under nitrogen limitation with the strains 
MS-1 and MS-5-pHCS harbouring the chromosomal integrations (section 4.7). It was reported 
that C. glutamicum strains lacking the gdh gene or cultivated under nitrogen limitation 
showed a somehow deregulated nitrogen response (Tesch et al., 1998, Müller et al., 2006). A 
gdh-defective strain has not been characterised under nitrogen limiting conditions, but the 
observed effects of lowered production titers indicate that the reported deregulated nitrogen 
response might cause a down-regulation of the “gdh”-locus at transcriptional level. To prove 
this assumption a gdh-defective strain has to be characterised under nitrogen limitation 
towards the nitrogen response. A further approach would be the analysis of the transcriptional 
level of the HCS gene under nitrogen surplus and limitation.  
Cultivation under “fed-batch” conditions with addition of extra carbon sources (glucose, 
acetate, glucose + acetate, glucose + 2-oxoglutarate) at the beginning of the stationary growth 
phase revealed strongly increased production titers of homocitrate and 2-oxoadipate. The 
highest yield was achieved by adding a combination of glucose and acetate, which resulted in 
a 7-fold increase up to 27 mM homocitrate (0.05 mol CHC/ mol Cglucose+acetate, Fig. 19). These 
results suggest that the production process is indeed limited by precursor supply. Most likely 
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acetyl-CoA is limiting, since additional glucose + 2-oxoglutarate did not further stimulate 
homocitrate accumulation compared to additional glucose alone.  
Interestingly, the increased titers obtained in shake flasks were not reached in bioreactor 
cultivations under controlled conditions (Fig. 17). Here, 2-oxoadipate accumulation was about 
80% decreased from 27 mM to 6 mM, independent of the applied feeding strategy. In 
comparison to shake flask experiments, cultivation in the bioreactor provides optimal 
controllable growth conditions. The conditions in shake flasks in which the cells have to cope 
with oxygen limitation seem to be more favourable for homocitrate/2-oxoadipate production 
than oxygen excess conditions in the bioreactor. This indicates that oxygen availability could 
be a crucial parameter for the production of homocitrate and 2-oxoadipate. It has been 
demonstrated that C. glutamicum wild type produces high amounts of organic acids, 
especially lactate, succinate and acetate, under oxygen deprivation (Inui et al., 2004, Okino et 
al., 2005). In the past years, C. glutamicum was also engineered to produce isobutanol, xylitol 
or D-alanine under oxygen deprivation (Blombach et al., 2011, Sasaki et al., 2010, Jojima et 
al., 2010). D-alanine production from pyruvate for example was engineered by deletion of 
ldhA and ppc genes to prevent formation of organic acids and by overexpressing a 
heterologous alanine dehydrogenase (Jojima et al., 2010). Further it was shown, that 
bioreactor cultivation of C. glutamicum with reduced oxygen content led to enhanced 
production of itaconate, whereas oxygen excess diminished the production (Otten, 2013). 
Thus, bioreactor cultivation under reduced oxygen availability to prevent loss of carbon for 
biomass formation but maintain the carbon flux via the citrate cycle could also be a promising 
strategy to enhance homocitrate and 2-oxoadipate production in the future.  
The second strategy to enhance production titers was metabolic engineering of the central 
carbon metabolism of the production strains. Cultivation under standard conditions revealed 
that only the combination of all three modifications (deletion of pta-ackA, chromosomally-
expressed pycP458S, and plasmid-based overexpression of lys20) introduced in strain MS-3-
pHCS led to enhanced homocitrate accumulation. In contrast, under conditions of additional 
carbon supply (222 mM glucose + 204 mM acetate) all tested strains (MS-1-pHCS, MS-2, 
MS-3, MS-3-pHCS, MS-4) obtained a higher product yield (Fig. 19), demonstrating that 
homocitrate production was significantly affected by the genetic modifications only under this 
condition. Compared to MS-2 harbouring a plasmid-based copy of pycP458S, the 
chromosomally integrated pycP458S of MS-3 led to a higher accumulation of homocitrate 
suggesting an improved availability of acetyl-CoA or underlining general advantages of 
plasmid-free strains. In consequence of the deletion of acetate forming genes pta and ackA, 
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C. glutamicum is unable to grow on acetate as sole carbon source (Reinscheid et al., 1999). 
Nevertheless, acetyl CoA:CoA transferase, encoded by catA, also catalyses CoA transfer to 
activate acetate to acetyl-CoA (Yasuda et al., 2007, Veit et al., 2009). The highest 
homocitrate production of up to 52 mM was achieved by using the strain MS-3-pHCS. This 
result corresponds to a yield of 0.21 mol CHC/ mol Cglucose+acetate, representing 32% of the 
theoretical yield (Fig. 19). 
 
Fig. 19: Overview about homocitrate and 2-oxoadipate production by the C. glutamicum strains 
constructed in this study. Values represent the highest concentration (mM) and the highest yield (molproduct/ 
molcarbon source) of homocitrate or 2-oxoadipate produced by the respective strain cultivated in CGXII minimal 
medium with 222 mM glucose as sole carbon source under standard conditions (red values), under nitrogen 
limitation (59.6 mM N, green values), and under “fed-batch” condition with addition of 222 mM glucose and 
204 mM acetate at the beginning of the stationary growth phase (blue values). 
2-Oxoadipate production was also improved by the addition of glucose and acetate. The 
parental strain MS-5 accumulated up to 20 mM, whereas the advanced strain MS-5-pHCS 
produced up to 27 mM, corresponding to yields of 0.065 mol C2-OA/mol Cglucose+acetate and 
0.13 mol C2-OA/mol Cglucose+acetate, respectively. In summary, the most promising 2-oxoadipate 
producer MS-5-pHCS achieved 20% of the maximal theoretical yield. Further, the by-product 
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accumulation of homocitrate showed that homocitrate was not fully converted to 2-oxoadipate 
under these conditions (Tab. 15). As mentioned above the aconitase/homoaconitase activity 
specific for the dehydration of homocitrate to form cis-homoaconitate is very likely the major 
limiting factor for 2-oxoadipate production. Therefore, additional expression von Aco2p from 
yeast or replacement of the homoaconitase by an enzyme variant catalysing both reactions 
from homocitrate to homoisocitrate should be beneficial for efficient conversion of 
homocitrate to 2-oxoadipate. 
In addition, by-product accumulation of 2-hydroxyglutarate and 2-hydroxyadipate in the 
supernatant of the 2-oxoadipate producer strains was verified by GC-ToF-MS measurements. 
In contrast to 2-hydroxyglutarate, formation of 2-hydroxyadipate is beneficial for the desired 
biosynthetic pathway towards adipate (Fig. 3), since conversion of 2-oxoadipate to 
2-hydroxyadipate represents the subsequent step in the pathway. In other organisms 
2-hydroxyglutarate dehydrogenase, which is involved in the butanoate metabolism, is 
described to convert 2-oxoglutarate to 2-hydroxyglutarate. Furthermore, it has been shown 
that the enzymes phosphoglycerate dehydrogenase and hydroxyacid-oxoacid 
transhydrogenase catalyse the reduction of the C5 compound 
(http://www.genome.jp/kegg/kegg2.html). Enzyme activity for the reduction of 2-oxoadipate 
to 2-hydroxyadipate was found in the human placenta and in the heart muscle of rats, however 
the reductase has not been identified yet (Suda et al., 1976, Suda et al., 1977). In the case of 
isocitrate dehydrogenase, it has been demonstrated for the enzyme in human brain cancer 
cells that a single amino acid exchange in the protein sequence leads to loss of the natural 
decarboxylation activity. This cancer-associated mutation results in a completely new ability 
of dehydrogenase activity, catalysing the reduction of 2-oxoglutarate to 2-hydroxyglutarate 
(Dang et al., 2009). Recently, Reitman and co-workers transferred the enzyme redesign, by 
homology comparisons, to the homoisocitrate dehydrogenase of S. cerevisiae. According to 
the cancer-derived mutations in the isocitrate dehydrogenase, the redesigned HICDH 
catalyses specifically the NADH-dependent reduction of 2-oxoadipate to 2-hydroxyadipate 
(Reitman et al., 2012). Since 2-hydroxyglutarate and 2-hydroxyadipate were not present in the 
wild-type control and no enzyme activity in C. glutamicum is described to catalyse the 
formation of 2-hydroxyglutarate or 2-hydroxyadipate, sequencing of isocitrate dehydrogenase 
(of C. glutamicum) and homoisocitrate dehydrogenase (of S. cerevisiae) of the production 
strains is an option to analyse whether spontaneous mutations within these sequences 
emerged. However, the occurrence of side-activities of enzymes, catalysing the reactions 
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mentioned above, seems to be more likely and should be tested in a NADH- or NADPH-
dependent enzyme assay. 
In conclusion, it has been shown that the production process of homocitrate and 
2-oxoadipate is limited by various bottlenecks at different stages: i) the production process is 
coupled to the metabolic status of growth-limited cells; ii) the enhanced 2-oxoglutarate/ 
2-hydroxyglutarate accumulation of the second generation homocitrate producers reveals a 
limitation of either HCS activity or of acetyl-CoA supply; iii) homocitrate accumulation 
during 2-oxoadipate production indicated limitation by homoaconitase and/or homoisocitrate 
dehydrogenase. 
To improve the production of 2-oxoadipate the discussed obstacles have to be addressed in 
further strain development. Also, the influence of oxygen availability should be tested. In 
addition, further metabolic engineering could improve the production: Additional gene copies 
coding for all three enzymes (HCS, HA, HICDH) should be chromosomally integrated. For 
this purpose the application of alternative enzymes (especially for the homoaconitase) of other 
organisms, for example of S. pombe, T. thermophilus or M. jannaschii can be tested. Besides 
different copy numbers, codon-optimised genes can be used to increase the protein level. 
Another option is to improve the protein translation efficiency by modulating the strength of 
the ribosomal binding site (Peralta-Yahya et al., 2012). Additionally, the assembly of the 
relevant enzymes to a synthetic protein scaffold could help to improve the efficiency of 
multistep reactions. It was shown, that this strategy resulted in 77-fold improved mevalonate 
production, an intermediate in the biosynthesis of the antimalarial drug artemisinin (Dueber et 
al., 2009). Furthermore, the metabolism has to be engineered toward an improved acetyl-CoA 
supply. This could be realised by overexpression of an acetyl-CoA synthetase (ACS) of 
Bacillus subtilis, which converts acetate via acetyl-AMP to acetyl-CoA. It was shown that 
overexpression of this enzyme led to an increased intracellular acetyl-CoA level in a 
C. glutamicum strain engineered for the aerobic succinate production (Zhu et al., 2013). 
Moreover, promoter exchange in front of the gltA transcript in C. glutamicum for attenuated 
expression down to 10% residual citrate synthase activity, led to an increase of acetyl-CoA 
without affecting flux to citrate and consequently to 2-oxoglutarate (van Ooyen et al., 2012). 
A further approach to improve the precursor supply could be to enhance the anaplerotic 
reactions by overexpression of the phosphoenolpyruvate carboxylase, which was shown to 
have the strongest effect on aerobic succinate production in C. glutamicum (Litsanov et al., 
2012a). Furthermore, several approaches have demonstrated that the efflux of the desired 
metabolite of the cell is a crucial challenge for an efficient production process. For example, 
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the amino acid exporter LysE was identified to be required for efficient L-lysine production 
(Bellmann et al., 2001, Vrljic et al., 1996). Similarly, the membrane protein SucE participates 
in the export of the dicarboxylic acid succinate (Huhn et al., 2011). In case of homocitrate and 
2-oxoadipate, the export is not characterised so far, but could be tested by determination of 
intracellular and extracellular concentrations using deletion mutants of candidate transporters. 
If export limitation is obvious, subsequent overexpression of the relevant exporter system 
seems to be a promising strategy to further enhance product formation.   
 
5.4  On the route toward adipate 
In the past years several approaches were performed using the organisms P. putida and 
E. coli to produce the adipate precursor cis, cis-muconate resulting in titers of up to 18.5 g l-1 
with 96% molar product yield and 36.8 g l-1 with 22% molar product yield, respectively (van 
Duuren et al., 2012, Niu et al., 2002). Very recently, formation of cis, cis-muconate has also 
been demonstrated with S. cerevisiae (Curran et al., 2013). However, since the resulting 
maximal titer of up to 0.2 g l-1 was very low, it was discussed that metabolic engineering of 
S. cerevisiae for cis, cis-muconate production seems to be much more difficult than with 
E. coli as the metabolic network in yeast is more rigid against modifications (Curran et al., 
2013). The precursor cis, cis-muconate has to be purified sufficiently from the cultivation 
broth and can be reduced in a hydrogenation process using platinum on carbon as catalyst to 
form adipate (Niu et al., 2002). However, hitherto no enzyme was found or described 
catalysing the reduction of cis, cis-muconate to adipate directly in the cell.  
Besides the approaches of engineering organisms for the production of cis, cis-muconate, 
the pathway to adipate via 2-oxoadipate as illustrated here, provides a new biosynthetic 
alternative toward the biotechnological production of adipate directly in the cell. In this work 
C. glutamicum was tested and engineered for the production of the adipate precursors 
homocitrate and 2-oxoadipate for the first time. The feasibility to produce homocitrate and 
2-oxoadipate with C. glutamicum was demonstrated by plasmid-based implementation as well 
as by chromosomal integration of the genes coding for enzymes of the α-aminoadipate 
pathway. The most promising strain MS-5-pHCS produced up to 4.4 g l-1 2-oxoadipate with a 
product yield of 20% in shake flasks. Furthermore, 3.2 g l-1 of the intermediate homocitrate 
was accumulated.  
The establishment of the aspired biosynthetic route from 2-oxoadipate to adipate requires 
five further enzymatic reactions via the intermediates, 2-hydroxyadipate and 2-hexendioate 
(Fig. 3). Since 2-hydroxyadipate has been identified in this work, an enzyme activity 
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catalysing this reaction appears to be already present in C. glutamicum and the enzyme has to 
be identified. To establish the first biosynthetic pathway by reduction of 2-oxoadipate to 
adipate, a feasible strategy seems to be evolving enzymes of the reductive citrate cycle, 
catalysing naturally the reduction of oxaloacetate to succinate via malate and fumarate. As 
described by Buckel and co-workers the direct dehydration of 2-hydroxyadipate to 
2-hexendioate is chemically not feasible and therefore CoA-activated intermediates has to be 
considered (Parthasarathy et al., 2011). Also, no enzyme activity for the final oxidation of 
2-hexendioate to adipate has been described. The development of an enzyme activity 
catalysing this step remains an open question to finalise the pathway for bio-based production 
of adipate via α-reduction of the AAA pathway intermediate 2-oxoadipate. 
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7.1  Sequences of used enzymes 
 
Homocitrate synthase of Thermus thermophilus 
 
>ttc1550, gene sequence 
ATGCGGGAGTGGAAGATTATTGACTCCACCTTACGGGAAGGGGAACAGTTTGAAAAGGCGAACTTCTCCACCCAG
GACAAGGTGGAGATCGCCAAGGCCCTGGACGAGTTCGGCATTGAGTACATTGAGGTCACCACCCCGGTGGCCTCC
CCCCAGTCCCGCAAGGACGCCGAGGTCCTCGCCTCCTTGGGCCTCAAGGCCAAGGTGGTGACCCACATCCAGTGC
CGCCTGGACGCGGCCAAGGTGGCGGTGGAGACGGGAGTCCAGGGGATTGACCTCCTCTTCGGCACGAGCAAGTAC 
CTCCGGGCGCCCCATGGGCGTGACATCCCCAGGATCATTGAGGAGGCCAAAGAGGTGATCGCCTACATCCGCGAG
GCGGCCCCCCACGTGGAGGTGCGCTTCTCCGCCGAGGACACCTTCCGCTCCGAGGAGCAGGACCTCCTCGCCGTC
TACGAGGCCGTCGCCCCCTACGTGGACCGGGTGGGACTGGCGGACACCGTGGGCGTGGCCACGCCCCGGCAGGTC
TACGCCCTGGTGCGGGAGGTGCGGCGGGTGGTGGGGCCCAGGGTGGACATTGAGTTCCACGGCCACAACGACACC 
GGGTGCGCCATCGCCAACGCGTATGAGGCCATTGAGGCCGGGGCCACCCACGTGGACACCACCATCCTGGGGATC
GGGGAGAGGAACGGGATCACGCCTTTGGGGGGGTTCCTCGCCCGCATGTACACCCTCCAGCCCGAGTACGTGCGC
AGGAAGTACAAGCTGGAGATGCTCCCCGAGCTGGACCGGATGGTGGCCCGGATGGTGGGGGTGGAGATCCCCTTC
AACAACTACATCACCGGGGAGACGGCCTTCAGCCACAAGGCGGGGATGCACCTCAAGGCCATCTACATCAACCCC 
GAGGCCTACGAGCCCTACCCCCCGGAGGTCTTCGGGGTGAAGCGGAAGCTCATCATCGCCTCGAGGCTCACCGGG
CGGCACGCCATCAAGGCGCGGGCGGAGGAGCTCGGCCTCCACTACGGGGAGGAGGAGCTCCACCGGGTCACCCAG
CACATCAAGGCCCTGGCCGACCGGGGCCAGCTCACCCTGGAGGAGCTGGACCGGATCCTCCGGGAGTGGATCACG
GCGTGA 
 
>Ttc1550, translated protein sequence 
MREWKIIDSTLREGEQFEKANFSTQDKVEIAKALDEFGIEYIEVTTPVASPQSRKDAEVLASLGLKAKVVTHIQC
RLDAAKVAVETGVQGIDLLFGTSKYLRAAHGRDIPRIIEEAKEVIAYIREAAPHVEVRFSAEDTFRSEEQDLLAV
YEAVAPYVDRVGLADTVGVATPRQVYALVREVRRVVGPRVDIEFHGHNDTGCAIANAYEAIEAGATHVDTTILGI
GERNGITPLGGFLARMYTLQPEYVRRKYKLEMLPELDRMVARMVGVEIPFNNYITGETAFSHKAGMHLKAIYINP 
EAYEPYPPEVFGVKRKLIIASRLTGRHAIKARAEELGLHYGEEELHRVTQHIKALADRGQLTLEELDRILREWIT
A 
 
Homocitrate synthase of Saccharomyces cerevisiae 
>lys20, gene sequence 
ATGACTGCTGCTAAACCAAATCCATATGCTGCCAAACCGGGCGACTATCTTTCTAATGTAAATAATTTCCAGTTA
ATCGATTCGACGCTGAGAGAAGGTGAACAATTTGCCAACGCATTCTTCGATACTGAAAAAAAGATCGAAATTGCT
AGAGCCTTGGACGATTTCGGTGTGGACTACATCGAGTTAACCTCACCAGTAGCATCTGAACAATCAAGAAAGGAC
TGTGAAGCTATATGTAAACTAGGTTTAAAGGCCAAGATCCTTACACACATTCGTTGTCATATGGATGACGCCAAA 
GTCGCCGTAGAGACTGGTGTCGACGGTGTCGATGTCGTTATCGGCACCTCCAAATTTTTAAGACAATATTCCCAC
GGTAAGGATATGAACTACATCGCCAAGAGTGCTGTTGAAGTCATTGAATTTGTCAAATCCAAAGGTATTGAAATC
AGATTTTCCTCTGAAGATTCCTTCAGAAGTGATCTCGTTGATCTTTTGAACATTTATAAAACCGTTGACAAGATC
GGTGTAAATAGAGTCGGTATTGCCGACACAGTTGGATGTGCCAACCCAAGACAAGTATATGAACTGATCAGAACT 
TTGAAGAGTGTTGTTTCATGTGACATCGAATGCCATTTCCACAACGATACTGGTTGTGCCATTGCAAACGCCTAC
ACTGCTTTGGAAGGTGGTGCCAGATTGATTGACGTCAGTGTACTGGGTATTGGTGAAAGAAACGGTATCACTCCT
CTAGGTGGGCTCATGGCAAGAATGATTGTTGCCGCACCAGACTATGTCAAGTCCAAATACAAGTTGCACAAGATC
AGAGACATTGAAAACCTGGTCGCTGATGCTGTGGAAGTTAACATTCCATTCAACAACCCTATCACCGGGTTCTGT 
GCATTCACACATAAAGCAGGTATCCATGCCAAGGCCATTTTGGCTAACCCATCTACCTACGAAATCTTGGACCCT
CACGATTTCGGTATGAAGAGGTATATCCACTTCGCCAACAGACTAACTGGCTGGAACGCCATCAAAGCCAGAGTC
GACCAGTTGAACTTGAACTTGACGGATGACCAAATCAAGGAAGTTACTGCTAAGATTAAGAAGCTGGGTGATGTC
AGATCGCTGAATATCGATGATGTTGACTCTATCATCAAGAACTTCCACGCAGAGGTCAGCACTCCTCAAGTACTA 
TCTGCAAAAAAGAACAAGAAGAATGACAGCGATGTACCGGAACTGGCCACCATCCCCGCCGCCAAGCGGACTAAG
CCATCCGCCTAA 
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>Lys20, translated protein sequence 
MTAAKPNPYAAKPGDYLSNVNNFQLIDSTLREGEQFANAFFDTEKKIEIARALDDFGVDYIELTSPVASEQSRKD
CEAICKLGLKAKILTHIRCHMDDAKVAVETGVDGVDVVIGTSKFLRQYSHGKDMNYIAKSAVEVIEFVKSKGIEI
RFSSEDSFRSDLVDLLNIYKTVDKIGVNRVGIADTVGCANPRQVYELIRTLKSVVSCDIECHFHNDTGCAIANAY
TALEGGARLIDVSVLGIGERNGITPLGGLMARMIVAAPDYVKSKYKLHKIRDIENLVADAVEVNIPFNNPITGFC 
AFTHKAGIHAKAILANPSTYEILDPHDFGMKRYIHFANRLTGWNAIKARVDQLNLNLTDDQIKEVTAKIKKLGDV
RSLNIDDVDSIIKNFHAEVSTPQVLSAKKNKKNDSDVPELATIPAAKRTKPSA 
 
 
L-lysine-insensitive homocitrate synthase from Saccharomyces cerevisiae 
>lys20R276K, gene sequence 
ATGACTGCTGCTAAACCAAATCCATATGCTGCCAAACCGGGCGACTATCTTTCTAATGTAAATAATTTCCAGTTA
ATCGATTCGACGCTGAGAGAAGGTGAACAATTTGCCAACGCATTCTTCGATACTGAAAAAAAGATCGAAATTGCT
AGAGCCTTGGACGATTTCGGTGTGGACTACATCGAGTTAACCTCACCAGTAGCATCTGAACAATCAAGAAAGGAC
TGTGAAGCTATATGTAAACTAGGTTTAAAGGCCAAGATCCTTACACACATTCGTTGTCATATGGATGACGCCAAA 
GTCGCCGTAGAGACTGGTGTCGACGGTGTCGATGTCGTTATCGGCACCTCCAAATTTTTAAGACAATATTCCCAC
GGTAAGGATATGAACTACATCGCCAAGAGTGCTGTTGAAGTCATTGAATTTGTCAAATCCAAAGGTATTGAAATC
AGATTTTCCTCTGAAGATTCCTTCAGAAGTGATCTCGTTGATCTTTTGAACATTTATAAAACCGTTGACAAGATC
GGTGTAAATAGAGTCGGTATTGCCGACACAGTTGGATGTGCCAACCCAAGACAAGTATATGAACTGATCAGAACT 
TTGAAGAGTGTTGTTTCATGTGACATCGAATGCCATTTCCACAACGATACTGGTTGTGCCATTGCAAACGCCTAC
ACTGCTTTGGAAGGTGGTGCCAGATTGATTGACGTCAGTGTACTGGGTATTGGTGAAAGAAACGGTATCACTCCT
CTAGGTGGGCTCATGGCAAGAATGATTGTTGCCGCACCAGACTATGTCAAGTCCAAATACAAGTTGCACAAGATC
AAAGACATTGAAAACCTGGTCGCTGATGCTGTGGAAGTTAACATTCCATTCAACAACCCTATCACCGGGTTCTGT 
GCATTCACACATAAAGCAGGTATCCATGCCAAGGCCATTTTGGCTAACCCATCTACCTACGAAATCTTGGACCCT
CACGATTTCGGTATGAAGAGGTATATCCACTTCGCCAACAGACTAACTGGCTGGAACGCCATCAAAGCCAGAGTC
GACCAGTTGAACTTGAACTTGACGGATGACCAAATCAAGGAAGTTACTGCTAAGATTAAGAAGCTGGGTGATGTC
AGATCGCTGAATATCGATGATGTTGACTCTATCATCAAGAACTTCCACGCAGAGGTCAGCACTCCTCAAGTACTA 
TCTGCAAAAAAGAACAAGAAGAATGACAGCGATGTACCGGAACTGGCCACCATCCCCGCCGCCAAGCGGACTAAG
CCATCCGCCTAA 
 
>Lys20R276K, translated protein sequence 
MTAAKPNPYAAKPGDYLSNVNNFQLIDSTLREGEQFANAFFDTEKKIEIARALDDFGVDYIELTSPVASEQSRKD
CEAICKLGLKAKILTHIRCHMDDAKVAVETGVDGVDVVIGTSKFLRQYSHGKDMNYIAKSAVEVIEFVKSKGIEI
RFSSEDSFRSDLVDLLNIYKTVDKIGVNRVGIADTVGCANPRQVYELIRTLKSVVSCDIECHFHNDTGCAIANAY
TALEGGARLIDVSVLGIGERNGITPLGGLMARMIVAAPDYVKSKYKLHKIKDIENLVADAVEVNIPFNNPITGFC 
AFTHKAGIHAKAILANPSTYEILDPHDFGMKRYIHFANRLTGWNAIKARVDQLNLNLTDDQIKEVTAKIKKLGDV
RSLNIDDVDSIIKNFHAEVSTPQVLSAKKNKKNDSDVPELATIPAAKRTKPSA 
 
Homocitrate synthase of Azotobacter vinelandii 
 
>nifV, gene sequence 
ATGGCTAGCGTGATCATCGACGACACTACCCTGCGTGACGGTGAACAGAGTGCCGGGGTCGCCTTCAATGCCGAC
GAGAAGATCGCTATCGCCCGCGCGCTCGCCGAACTGGGCGTGCCGGAGTTGGAGATCGGCATTCCCAGCATGGGC
GAGGAAGAGCGCGAGGTGATGCACGCCATCGCCGGTCTCGGCCTGTCGTCTCGCCTGCTGGCCTGGTGCCGGCTA
TGCGACGTCGATCTCGCGGCGGCGCGCTCCACCGGGGTGACCATGGTCGACCTTTCGCTGCCGGTCTCCGACCTG 
ATGCTGCACCACAAGCTCAATCGCGATCGCGACTGGGCCTTGCGCGAAGTGGCCAGGCTGGTCGGCGAAGCGCGC
ATGGCCGGGCTCGAGGTGTGCCTGGGCTGCGAGGACGCCTCGCGGGCGGATCTGGAGTTCGTCGTGCAGGTGGGC
GAAGTGGCGCAGGCCGCCGGCGCCCGTCGGCTGCGCTTCGCCGACACCGTCGGGGTCATGGAGCCCTTCGGCATG
CTCGACCGCTTCCGTTTCCTCAGCCGGCGCCTGGACATGGAGCTGGAAGTGCACGCCCACGATGATTTCGGGCTG
GCCACGGCCAACACCCTGGCCGCGGTGATGGGCGGGGCGACTCATATCAACACCACGGTCAACGGGCTCGGCGAG
CGTGCCGGCAACGCCGCGCTGGAAGAGTGCGTGCTGGCGCTCAAGAACCTCCACGGTATCGACACCGGTATCGAT
ACCCGCGGCATCCCGGCCATCTCCGCGCTGGTCGAGCGGGCCTCGGGGCGCCAGGTGGCCTGGCAGAAGAGCGTG
GTCGGCGCCGGGGTGTTCACTCACGAGGCCGGTATCCACGTCGACGGACTGCTCAAGCATCGGCGCAACTACGAG 
GGGCTGAATCCCGACGAACTCGGTCGCAGCCACAGTCTGGTGCTGGGCAAGCATTCCGGGGCGCACATGGTGCGC
AACACGTACCGCGATCTGGGTATCGAGCTGGCGGACTGGCAGAGCCAAGCGCTGCTCGGCCGCATCCGTGCCTTC
TCCACCAGGACCAAGCGCCGCAGCCCGCAGCCTGCCGAGCTGCAGGATTTCTATCGGCAGTTGTGCGAGCAAGGC
AATCCCGAACTGGCCGCAGGAGGAATGGCATGA 
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>NifV, translated protein sequence 
MASVIIDDTTLRDGEQSAGVAFNADEKIAIARALAELGVPELEIGIPSMGEEEREVMHAIAGLGLSSRLLAWCRL
CDVDLAAARSTGVTMVDLSLPVSDLMLHHKLNRDRDWALREVARLVGEARMAGLEVCLGCEDASRADLEFVVQVG
EVAQAAGARRLRFADTVGVMEPFGMLDRFRFLSRRLDMELEVHAHDDFGLATANTLAAVMGGATHINTTVNGLGE
RAGNAALEECVLALKNLHGIDTGIDTRGIPAISALVERASGRQVAWQKSVVGAGVFTHEAGIHVDGLLKHRRNYE 
GLNPDELGRSHSLVLGKHSGAHMVRNTYRDLGIELADWQSQALLGRIRAFSTRTKRRSPQPAELQDFYRQLCEQG
NPELAAGGMA 
 
Homoaconitase of Saccharomyces cerevisiae 
 
>lys4, gene sequence 
ATGCTACGATCAACCACATTTACTCGTTCGTTCCACAGTTCTAGGGCCTGGTTGAAAGGTCAGAACCTAACTGAA
AAAATTGTTCAGTCGTATGCGGTCAACCTTCCCGAGGGTAAAGTTGTGCATTCTGGTGACTATGTATCGATCAAG
CCGGCACACTGTATGTCCCACGATAATTCGTGGCCTGTAGCTTTGAAATTCATGGGGCTTGGCGCTACCAAGATC
AAGAATCCTTCACAGATTGTGACCACTCTGGACCACGATATTCAGAACAAATCAGAGAAAAATTTGACCAAGTAC 
AAGAACATCGAAAATTTTGCTAAGAAACACCATATAGACCACTACCCTGCCGGTAGAGGTATTGGTCATCAAATT
ATGATTGAGGAGGGCTATGCTTTCCCCTTGAACATGACTGTCGCATCTGACTCGCATTCAAACACCTACGGTGGT
CTGGGGTCGCTGGGCACTCCAATAGTGAGAACAGACGCTGCAGCCATATGGGCCACGGGACAGACGTGGTGGCAG
ATCCCACCAGTGGCTCAGGTTGAGTTGAAAGGTCAATTGCCTCAGGGTGTTTCCGGAAAAGATATCATTGTCGCA 
TTATGTGGGCTTTTCAACAATGATCAAGTTCTAAATCACGCCATTGAATTCACGGGTGACTCTTTGAATGCATTG
CCTATCGATCACAGACTCACTATTGCTAACATGACCACCGAGTGGGGGGCTCTTTCTGGTTTGTTCCCCGTGGAC
AAAACTTTGATCGACTGGTATAAAAACCGTTTGCAAAAGCTGGGCACCAATAATCATCCAAGGATTAATCCAAAG
ACTATCCGCGCACTAGAAGAAAAGGCGAAGATTCCGAAAGCAGACAAGGATGCACATTATGCCAAGAAACTGATC 
ATCGATCTAGCCACGCTAACTCACTACGTCTCAGGTCCAAATAGTGTTAAGGTCTCCAACACCGTGCAAGATCTA
TCTCAACAAGACATCAAGATAAATAAAGCTTATCTAGTGTCATGTACAAACTCCCGTCTATCTGATTTGCAATCT
GCAGCGGATGTGGTTTGTCCTACTGGAGACTTAAACAAAGTCAACAAGGTGGCTCCAGGTGTGGAGTTCTATGTC
GCTGCTGCCTCTTCAGAAATTGAGGCTGATGCCCGTAAATCAGGCGCTTGGGAAAAGCTGCTAAAGGCTGGCTGT 
ATCCCACTGCCTTCTGGTTGTGGTCCATGCATCGGTCTAGGTGCGGGATTACTGGAACCAGGTGAAGTTGGTATC
AGTGCCACAAACAGAAACTTCAAAGGTAGAATGGGTTCCAAGGATGCATTGGCTTACTTAGCTTCCCCTGCTGTA
GTCGCCGCTTCTGCCGTGCTGGGTAAGATTAGTTCTCCTGCTGAGGTATTGTCCACAAGCGAAATTCCATTCAGC
GGCGTTAAGACTGAGATAATTGAGAATCCCGTGGTTGAAGAGGAAGTTAACGCTCAAACAGAGGCTCCAAAACAA 
TCCGTTGAGATATTAGAAGGTTTCCCAAGAGAGTTTTCTGGTGAATTAGTTTTATGTGATGCCGATAACATCAAT
ACCGATGGTATATATCCTGGTAAGTACACTTATCAGGATGATGTGCCTAAAGAAAAGATGGCGCAAGTTTGTATG
GAAAATTATGATGCCGAGTTCAGAACCAAGGTTCATCCAGGTGATATAGTGGTCAGTGGGTTCAATTTCGGTACC
GGTTCCTCCAGGGAACAAGCGGCCACCGCCTTATTGGCTAAAGGTATCAACTTAGTTGTTTCAGGATCTTTTGGT 
AATATTTTTTCAAGAAACTCCATTAACAATGCTCTTCTGACCTTGGAAATCCCAGCATTAATCAAAAAATTACGT
GAGAAATATCAAGGTGCTCCAAAAGAACTTACAAGAAGAACTGGTTGGTTTTTGAAATGGGATGTAGCTGATGCT
AAAGTGGTCGTTACCGAAGGTTCTTTGGACGGCCCTGTGATCTTGGAGCAAAAAGTGGGTGAGCTAGGTAAGAAC
CTACAAGAAATTATTGTAAAAGGAGGCTTGGAAGGTTGGGTCAAATCCCAACTATAA 
 
>Lys4, translated protein sequence 
MLRSTTFTRSFHSSRAWLKGQNLTEKIVQSYAVNLPEGKVVHSGDYVSIKPAHCMSHDNSWPVALKFMGLGATKI
KNPSQIVTTLDHDIQNKSEKNLTKYKNIENFAKKHHIDHYPAGRGIGHQIMIEEGYAFPLNMTVASDSHSNTYGG
LGSLGTPIVRTDAAAIWATGQTWWQIPPVAQVELKGQLPQGVSGKDIIVALCGLFNNDQVLNHAIEFTGDSLNAL
PIDHRLTIANMTTEWGALSGLFPVDKTLIDWYKNRLQKLGTNNHPRINPKTIRALEEKAKIPKADKDAHYAKKLI 
IDLATLTHYVSGPNSVKVSNTVQDLSQQDIKINKAYLVSCTNSRLSDLQSAADVVCPTGDLNKVNKVAPGVEFYV
AAASSEIEADARKSGAWEKLLKAGCIPLPSGCGPCIGLGAGLLEPGEVGISATNRNFKGRMGSKDALAYLASPAV
VAASAVLGKISSPAEVLSTSEIPFSGVKTEIIENPVVEEEVNAQTEAPKQSVEILEGFPREFSGELVLCDADNIN
TDGIYPGKYTYQDDVPKEKMAQVCMENYDAEFRTKVHPGDIVVSGFNFGTGSSREQAATALLAKGINLVVSGSFG 
NIFSRNSINNALLTLEIPALIKKLREKYQGAPKELTRRTGWFLKWDVADAKVVVTEGSLDGPVILEQKVGELGKN
LQEIIVKGGLEGWVKSQL 
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Homoisocitrate dehydrogenase of Saccharomyces cerevisiae 
>lys12, gene sequence 
ATGTTTAGATCTGTTGCTACTAGATTATCTGCCTGCCGTGGGTTAGCATCTAACGCTGCTCGCAAATCACTCACT
ATTGGTCTTATCCCCGGTGACGGTATCGGTAAGGAAGTCATTCCTGCTGGTAAGCAAGTTTTGGAAAACCTTAAC
TCCAAGCACGGCCTAAGCTTCAACTTTATTGATCTCTACGCCGGTTTCCAAACATTCCAAGAAACAGGAAAGGCG
TTGCCTGATGAGACTGTTAAAGTGTTGAAGGAACAATGTCAAGGTGCTCTTTTCGGTGCAGTTCAGTCTCCAACT 
ACTAAGGTGGAAGGTTACTCCTCACCAATTGTTGCTCTAAGGAGGGAAATGGGCCTTTTCGCTAATGTTCGTCCT
GTTAAGTCTGTAGAGGGAGAAAAGGGTAAACCAATTGACATGGTTATCGTCAGAGAAAATACTGAGGACCTGTAC
ATTAAAATTGAAAAAACATACATTGACAAGGCCACAGGTACAAGAGTTGCTGATGCCACAAAGAGAATATCCGAA
ATTGCAACAAGAAGAATTGCAACCATTGCATTAGATATTGCCTTGAAAAGATTACAAACAAGAGGCCAAGCCACT 
TTGACAGTGACTCATAAATCAAATGTTCTATCTCAAAGTGATGGTCTATTCAGAGAAATCTGTAAGGAAGTCTAC
GAATCTAACAAGGACAAGTACGGTCAAATCAAATATAACGAACAAATTGTGGATTCCATGGTTTATAGGCTGTTC
AGAGAACCACAATGTTTTGATGTGATAGTGGCACCAAACCTATACGGGGATATATTATCTGACGGTGCTGCTGCT
TTAGTCGGTTCATTAGGTGTTGTTCCAAGCGCCAACGTAGGTCCAGAAATTGTCATTGGTGAACCATGCCATGGT 
TCTGCACCAGATATTGCTGGTAAAGGTATTGCTAACCCAATCGCCACTATAAGATCTACTGCTTTGATGTTGGAA
TTCTTGGGCCACAACGAAGCTGCCCAAGATATCTACAAGGCTGTTGATGCTAACTTAAGAGAGGGTTCTATCAAG
ACACCAGATTTAGGTGGTAAGGCTTCTACTCAACAAGTCGTTGACGACGTTTTGTCGAGATTATAG 
 
 
>Lys12, translated protein sequence 
MFRSVATRLSACRGLASNAARKSLTIGLIPGDGIGKEVIPAGKQVLENLNSKHGLSFNFIDLYAGFQTFQETGKA
LPDETVKVLKEQCQGALFGAVQSPTTKVEGYSSPIVALRREMGLFANVRPVKSVEGEKGKPIDMVIVRENTEDLY
IKIEKTYIDKATGTRVADATKRISEIATRRIATIALDIALKRLQTRGQATLTVTHKSNVLSQSDGLFREICKEVY
ESNKDKYGQIKYNEQIVDSMVYRLFREPQCFDVIVAPNLYGDILSDGAAALVGSLGVVPSANVGPEIVIGEPCHG 
SAPDIAGKGIANPIATIRSTALMLEFLGHNEAAQDIYKAVDANLREGSIKTPDLGGKASTQQVVDDV
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